<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Physiol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Physiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Physiology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-042X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27313535</article-id>
<article-id pub-id-type="pmc">4890531</article-id>
<article-id pub-id-type="doi">10.3389/fphys.2016.00195</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Physiology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Influence of Na<sup>+</sup>, K<sup>+</sup>-ATPase on Glutamate Signaling in Neurodegenerative Diseases and Senescence</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Kinoshita</surname>
<given-names>Paula F.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/212126/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Leite</surname>
<given-names>Jacqueline A.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/348868/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Orellana</surname>
<given-names>Ana Maria M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/313823/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vasconcelos</surname>
<given-names>Andrea R.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/295384/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Quintas</surname>
<given-names>Luis E. M.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/332893/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kawamoto</surname>
<given-names>Elisa M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/51551/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scavone</surname>
<given-names>Cristoforo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/126642/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Pharmacology, Institute of Biomedical Science, University of São Paulo</institution>
<country>São Paulo, Brazil</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Laboratory of Biochemical and Molecular Pharmacology, Institute of Biomedical Sciences, Federal University of Rio de Janeiro</institution>
<country>Rio de Janeiro, Brazil</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Sigrid A. Langhans, Nemours/Alfred I. duPont Hospital for Children, USA</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Habibeh Khoshbouei, Univeristy of Florida, USA; Karin Lykke-Hartmann, Aarhus University, Denmark</p>
</fn>
<corresp id="fn001">*Correspondence: Cristoforo Scavone <email xlink:type="simple">criscavone@usp.br</email>; <email xlink:type="simple">cristoforo.scavone@gmail.com</email></corresp>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Membrane Physiology and Membrane Biophysics, a section of the journal Frontiers in Physiology</p>
</fn>
<fn fn-type="other" id="fn003">
<p>†These authors have contributed equally to this work.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>6</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>7</volume>
<elocation-id>195</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>5</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2016 Kinoshita, Leite, Orellana, Vasconcelos, Quintas, Kawamoto and Scavone.</copyright-statement>
<copyright-year>2016</copyright-year>
<copyright-holder>Kinoshita, Leite, Orellana, Vasconcelos, Quintas, Kawamoto and Scavone</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>Decreased Na<sup>+</sup>, K<sup>+</sup>-ATPase (NKA) activity causes energy deficiency, which is commonly observed in neurodegenerative diseases. The NKA is constituted of three subunits: α, β, and γ, with four distinct isoforms of the catalytic α subunit (α<sub>1−4</sub>). Genetic mutations in the <italic>ATP1A2</italic> gene and <italic>ATP1A3</italic> gene, encoding the α<sub>2</sub> and α<sub>3</sub> subunit isoforms, respectively can cause distinct neurological disorders, concurrent to impaired NKA activity. Within the central nervous system (CNS), the α<sub>2</sub> isoform is expressed mostly in glial cells and the α<sub>3</sub> isoform is neuron-specific. Mutations in <italic>ATP1A2</italic> gene can result in familial hemiplegic migraine (FHM2), while mutations in the <italic>ATP1A3</italic> gene can cause Rapid-onset dystonia-Parkinsonism (RDP) and alternating hemiplegia of childhood (AHC), as well as the cerebellar ataxia, areflexia, pescavus, optic atrophy and sensorineural hearing loss (CAPOS) syndrome. Data indicates that the central glutamatergic system is affected by mutations in the α<sub>2</sub> isoform, however further investigations are required to establish a connection to mutations in the α<sub>3</sub> isoform, especially given the diagnostic confusion and overlap with glutamate transporter disease. The age-related decline in brain α<sub>2∕3</sub> activity may arise from changes in the cyclic guanosine monophosphate (cGMP) and cGMP-dependent protein kinase (PKG) pathway. Glutamate, through nitric oxide synthase (NOS), cGMP and PKG, stimulates brain α<sub>2∕3</sub> activity, with the glutamatergic N-methyl-D-aspartate (NMDA) receptor cascade able to drive an adaptive, neuroprotective response to inflammatory and challenging stimuli, including amyloid-β. Here we review the NKA, both as an ion pump as well as a receptor that interacts with NMDA, including the role of NKA subunits mutations. Failure of the NKA-associated adaptive response mechanisms may render neurons more susceptible to degeneration over the course of aging.</p>
</abstract>
<kwd-group>
<kwd>Na<sup>+</sup></kwd>
<kwd>K<sup>+</sup>-ATPase</kwd>
<kwd>glutamate</kwd>
<kwd>aging</kwd>
<kwd><italic>ATP1A2</italic> and <italic>ATP1A3</italic> mutations</kwd>
<kwd>neurodegenerative diseases</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Fundação de Amparo à Pesquisa do Estado de São Paulo<named-content content-type="fundref-id">10.13039/501100001807</named-content></funding-source>
<award-id rid="cn001">2014/05026-0</award-id>
<award-id rid="cn001">2011/21308-8</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="332"></ref-count>
<page-count count="19"></page-count>
<word-count count="19193"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<sec>
<title>Na<sup>+</sup>, K<sup>+</sup>-ATPase</title>
<p>In 1957, the Danish physician Jens C. Skou discovered the mechanism behind active ion transport in homogenates of leg nerve from shore crabs: a Mg<sup>2+</sup>-dependent ATPase stimulated by Na<sup>+</sup> and K<sup>+</sup>, speculated to be located at the plasma membrane (Skou, <xref ref-type="bibr" rid="B268">1957</xref>). In the same year that Skou published his ATPase work, Robert L. Post and Philip Jolly showed that interdependent active Na<sup>+</sup> efflux and K<sup>+</sup> influx followed an electrogenic stoichiometry of 3:2 (Post and Jolly, <xref ref-type="bibr" rid="B226">1957</xref>), an exchange previously shown to be blocked by the cardiotonic steroid (CTS) isolated from plant species of the genus <italic>Strophanthus</italic>, strophantin, widely known as ouabain (OUA) (Schatzmann, <xref ref-type="bibr" rid="B256">1953</xref>; Schatzmann and Witt, <xref ref-type="bibr" rid="B257">1954</xref>). In 1960, Post and colleagues demonstrated the presence of Na<sup>+</sup>, K<sup>+</sup>-ATPase (NKA) in the plasma membrane of human red blood cells (Post et al., <xref ref-type="bibr" rid="B228">1960</xref>), including its transient phosphorylation by ATP on an aspartyl residue (Post et al., <xref ref-type="bibr" rid="B229">1965</xref>; Post and Kume, <xref ref-type="bibr" rid="B227">1973</xref>). Subsequent work indicated a feed-forward reaction, whereby as Na<sup>+</sup> binds to the enzyme, it stimulates a Mg<sup>2+</sup>-dependent phosphorylation via ATP, while K<sup>+</sup> binding facilitates dephosphorylation, giving a transition of two conformations named E1 and E2, respectively (Post et al., <xref ref-type="bibr" rid="B225">1972</xref>). Later work made it clear that activity of this molecular motor is vital for cell integrity, given its maintenance of the osmotic balance and its powerful role in cell homeostasis, including preserving and contributing to the resting membrane potential, electrolyte constitution of the cerebrospinal fluid (CSF) and influencing the cellular and/or transcellular transport of other ions, energy substrates and neurotransmitters (Blanco and Mercer, <xref ref-type="bibr" rid="B33">1998</xref>; Skou, <xref ref-type="bibr" rid="B269">1998</xref>; Blanco, <xref ref-type="bibr" rid="B31">2005</xref>).</p>
<p>The enzyme is composed of two distinct polypeptides (Kyte, <xref ref-type="bibr" rid="B158">1971</xref>), with equimolar stoichiometry (Craig and Kyte, <xref ref-type="bibr" rid="B64">1980</xref>). The larger one is the α subunit, with an amino acid sequence (&gt;1010 amino acids) that was first deduced from sheep kidney complementary DNA in 1985 by Jerry Lingrel's group (Shull et al., <xref ref-type="bibr" rid="B266">1985</xref>). The α subunit has a mass of 110–112 kDa, with 10 transmembrane domains, mostly with protein resides in the cytoplasm side and with less than 10% exposed to the extracellular milieu (Blanco, <xref ref-type="bibr" rid="B31">2005</xref>). The α subunit is also known as the catalytic or functional subunit, since it contains the binding sites for Na<sup>+</sup> and K<sup>+</sup>, as well as for CTS. The α subunit is subject to transient phosphorylation and breaks down Mg<sup>2+</sup>-ATPase (Kyte, <xref ref-type="bibr" rid="B159">1975</xref>; Blanco, <xref ref-type="bibr" rid="B31">2005</xref>). The smaller β subunit is a type II (one transmembrane domain with intracellular N-terminal) glycoprotein of 302–304 amino acids that noncovalently binds to the α subunit (Shull et al., <xref ref-type="bibr" rid="B266">1985</xref>). Although the α subunit can display independent ATP catalysis (Blanco et al., <xref ref-type="bibr" rid="B32">1994</xref>), it is only when it is associated with the β subunit that normal pumping activity is achieved. The β subunit also influences the NKA kinetic characteristics, assisting the correct assembly and membrane delivery of the enzyme (chaperone function), as well as helping in cell adhesion and cell polarity (Blanco, <xref ref-type="bibr" rid="B31">2005</xref>; Geering, <xref ref-type="bibr" rid="B105">2008</xref>; Cereijido et al., <xref ref-type="bibr" rid="B51">2012</xref>; Vagin et al., <xref ref-type="bibr" rid="B294">2012</xref>). A third partner comprises the αβ protomer (formerly termed the γ subunit) (Forbush et al., <xref ref-type="bibr" rid="B99">1978</xref>). This type I (one transmembrane domain with intracellular C-terminal) protein is small—around 65 amino acids, with a mass of 7 kDa—and belongs to the FXYD family of ion transport regulators. FXYD represents the signature motif found in all 7 members. FXYD2 is the original γ subunit, although all can interact with NKA (Geering, <xref ref-type="bibr" rid="B105">2008</xref>). However, they are not necessary for enzymatic activity, modulating, usually decreasing, pump affinity for cations (Geering, <xref ref-type="bibr" rid="B104">2006</xref>, <xref ref-type="bibr" rid="B105">2008</xref>). The electrophoresis technique has unveiled puzzling pharmacological data that demonstrate differences in the potency and affinity of CTS for NKA, when NKA is derived from different tissues and species (Akera et al., <xref ref-type="bibr" rid="B4">1972</xref>; Tobin and Brody, <xref ref-type="bibr" rid="B288">1972</xref>; De Pover and Godfraind, <xref ref-type="bibr" rid="B76">1976</xref>, <xref ref-type="bibr" rid="B77">1979</xref>; Marks and Seeds, <xref ref-type="bibr" rid="B181">1978</xref>; Noel and Godfraind, <xref ref-type="bibr" rid="B202">1984</xref>). By the end of 1970's, Kathlyn Sweadner demonstrated in brain preparations of several mammalian species that two protein bands of slightly different molecular weights could be clearly defined, with the biochemical characteristics of NKA (Sweadner, <xref ref-type="bibr" rid="B274">1979</xref>). The kidney α subunit co-migrated with the brain lower migrating (lighter) band in gel and was designated α (now α1), with the other brain band, heavier and not present in kidney, designated α(+) (Sweadner and Gilkeson, <xref ref-type="bibr" rid="B276">1985</xref>). A third form was revealed from rat brain cDNA sequence analysis and named αIII (now α3), a major form in the central nervous system (CNS) (Shull et al., <xref ref-type="bibr" rid="B265">1986</xref>; Schneider et al., <xref ref-type="bibr" rid="B258">1988</xref>; Sweadner, <xref ref-type="bibr" rid="B275">1989</xref>). α(+) was indeed a mixture of α2 and α3. Years later, a fourth α isoform was discovered and characterized (Shamraj and Lingrel, <xref ref-type="bibr" rid="B260">1994</xref>; Woo et al., <xref ref-type="bibr" rid="B317">1999</xref>; Blanco et al., <xref ref-type="bibr" rid="B34">2000</xref>). All isoforms are encoded by different genes, have a high degree of sequence homology and are expressed in a cell/tissue-specific manner (Broude et al., <xref ref-type="bibr" rid="B46">1989</xref>; Mobasheri et al., <xref ref-type="bibr" rid="B189">2000</xref>; Blanco, <xref ref-type="bibr" rid="B31">2005</xref>): α1 is expressed in all mammalian tissue, being virtually the only α isoform expressed in the kidney across species; α2 is found in striated and smooth muscles, adipose tissue, nervous tissue and some other tissues; α3 and α4 have a more restricted distribution, with the former being primarily found in nervous tissue, more specifically in neurons, where it may be considered a brain neuronal marker (Dobretsov and Stimers, <xref ref-type="bibr" rid="B86">2005</xref>), and the latter is only expressed in the midpiece of the sperm, where it is important for sperm motility (Sanchez et al., <xref ref-type="bibr" rid="B251">2006</xref>).</p>
</sec>
<sec>
<title>A pump or a receptor: the janus face of an ATPase</title>
<p>NKA has been classically conceptualized as a pump, with its specific inhibition by CTS that increases intracellular Na<sup>+</sup> and Ca<sup>2+</sup> concentrations leading to cell ionic imbalance (Akera and Brody, <xref ref-type="bibr" rid="B3">1977</xref>). This was challenged by a series of elegant studies headed by Zi-Jian Xie and Amir Askari 20 years ago. These researchers observed that OUA induced myocyte hypertrophy by activating proto-oncogenes and late response genes, with effects mediated by the Ras-Raf-ERK1/2-pathway (Peng et al., <xref ref-type="bibr" rid="B214">1996</xref>; Huang L. et al., <xref ref-type="bibr" rid="B122">1997</xref>; Kometiani et al., <xref ref-type="bibr" rid="B154">1998</xref>). This was preceded by EGFR transactivation through the nonreceptor Tyr kinase, Src, steps not dependent on Ca<sup>2+</sup>(Haas et al., <xref ref-type="bibr" rid="B116">2000</xref>). Such signal transducer pump effects arise from activity in restricted areas of the plasma membrane, within a subset of lipid rafts known as caveolae (Liu et al., <xref ref-type="bibr" rid="B171">2003</xref>; Wang et al., <xref ref-type="bibr" rid="B305">2004</xref>; Quintas et al., <xref ref-type="bibr" rid="B232">2010</xref>). NKA (E1 state) can interact with Src at the kinase and SH3 domain with OUA, by arresting the E2 conformation of the ATPase, unleashing the kinase domain of Src, thereby inducing protein-protein signaling (Liang et al., <xref ref-type="bibr" rid="B166">2006</xref>; Tian et al., <xref ref-type="bibr" rid="B287">2006</xref>; Ye et al., <xref ref-type="bibr" rid="B322">2013</xref>). As such, NKA-Src forms a binary receptor that transduces signals after CTS binding.</p>
<p>After the first reports on the novel signaling role of NKA, a number of different intracellular pathways involved in distinct cell fates has been unveiled, confirming NKA as more than an ion pump (Nesher et al., <xref ref-type="bibr" rid="B196">2007</xref>; Cai et al., <xref ref-type="bibr" rid="B49">2008</xref>; Riganti et al., <xref ref-type="bibr" rid="B239">2011</xref>; Arnaud-Batista et al., <xref ref-type="bibr" rid="B13">2012</xref>; Lucas et al., <xref ref-type="bibr" rid="B174">2012</xref>) and helping to clarify how endogenous CTS can produce their effects <italic>in vivo</italic>, even at very low concentrations (Xie and Xie, <xref ref-type="bibr" rid="B318">2005</xref>; Aperia et al., <xref ref-type="bibr" rid="B11">2016</xref>).</p>
</sec>
<sec>
<title>NKA mutations and diseases</title>
<p>Considering the importance of NKA in basic cellular functions, it has been suggested that NKA mutations affecting α1 (<italic>ATP1A1</italic>), α2 (<italic>ATP1A2</italic>), and α3 (<italic>ATP1A3</italic>) genes can contribute to the pathogenesis of several CNS diseases.</p>
<sec>
<title>ATP1A1 mutations</title>
<p>Mutation in the <italic>ATP1A1</italic> gene leads to primary aldosteronism (Azizan et al., <xref ref-type="bibr" rid="B16">2013</xref>), which is the main cause of secondary hypertension. Aldosterone production is elevated and non-suppressible by sodium loading (Duan and Mete, <xref ref-type="bibr" rid="B89">2015</xref>). The mutation causes a decrease in NKA activity and in K<sup>+</sup> affinity, consequently leading to an inappropriate cellular depolarization (Beuschlein et al., <xref ref-type="bibr" rid="B29">2013</xref>). Primary aldosteronism can also be caused by mutations in ATP2B3 (Ca<sup>2+</sup>-ATPase), CACNA1D (Cav1.3), and KCNJ5 (K<sup>+</sup> channel) (Azizan et al., <xref ref-type="bibr" rid="B16">2013</xref>; Zennaro et al., <xref ref-type="bibr" rid="B326">2015</xref>). In a study with 474 patients, <italic>ATP1A1</italic> mutation was found in 5.3% of the sample, although the relationship between the disorder and the <italic>ATP1A1</italic> mutation was only discovered recently, requiring further investigations as to the mechanism involved (Fernandes-Rosa et al., <xref ref-type="bibr" rid="B97">2014</xref>).</p>
</sec>
<sec>
<title>ATP1A3 mutations</title>
<p><italic>ATP1A3</italic> is only expressed in CNS neurons, mostly in the cerebellum and basal ganglia, key structures in the regulation of a range of functions, including motor activity, memory and spatial learning. The <italic>ATP1A3</italic> mutations are common in the conserved transmembrane or N-terminus domain of NKA and are related to rare disorders, such as rapid-onset dystonia-parkinsonism (RDP), alternating hemiplegia of childhood (AHC), and cerebellar ataxia, areflexia, pescavus, optic atrophy, and sensorineural hearing loss (CAPOS) syndrome. Although having many common features, these three diseases have quite distinct phenotypes (Sweney et al., <xref ref-type="bibr" rid="B277">2015</xref>).</p>
<p>RDP (or DYT12) is a type of dystonia, being classed as a hyperkinetic movement disorder. RDP onset can be highly variable, occurring from 18 months to 55 years, suggesting considerable heterogeneity in its pathophysiology (Sweney et al., <xref ref-type="bibr" rid="B277">2015</xref>). The main features are involuntary muscle contractions, abnormal posture and repetitive movements. RDP was first linked to <italic>ATP1A3</italic> mutations by De Carvalho Aguiar and colleagues in 2004 (de Carvalho Aguiar et al., <xref ref-type="bibr" rid="B70">2004</xref>), having an autosomal dominant inheritance. However, this disorder can also be sporadic or not related to any mutation in <italic>ATP13A</italic> (Kabakci et al., <xref ref-type="bibr" rid="B139">2005</xref>). Although some RDP symptoms resemble Parkinson's disease, with both disorders showing evidence of abnormal CSF dopamine metabolites, RDP patients are unresponsive to deep brain stimulation (Charlesworth et al., <xref ref-type="bibr" rid="B52">2013</xref>) or to L-DOPA treatment (Asmus and Gasser, <xref ref-type="bibr" rid="B15">2010</xref>). RDP differentiation from Parkinson's disease is based on: triggering by physical or emotional stress, abrupt onset, bulbar involvement and normal computed tomography in the striatum (Zanotti-Fregonara et al., <xref ref-type="bibr" rid="B325">2008</xref>; Asmus and Gasser, <xref ref-type="bibr" rid="B15">2010</xref>).</p>
<p>Twelve mutations are associated with RDP, each being related to different severity levels. RDP treatment is only symptomatic, mostly utilizing benzodiazepines (Sweney et al., <xref ref-type="bibr" rid="B277">2015</xref>). The T613M mutation is the most common and with the most severe outcome. Psychiatric conditions, such as bipolar disorder and anxiety, seem to be related to RDP (Barbano et al., <xref ref-type="bibr" rid="B17">2012</xref>). A growing variety of clinical presentations have been reported in association with these mutations, including episodes of flaccidity and lack of motion for hours leading to stiffness (Anselm et al., <xref ref-type="bibr" rid="B10">2009</xref>) or delayed motor development and hypotonia that lead to a uncoordinated gait, as well as speech and swallowing difficulties in R756H and D823N mutations.</p>
<p>Recent studies on a family with RDP, where only women present with a symptomatic phenotype, indicate a new mutation that causes a deletion (c.443_445delGAG, p.Ser148del). A male member from the same family also carries the p.Ser148del mutation, but he does not have any symptoms, suggesting a reduced penetrance of this mutation (Wilcox et al., <xref ref-type="bibr" rid="B313">2015</xref>). RDP patients are still commonly misdiagnosed, indicating the need to incorporate new features in order to make an appropriate diagnosis (Brashear et al., <xref ref-type="bibr" rid="B43">2012</xref>).</p>
<p>The onset of motor symptoms in RDP patients occurs usually by 25 years of age, with initial symptoms occurring in the upper body. Following initial diagnosis, patients have been shown to have poor learning, memory and psychomotor speed vs. controls (Cook et al., <xref ref-type="bibr" rid="B62">2014</xref>). This would seem to arise from α3 being highly expressed in all nuclei of the basal ganglia and cerebellum, which are important regions for the control of movement, and in the hippocampus, which is crucial to spatial learning and memory (Oblak et al., <xref ref-type="bibr" rid="B204">2014</xref>). Experiments utilizing <italic>in vitro</italic> and <italic>in vivo</italic> models have investigated the alterations driven by these mutations, including the role of impaired NKA activity. A C-terminus protein mutation decreases Na<sup>+</sup> affinity, although no abnormality in biogenesis or plasma membrane targeting was found. Also, a decreased survival in these neuronal cells was observed when they were treated with OUA (Blanco-Arias et al., <xref ref-type="bibr" rid="B35">2009</xref>).</p>
<p>Other mutations were also tested in COS7 cells, with no phosphorylation from ATP and low Na<sup>+</sup> affinity being detected in most mutations. Consequently, increased intracellular Na<sup>+</sup> and decreased extracellular K<sup>+</sup> were observed. Thus, the affinity of Na<sup>+</sup> may be an important concern in RDP (Toustrup-Jensen et al., <xref ref-type="bibr" rid="B289">2014</xref>) (Figure <xref ref-type="fig" rid="F1">1</xref>). In mutated α3 mice (Het mice), stress exposure was capable of causing motor and balance deficits characteristic of RDP (DeAndrade et al., <xref ref-type="bibr" rid="B69">2011</xref>). These authors also showed significant alterations in monoamine metabolism and thermal sensitivity in this model (DeAndrade et al., <xref ref-type="bibr" rid="B69">2011</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p><bold>Schematic representation of the influence of <italic>ATP1A2</italic> mutations in glia and <italic>ATP1A3</italic> mutations in neurons on glutamatergic system activity</bold>. Mutations cause a dysfunctional NKA activity, <bold>(A)</bold>
<italic>ATP1A3</italic> mutation in neurons decreases the NKA activity and increases intracellular Na<sup>+</sup>, which increases the cellular excitability, thereby affecting neuronal functions. Flumarazine and topiramate could be used as treatment in some cases. <bold>(B)</bold>
<italic>ATP1A2</italic> in astrocytes results in change of metabolism, more K<sup>+</sup>, and glutamate in the extracellular space and rendering the CNS more vulnerable to migraine, seizures, and neurodegenerative process.</p>
</caption>
<graphic xlink:href="fphys-07-00195-g0001"></graphic>
</fig>
<p>AHC is a neurodevelopmental disorder described initially in 1971 by Verret and Steele (<xref ref-type="bibr" rid="B300">1971</xref>). However, it was only in 2012 that AHC was discovered to be a heterozygous <italic>ATP1A3 de novo</italic> mutation (Heinzen et al., <xref ref-type="bibr" rid="B119">2012</xref>; Rosewich et al., <xref ref-type="bibr" rid="B244">2014</xref>). AHC patients present with an onset before the age of 18 months and following an environmental or physiological stimulus, which is also present in RDP. AHC patients present with motor delay and attacks of hemiplegia, as well as cognitive and intellectual deficits (Sweney et al., <xref ref-type="bibr" rid="B277">2015</xref>). AHC disorder can be difficult to differential diagnosis especially in relation to familial hemiplegic migraine (FHM) and glutamate transport disease (Jen et al., <xref ref-type="bibr" rid="B134">2005</xref>). Sleep can stop AHC attacks, although even after sleep, attacks can return. Avoidance of the possible triggers is also important to prophylaxis, whilst antiepileptic drugs should only be used in patients showing <italic>status epilepticus</italic> (Rosewich et al., <xref ref-type="bibr" rid="B244">2014</xref>; Paciorkowski et al., <xref ref-type="bibr" rid="B209">2015</xref>). Flunarizine is a Ca<sup>2+</sup> and Na<sup>+</sup> channel blocker, which was developed to treat migraine and is currently the main AHC treatment, although the mechanism of action is unknown. Similarly, topiramate's mode of efficacy is unknown and may include its inhibition of 2-amino-3-(3-hydroxyl-5-methyl-4-isoxazolyl) propionic acid (AMPA) receptors and carbonic anhydrase, thereby lowering extracellular pH (Hoei-Hansen Et al., <xref ref-type="bibr" rid="B121">2014</xref>; Yang et al., <xref ref-type="bibr" rid="B320">2014</xref>) (Figure <xref ref-type="fig" rid="F1">1</xref>).</p>
<p>Another strategy used in AHC patients is the ketogenic diet/modified Atkins diet, given that a family with the p.Asp923Asn mutation was initially misdiagnosed as GLUT1DS (glucose transporter deficiency syndrome), with 15 months of diet management leading to no further attacks. A ketogenic diet provides an alternative energy source for the brain and may decrease neuroexcitability (Roubergue et al., <xref ref-type="bibr" rid="B247">2015</xref>). In some cases, when a patient has two mutations in SLC2A1 and <italic>ATP1A3</italic>, flunarizine provides an incomplete response, with concurrent use of a ketogenic diet improving the utility of flunarizine (Ulate-Campos et al., <xref ref-type="bibr" rid="B292">2014</xref>). A patient with c.2401G&gt;A; p.D801N mutation failed to respond to all the treatment strategies and only the use of a corticosteroid achieved complete remission (Wong and Kwong, <xref ref-type="bibr" rid="B316">2015</xref>).</p>
<p>In Japan, the more severe phenotype arising from the E815K mutation was found to be more common than in other countries, occurring in 50% of investigated patients. The more severe phenotype evident in these mutations includes: earlier age of onset, more epileptic episodes and increased motor impairment (Ishii et al., <xref ref-type="bibr" rid="B131">2013</xref>). Usually patients with no detectable mutation have less symptomatology (Hoei-Hansen et al., <xref ref-type="bibr" rid="B121">2014</xref>), whilst an early onset of AHC symptoms seems positively correlated with a more severe clinical course (Viollet et al., <xref ref-type="bibr" rid="B303">2015</xref>).</p>
<p>A Danish study showed bilateral episodes to be common, with hemiplegic episodes not always alternating. Consequently, the term AHC may not be the most appropriate (Hoei-Hansen Et al., <xref ref-type="bibr" rid="B121">2014</xref>). A recent study of 155 patients showed 34 mutations to be related to AHC, with at least one being detected in 85% of patients. The three major mutations were found p.Glu815Lys, p.Asp801Asn, and p.Gly947Arg, with the first having the most severe phenotype, as indicated by greater intellectual impairment and motor disability. In contrast, p.Asp801Asn presents with a milder phenotype, whilst p.Gly947Arg appears to have the most favorable prognosis, in comparison to other mutations (Panagiotakaki et al., <xref ref-type="bibr" rid="B210">2015</xref>).</p>
<p>Some mutations show a symptomatology that indicates a combination of RDP and AHC, including c.2600G&gt;A, D923N and R756 (Rosewich et al., <xref ref-type="bibr" rid="B244">2014</xref>). The E277K and D923N mutations have been described in both (Boelman et al., <xref ref-type="bibr" rid="B37">2014</xref>). The difference between RDP and AHC may be due to different regions and cells affected by the mutations in ATP13A, with differential impacts arising from effects within a developmental context (Ozelius, <xref ref-type="bibr" rid="B208">2012</xref>). Patients with epilepsy had an earlier onset, although no relationship with a specific mutation (Panagiotakaki et al., <xref ref-type="bibr" rid="B210">2015</xref>). AHC patients have electrocardiogram and repolarization abnormalities compared to people with epilepsy, contributing to episodes of collapse unrelated to seizures, as well as to some premature deaths (Novy et al., <xref ref-type="bibr" rid="B203">2014</xref>; Jaffer et al., <xref ref-type="bibr" rid="B132">2015</xref>). Activated platelets from AHC patients have functional and structural abnormalities, with 93 proteins related to metabolism being differentially expressed in comparison to healthy controls. Cathepsin B was also more highly expressed, indicating an important role of apoptotic pathway activation in driving mutation-associated cell death (Di Michele et al., <xref ref-type="bibr" rid="B85">2013</xref>). An AHC patient showing a mutation in SLC2A1 p.Gly18Arg, which leads to the loss of GLUT1 expression, was also diagnosed with hemiplegic migraine, which can be related to increases in cortex glutamate levels. As such, glutamate levels should also be investigated in mutation-associated AHC patients (Weller et al., <xref ref-type="bibr" rid="B310">2015</xref>).</p>
<p>Mutations of <italic>ATP1A3</italic> that can be evident in AHC patients, have been tested in Sf9 cells. OUA binding, NKA activity and phosphorylation were measured for each mutant and were found to be abnormal in I274N, E815K, and G947R mutations. Some mutations showed normal bind to OUA, although no NKA activity or phosphorylation were found. Such differences may be associated with phenotype severity (Weigand et al., <xref ref-type="bibr" rid="B309">2014</xref>). In a murine AHC model, the D801N mutant mouse (Mashlool, Mashl+/), a similar symptomatology is found as that evident in AHC patients, including abnormalities in gait and motor coordination, as well as spontaneous recurrent seizures and hemiplegia. The study of hippocampal slices showed increased excitability, which contributes to abnormal plasticity and a predisposition to more spontaneous seizures (Hunanyan et al., <xref ref-type="bibr" rid="B124">2015</xref>).</p>
<p>Another animal model, the Myshkin (Myk) model, carries the I810N mutation, which presents with a reduced threshold for hippocampal seizures and neuronal loss. Although α3 is normally expressed, NKA activity is reduced with a consequent reduction in thalamocortical functional connectivity (Clapcote et al., <xref ref-type="bibr" rid="B59">2009</xref>; Kirshenbaum et al., <xref ref-type="bibr" rid="B151">2013</xref>). This murine model is also used as a model of bipolar disorder, with symptoms being improved by melatonin and physical exercise (Kirshenbaum et al., <xref ref-type="bibr" rid="B150">2014</xref>). An α3 mutation is evident in the Atp1a3tm1Ling murine model, leading to a reduction in hippocampal α3 expression, thereby lowering NKA activity. Dystonia is only induced in this model after kainate injection into the cerebellum (Ikeda et al., <xref ref-type="bibr" rid="B127">2013</xref>).</p>
<p>In 1996, CAPOS syndrome was described, with only the c.2452G&gt; mutation in <italic>ATP1A3</italic> being found in four families studied. This is a gain-of-function mutation, which differs from the loss mutations evident in RDP and AHC (Demos et al., <xref ref-type="bibr" rid="B74">2014</xref>). CAPOS is a rare syndrome associated with febrile illness, with each patient differing in regard to severity and outcome (Sweney et al., <xref ref-type="bibr" rid="B277">2015</xref>). Recently, CAPOS syndrome has been shown to cause hemiplegic migraine in a single case study (Potic et al., <xref ref-type="bibr" rid="B230">2015</xref>).</p>
</sec>
<sec>
<title>ATP1A2 mutations</title>
<p>Migraine is a brain disorder that affects over 10% of the population, characterized by a headache associated with neurological and autonomic symptoms. Moreover, it frequently occurs as a pulsating and unilateral headache, usually followed by phono/photophobia and nausea (Russell et al., <xref ref-type="bibr" rid="B249">1994</xref>). Migraine is thought to be initiated by brain dysregulation, leading to activation and increased vulnerability of the trigeminovascular system, mainly the trigeminal nociceptive afferents innervating the meninges (Goadsby et al., <xref ref-type="bibr" rid="B109">2002</xref>; Pietrobon and Striessnig, <xref ref-type="bibr" rid="B222">2003</xref>; Pietrobon, <xref ref-type="bibr" rid="B221">2005</xref>). Migraine disorders may be preceded, or not, by neurological symptoms that are often visual, and can therefore be classified as migraine with or without aura (Pietrobon and Striessnig, <xref ref-type="bibr" rid="B222">2003</xref>; Pietrobon, <xref ref-type="bibr" rid="B221">2005</xref>). Clinical studies indicate that migraine aura is related with a wave of cortical spreading depression (CSD). CSD is a strong wave of short duration of neuronal and glial cell depolarization, which extends over the cortex and is accompanied by long-lasting depression of neuronal activity (Lauritzen, <xref ref-type="bibr" rid="B161">1994</xref>; Cutrer et al., <xref ref-type="bibr" rid="B65">1998</xref>; Bowyer et al., <xref ref-type="bibr" rid="B42">2001</xref>; Hadjikhani et al., <xref ref-type="bibr" rid="B117">2001</xref>). Studies have shown a relationship between CSD and migraine aura in humans and animal models and its importance to trigeminal activation (Russell et al., <xref ref-type="bibr" rid="B249">1994</xref>; Bowyer et al., <xref ref-type="bibr" rid="B42">2001</xref>; Hadjikhani et al., <xref ref-type="bibr" rid="B117">2001</xref>; Bolay et al., <xref ref-type="bibr" rid="B38">2002</xref>; Goadsby, <xref ref-type="bibr" rid="B108">2002</xref>; Dalkara et al., <xref ref-type="bibr" rid="B66">2006</xref>; Zhang et al., <xref ref-type="bibr" rid="B330">2010</xref>).</p>
<p>FHM is a special autosomal dominant subtype of migraine with aura, characterized by some degree of motor frailty or paralysis, often hemiparesis (Thomsen et al., <xref ref-type="bibr" rid="B285">2002</xref>). Furthermore, severe cases have been associated with symptoms such as progressive cerebellar ataxia, coma, fever, and/or epileptic seizures (Ducros et al., <xref ref-type="bibr" rid="B90">1997</xref>). FHM is a genetically heterogeneous disease, in which mutations can occur in the ion transportation genes <italic>CACNA1A, ATP1A2</italic>, and <italic>SCN1A</italic> (Rogawski, <xref ref-type="bibr" rid="B241">2008</xref>), promoting the different types of familial migraines, FHM1, FHM2 and FHM3 (Russell et al., <xref ref-type="bibr" rid="B249">1994</xref>; Pierelli et al., <xref ref-type="bibr" rid="B220">2006</xref>; Deprez et al., <xref ref-type="bibr" rid="B78">2008</xref>). FHM1 is induced by mutations in <italic>CACNA1A</italic> at chromosome 19p13, which encodes the Cav2.1 (P/Q-type) (Ophoff et al., <xref ref-type="bibr" rid="B206">1996</xref>). FHM2 is occasioned by mutations in the <italic>ATP1A2</italic> at chromosome 1q23 (De Fusco et al., <xref ref-type="bibr" rid="B71">2003</xref>). The last gene is <italic>SCN1A</italic>, encoding the α1 subunit of the neuronal sodium channel, the mutation in which leads to FHM3 (Dichgans et al., <xref ref-type="bibr" rid="B82">2005</xref>). In this review, we describe only mutations in <italic>ATP1A2</italic>, as well as the role of glutamate in the development of FHM. FHM was the first human disease linked to mutations of the α2 catalytic subunit, which was first demonstrated in two Italian families (De Fusco et al., <xref ref-type="bibr" rid="B71">2003</xref>). There is also a linkage between sporadic hemiplegic migraine (SHM) and mutations in α2 (Thomsen and Olesen, <xref ref-type="bibr" rid="B286">2004</xref>; Kirchmann et al., <xref ref-type="bibr" rid="B148">2006</xref>), with other brain disorders also associated with α2 mutations.</p>
<p>In the mouse, α2 is expressed in cardiac and skeletal muscle throughout life. However, in neurons, <italic>Atp1a2</italic> is only expressed during embryonic development (Moseley et al., <xref ref-type="bibr" rid="B191">2003</xref>), being present in astrocytes and meningeal tissues in adulthood (McGrail et al., <xref ref-type="bibr" rid="B185">1991</xref>; Watts et al., <xref ref-type="bibr" rid="B308">1991</xref>; Peng et al., <xref ref-type="bibr" rid="B213">1997</xref>). During neuronal activity, NKA is important for removing K<sup>+</sup> from the synaptic cleft. Moreover, it is fundamental for the re-uptake of released glutamate from the extracellular space, since active transport of glutamate into neurons and astrocytes is regulated by Na<sup>+</sup> and K<sup>+</sup> gradients, emphasizing the importance of NKA in synaptic regulation (Ransom et al., <xref ref-type="bibr" rid="B234">2000</xref>; D'Ambrosio et al., <xref ref-type="bibr" rid="B67">2002</xref>; Jorgensen et al., <xref ref-type="bibr" rid="B136">2003</xref>). <italic>Atp1a2</italic>-deficient embryos have impaired neurotransmitter clearance, as well as potentiated neural excitation and cell death, specifically in the amygdala and piriform cortex. Consequently, heterozygous adult mice show increased levels of anxiety/fear behaviors, concurrent to raised levels of c-Fos and increased neuronal activity in the piriform cortex and amygdala after fear stimuli. This indicates a role for α2 in regulating not only neural activity (Ikeda et al., <xref ref-type="bibr" rid="B125">2003</xref>), but also affective processing, including in the role of the amygdala in cortex development.</p>
<p>Kawakami et al. (<xref ref-type="bibr" rid="B143">2005</xref>) reported that heterozygous <italic>Atp1a2</italic> mice, <inline-formula><mml:math id="M1"><mml:msubsup><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mo>+</mml:mo><mml:mo>∕</mml:mo><mml:mo>-</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula>KOE<sub>21</sub>, show spontaneous epileptic seizures. In addition, their data demonstrated neuronal apoptosis in the piriform cortex and amygdala (Ikeda et al., <xref ref-type="bibr" rid="B125">2003</xref>), being a possible explanation as to the manifestation of epilepsy in 20% of FHM2/SHM families (Bianchin et al., <xref ref-type="bibr" rid="B30">2010</xref>). These epileptic seizures arise when neurons situated in temporal lobe regions, including the amygdala, piriform cortex and hippocampus become hyperexcitable (Aroniadou-Anderjaska et al., <xref ref-type="bibr" rid="B14">2008</xref>). However, histological changes were not observed in the piriform cortex and amygdala in the brains of <inline-formula><mml:math id="M2"><mml:msubsup><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mo>-</mml:mo><mml:mo>∕</mml:mo><mml:mo>-</mml:mo></mml:mrow></mml:msubsup></mml:math></inline-formula>KOE<sub>21</sub> knockout mice (Ikeda et al., <xref ref-type="bibr" rid="B126">2004</xref>). A colocalization of the NKA α2 with NCX occurs in astrocyte cultures, suggesting a central NKA role in the modulation of intracellular Ca<sup>2+</sup> of the endoplasmic reticulum (Juhaszova and Blaustein, <xref ref-type="bibr" rid="B137">1997</xref>). In addition, high levels of intracellular and intra-endoplasmic reticulum Ca<sup>2+</sup> ions were detected in cultured astrocytes from <italic>Atp1a2</italic>-deficient mice (Golovina et al., <xref ref-type="bibr" rid="B111">2003</xref>), linking NKA α2 to the manifold consequences of Ca<sup>2+</sup> dysregulation.</p>
<p>Mutation in astrocyte NKA α2 facilitates both neuronal paroxysmal depolarizing shifts and hyper-excitability, triggering seizures as well as CSD induction and propagation in FHM/SHM patients (Pietrobon, <xref ref-type="bibr" rid="B221">2005</xref>). Bolay et al. (<xref ref-type="bibr" rid="B38">2002</xref>), using an animal model of migraine, observed that CSD activates a N-methyl-D-aspartate (NMDA)-dependent pathway leading to an activation of nociceptive trigeminal afferents in the meninges, resulting in headache. Additionally, a specific role for NKA in glutamate clearance during synaptic transmission has also been established, with NKA being stimulated by glutamate in astrocyte cultures (Pellerin and Magistretti, <xref ref-type="bibr" rid="B212">1997</xref>). Furthermore, a colocalization and functional coupling between NKA and glutamate transporters has also been demonstrated (Rose et al., <xref ref-type="bibr" rid="B243">2009</xref>), with α2 having a similar perisynaptic glial localization to the glutamate transporters GLAST and GLT-1in the rat somatosensory cortex (Cholet et al., <xref ref-type="bibr" rid="B58">2002</xref>; Rose et al., <xref ref-type="bibr" rid="B243">2009</xref>). As such, inefficient astrocyte glutamate reuptake resulting in increased cortical excitatory neurotransmission, specifically as driven by NMDA receptor-dependent transmission during high-frequency action potential sequences, may enhance the sensibility to CSD in FHM2 (Tzingounis and Wadiche, <xref ref-type="bibr" rid="B291">2007</xref>). Wider ionic dysregulation may also be evident, with the increase of extracellular K<sup>+</sup> levels resulting from the impaired clearance by NKA, and an increase in the intracellular Na<sup>+</sup> resulting in an elevation in the intracellular Ca<sup>2+</sup> level through the NCX (Pietrobon, <xref ref-type="bibr" rid="B221">2005</xref>), contributing to wider central disruption. Moreover, recent data indicates that impaired glutamate clearance by astrocytes, and involving the α2, is an important molecular mechanism of FHM2 (Figure <xref ref-type="fig" rid="F1">1</xref>). This <italic>in vitro</italic> study, in a hippocampal mixed astrocyte and neuronal culture derived from homozygous <inline-formula><mml:math id="M3"><mml:msubsup><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mtext>G</mml:mtext><mml:mn>301</mml:mn><mml:mtext>R</mml:mtext><mml:mo>∕</mml:mo><mml:mtext>G</mml:mtext><mml:mn>301</mml:mn><mml:mtext>R</mml:mtext></mml:mrow></mml:msubsup></mml:math></inline-formula> E17 embryonic mice, demonstrated reduced glutamate uptake due to the loss of functional NKAα2 in astrocytes. Interestingly, <italic>in vivo</italic> data in the same study showed a relationship between the glutamate system and the female sex hormone in psychiatric manifestations of FHM2. Furthermore, higher glutamate levels were evident in different brain regions from adult female <inline-formula><mml:math id="M4"><mml:msubsup><mml:mrow><mml:mi>α</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn></mml:mrow><mml:mrow><mml:mo>+</mml:mo><mml:mo>∕</mml:mo><mml:mi>G</mml:mi><mml:mn>301</mml:mn><mml:mi>R</mml:mi></mml:mrow></mml:msubsup></mml:math></inline-formula> mice, compared to male mice (Bøttger et al., <xref ref-type="bibr" rid="B41">2016</xref>).</p>
<p>In support of a role for glutamatergic dysregulation in migraine, MTDH, a regulator of glutamate transporters, associates with the frequent form of migraine with aura. Furthermore, a mutation in the SLCA3 gene that encodes the glial excitatory amino acid transporter type 1 (EAAT1) has also been found, leading to neuronal hyper-excitability and consequent hemiplegia, as well as seizures and episodic ataxia, which arise as a consequence of impaired glutamate uptake (Jen et al., <xref ref-type="bibr" rid="B134">2005</xref>).</p>
<p>Recent studies have demonstrated a link between long-term memory formation in the rat hippocampus and the astrocyte-neuron lactate transport (Suzuki et al., <xref ref-type="bibr" rid="B273">2011</xref>). Furthermore, there is a relationship between NKA and the astrocyte specific glutamate-dependent transport of lactate (Kleene et al., <xref ref-type="bibr" rid="B152">2007</xref>). This interesting finding may contribute to the pathophysiological processes underlying language disorder, cognitive impairment and mental retardation evident in FHM2/SHM patients (Le Pira et al., <xref ref-type="bibr" rid="B163">2004</xref>; Kalaydjian et al., <xref ref-type="bibr" rid="B140">2007</xref>). As such, evidence suggests that the central glutamatergic system has an important role in driving the consequences of <italic>ATP1A2</italic> mutations and should also be more explored in <italic>ATP13A</italic> mutations, due to the diagnostic confusion and overlap with glutamate transporter diseases.</p>
</sec>
</sec>
<sec>
<title>Glutamatergic signaling: a brief introduction</title>
<p>Glutamate is an amino acid, which is considered the main central excitatory neurotransmitter, being highly abundant in the majority of animals, especially in the cortex, hippocampus and caudate nucleus (reviewed in Erecinska and Silver, <xref ref-type="bibr" rid="B95">1990</xref>). Glutamate's cellular actions are mediated through the activation of metabotropic and ionotropic receptors. The ionotropic receptors are divided according to their affinities for specific agonists, namely NMDA, AMPA, and kainate (McLennan, <xref ref-type="bibr" rid="B187">1981</xref>). The glutamatergic metabotropic receptors were first investigated in late 1980's (Nicoletti et al., <xref ref-type="bibr" rid="B198">1986</xref>). There are eight types of metabotropic receptors divided into three groups (Groups I, II, and III) depending on DNA sequence and the signaling pathway they activate (reviewed in Wieronska et al., <xref ref-type="bibr" rid="B312">2016</xref>).</p>
<p>Glutamate has many roles, including being part of intermediary metabolism in the brain (Krebs, <xref ref-type="bibr" rid="B155">1935</xref>; Berl et al., <xref ref-type="bibr" rid="B24">1961</xref>) as well as acting as a precursor for different compounds, such as the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) (Roberts and Frankel, <xref ref-type="bibr" rid="B240">1950</xref>). By acting through metabotropic and/or ionotropic receptors, glutamate is also an important element in a variety of core processes such as learning and memory, partly by regulating synaptic plasticity <italic>via</italic> long-term potentiation (LTP) (Bliss and Collingridge, <xref ref-type="bibr" rid="B36">1993</xref>; Vickery et al., <xref ref-type="bibr" rid="B302">1997</xref>), long-term depression (LTD) (Dudek and Bear, <xref ref-type="bibr" rid="B91">1992</xref>; Yokoi et al., <xref ref-type="bibr" rid="B323">1996</xref>; Nicoll et al., <xref ref-type="bibr" rid="B199">1998</xref>; Dong et al., <xref ref-type="bibr" rid="B87">2013</xref>) or both (Manahan-Vaughan, <xref ref-type="bibr" rid="B178">1997</xref>; Huang L. Q. et al., <xref ref-type="bibr" rid="B123">1997</xref>; Wang et al., <xref ref-type="bibr" rid="B306">2015</xref>). The hippocampus and cortex are the major brain regions investigated in studies of cognition, with these regions also showing the highest concentrations of brain glutamate. Glutamate is crucial to many other brain processes, including motor behavior (Conquet et al., <xref ref-type="bibr" rid="B61">1994</xref>; Pekhletski et al., <xref ref-type="bibr" rid="B211">1996</xref>; Coesmans et al., <xref ref-type="bibr" rid="B60">2003</xref>; Talpalar and Kiehn, <xref ref-type="bibr" rid="B280">2010</xref>; Ohtani et al., <xref ref-type="bibr" rid="B205">2014</xref>; Guimaraes et al., <xref ref-type="bibr" rid="B114">2015</xref>), as well as in brain development (Deisseroth et al., <xref ref-type="bibr" rid="B72">2004</xref>; Poulsen et al., <xref ref-type="bibr" rid="B231">2005</xref>; DeSilva et al., <xref ref-type="bibr" rid="B80">2012</xref>; Yamasaki et al., <xref ref-type="bibr" rid="B319">2014</xref>; Jantzie et al., <xref ref-type="bibr" rid="B133">2015</xref>).</p>
<p>Abnormalities in glutamate function can arise from alterations in a variety of factors, including: glutamate transporters and glutamatergic receptors, as well as glutamate metabolism and synthesis. Also, changes in the levels of glutamate's precursor, glutamine, may drive alterations in the extracellular glutamate concentration. Inflammation is linked to a host of medical conditions, with effects linked to sustained glutamate elevations (Takaki et al., <xref ref-type="bibr" rid="B279">2012</xref>) or changes in glutamatergic receptor expression (Drouin-Ouellet et al., <xref ref-type="bibr" rid="B88">2011</xref>). Increased levels of glutamate contribute to inflammatory process, as indicated by the efficacy of glutamatergic receptor antagonist in reducing inflammation (Bonnet et al., <xref ref-type="bibr" rid="B40">2015</xref>).</p>
<p>Lack of glutamate could lead to memory deficits, given that LTP in some brain areas is NMDA receptor-dependent (Malenka and Bear, <xref ref-type="bibr" rid="B177">2004</xref>). However, excess glutamate can be excitotoxic to neurons. A number of studies show a strong correlation between abnormal glutamatergic signaling pathway and neurodegenerative/psychiatric diseases, including Alzheimer's disease (Takahashi et al., <xref ref-type="bibr" rid="B278">2015</xref>; Haas et al., <xref ref-type="bibr" rid="B115">2016</xref>), Parkinson's disease (Alvarsson et al., <xref ref-type="bibr" rid="B7">2015</xref>; Morin et al., <xref ref-type="bibr" rid="B190">2015</xref>), Huntington's disease (Behrens et al., <xref ref-type="bibr" rid="B23">2002</xref>; Estrada-Sánchez et al., <xref ref-type="bibr" rid="B96">2009</xref>), amyotrophic lateral sclerosis (Plaitakis et al., <xref ref-type="bibr" rid="B223">1988</xref>; Veyrat-Durebex et al., <xref ref-type="bibr" rid="B301">2015</xref>), epilepsy (Wong et al., <xref ref-type="bibr" rid="B315">2015</xref>), ischemia (Dhami et al., <xref ref-type="bibr" rid="B81">2013</xref>), migraine (Peres et al., <xref ref-type="bibr" rid="B216">2004</xref>; Campos et al., <xref ref-type="bibr" rid="B50">2013</xref>), schizophrenia (Spangaro et al., <xref ref-type="bibr" rid="B271">2012</xref>; Matsuno et al., <xref ref-type="bibr" rid="B183">2015</xref>), depression (Berman et al., <xref ref-type="bibr" rid="B25">2000</xref>; Duric et al., <xref ref-type="bibr" rid="B93">2013</xref>; Peng et al., <xref ref-type="bibr" rid="B215">2016</xref>), addiction (Aitta-aho et al., <xref ref-type="bibr" rid="B2">2012</xref>; Perry et al., <xref ref-type="bibr" rid="B217">2016</xref>), and autism spectrum disorder (Bristot Silvestrin et al., <xref ref-type="bibr" rid="B45">2013</xref>).</p>
</sec>
<sec>
<title>NKA and glutamatergic signaling</title>
<p>In the mammalian CNS, astrocytes are the most abundant glial cells. Astrocytes show two different NKA α isoforms, α1 and α2, with α1 being ubiquitously expressed (Geering, <xref ref-type="bibr" rid="B105">2008</xref>). Under physiological conditions, during excitatory synaptic activity, astrocytes are responsible for glutamate uptake from the synaptic space, keeping extracellular levels of glutamate at nanomolar concentrations, and thereby avoiding the harmful consequences of glutamate receptor over-stimulation (Rothstein et al., <xref ref-type="bibr" rid="B245">1996</xref>; Herman and Jahr, <xref ref-type="bibr" rid="B120">2007</xref>; Kirischuk et al., <xref ref-type="bibr" rid="B149">2012</xref>; Illarionova et al., <xref ref-type="bibr" rid="B128">2014</xref>; Zhang et al., <xref ref-type="bibr" rid="B329">2016</xref>). Astrocytes are therefore considered significant regulators of glutamatergic synaptic transmission (Amara and Fontana, <xref ref-type="bibr" rid="B8">2002</xref>; Zhang et al., <xref ref-type="bibr" rid="B329">2016</xref>). The glial glutamate transporters (GluTs) that mediate glutamate uptake rely on the NKA electrochemical gradient (Levy et al., <xref ref-type="bibr" rid="B164">1998</xref>; Anderson and Swanson, <xref ref-type="bibr" rid="B9">2000</xref>; Chatton et al., <xref ref-type="bibr" rid="B53">2000</xref>; Kanner, <xref ref-type="bibr" rid="B142">2006</xref>). The family of excitatory amino acid transporters (EAAT) are composed of the glutamate transporters, with GLAST (glutamate/aspartate transporter or EAAT1) and GLT-1 (glutamate transporter 1, or EAAT2) being considered the most important (Tanaka, <xref ref-type="bibr" rid="B282">2000</xref>; Zhang et al., <xref ref-type="bibr" rid="B329">2016</xref>) and the predominant type of GluT in adult astrocytes (Rothstein et al., <xref ref-type="bibr" rid="B245">1996</xref>; Dunlop, <xref ref-type="bibr" rid="B92">2006</xref>; Matos et al., <xref ref-type="bibr" rid="B182">2013</xref>). As such, an alteration in the NKA ionic and electrochemical gradient is intimately associated with astrocyte regulation of glutamatergic activity.</p>
<p>In the cell, ATP depletion can lead to a reversal (Longuemare et al., <xref ref-type="bibr" rid="B173">1999</xref>), or inhibition, of glutamate uptake (Sheean et al., <xref ref-type="bibr" rid="B262">2013</xref>; Shan et al., <xref ref-type="bibr" rid="B261">2014</xref>), as shown by inhibitory doses of OUA, which impairs glutamate transport (Pellerin and Magistretti, <xref ref-type="bibr" rid="B212">1997</xref>; Rose et al., <xref ref-type="bibr" rid="B243">2009</xref>; Genda et al., <xref ref-type="bibr" rid="B107">2011</xref>) and leads to the redistribution and clustering of GluTs (Nakagawa et al., <xref ref-type="bibr" rid="B194">2008</xref>; Nguyen et al., <xref ref-type="bibr" rid="B197">2010</xref>). Some studies indicate a co-localization and physical interaction between the α2 subunit and GluTs (Cholet et al., <xref ref-type="bibr" rid="B58">2002</xref>; Rose et al., <xref ref-type="bibr" rid="B243">2009</xref>; Genda et al., <xref ref-type="bibr" rid="B107">2011</xref>; Matos et al., <xref ref-type="bibr" rid="B182">2013</xref>; Illarionova et al., <xref ref-type="bibr" rid="B128">2014</xref>), suggesting NKA regulation of GluTs by direct contact, as well as <italic>via</italic> the electrochemical gradient.</p>
<p>Elevated glutamate concentrations (up to 50 μM) may stimulate NKA activity (Gegelashvili et al., <xref ref-type="bibr" rid="B106">2007</xref>). This was observed in a study of human fetal astrocytes, which showed that during synaptic activity, when glutamate is elevated, there is an increase in cell membrane expression of the NKA FXYD2/γ subunit and GLAST, suggesting a possible interaction between them (Gegelashvili et al., <xref ref-type="bibr" rid="B106">2007</xref>; Nguyen et al., <xref ref-type="bibr" rid="B197">2010</xref>; Zhang et al., <xref ref-type="bibr" rid="B329">2016</xref>). Furthermore, the inhibition of Src in forebrain synaptosomes with PP2 or SU6656, as well as the inhibition of NKA by OUA, both decreased glutamate transport activity to the same level (Rose et al., <xref ref-type="bibr" rid="B243">2009</xref>), suggesting the existence of a possible protein complex formed between NKA/Src/GluT (Rose et al., <xref ref-type="bibr" rid="B243">2009</xref>). Moreover, adenosine can modulate glutamate uptake through activation of astrocyte adenosine A<sub>2A</sub> receptors (A<sub>2A</sub>Rs), which can interact with the α2 isoform in the adult mouse brain, leading to the inhibition of astrocyte glutamate uptake (Matos et al., <xref ref-type="bibr" rid="B182">2013</xref>). This data strengthens the idea of a macromolecular complex in astrocytic membranes encompassing A<sub>2</sub>ARs, α2 and GLT-I (Matos et al., <xref ref-type="bibr" rid="B182">2013</xref>; Reinhard et al., <xref ref-type="bibr" rid="B238">2013</xref>), with parallels in neurons. In 2009, Rose and colleagues showed that in the rat hippocampus GLT-1b isoform is co-expressed with α2 in astrocytes, whereas GLT-1a isoform was co-expressed with α3, a neuronal specific isoform (Chen et al., <xref ref-type="bibr" rid="B54">2004</xref>; Bassan et al., <xref ref-type="bibr" rid="B18">2008</xref>; Furness et al., <xref ref-type="bibr" rid="B101">2008</xref>; González-González et al., <xref ref-type="bibr" rid="B112">2008</xref>; Rose et al., <xref ref-type="bibr" rid="B243">2009</xref>; Petr et al., <xref ref-type="bibr" rid="B219">2015</xref>).</p>
<p>Notwithstanding the existence of a well described physical interaction between α2 and GluTs (Cholet et al., <xref ref-type="bibr" rid="B58">2002</xref>; Porras et al., <xref ref-type="bibr" rid="B224">2008</xref>; Rose et al., <xref ref-type="bibr" rid="B243">2009</xref>; Genda et al., <xref ref-type="bibr" rid="B107">2011</xref>; Bauer et al., <xref ref-type="bibr" rid="B19">2012</xref>; Matos et al., <xref ref-type="bibr" rid="B182">2013</xref>; Rose and Chatton, <xref ref-type="bibr" rid="B242">2016</xref>), the substantial Na<sup>+</sup> influx that is driven into astrocytes during synaptic activity has been related to a possible functional interaction, whereby astrocytes increase the local availability of metabolic substrates (Rose and Chatton, <xref ref-type="bibr" rid="B242">2016</xref>). During glutamate stimulation, there is a dramatic reduction in neuronal ATP mediated by NMDA receptor activation followed by an increase in NKA activity (Foo et al., <xref ref-type="bibr" rid="B98">2012</xref>).</p>
<p>In the 1990's, Inoue and Matsui observed an increase in K<sup>+</sup> uptake by α2 and α3 after stimulation of rat embryonic neurons with glutamate (100 μM) (Inoue and Matsui, <xref ref-type="bibr" rid="B129">1990</xref>). Similar results were observed some years later in Wistar adult rat slices (Nathanson et al., <xref ref-type="bibr" rid="B195">1995</xref>; Munhoz et al., <xref ref-type="bibr" rid="B192">2005</xref>) by Munhoz et al. (<xref ref-type="bibr" rid="B192">2005</xref>), which described a pathway whereby glutamate stimulation of NMDA receptor-NOS leads to increased NKA activity, possibly due to increased cyclic GMP (cGMP) synthesis. Glutamate-induced Ca<sup>2+</sup> influx leads to the activation of neuronal nitric oxide synthase (nNOS) and increased production of nitric oxide (NO). NO, by activating soluble guanylylcyclase (sGC) enzyme, increases concentrations of the second messenger cGMP, thereby up-regulating cGMP-dependent protein kinase (PKG). PKG modulates NKA, altering the activity of NKA isoforms, both centrally and peripherally (McKee et al., <xref ref-type="bibr" rid="B186">1994</xref>; de Oliveira Elias et al., <xref ref-type="bibr" rid="B75">1999</xref>; Munhoz et al., <xref ref-type="bibr" rid="B192">2005</xref>; Scavone et al., <xref ref-type="bibr" rid="B255">2005</xref>). Accordingly, a strong correspondence occurs between pharmacologically induced cGMP and NKA modulation in the cerebellum, reinforcing the role of the glutamate-NO-cGMP pathway in NKA regulation (Nathanson et al., <xref ref-type="bibr" rid="B195">1995</xref>).</p>
<p>In 1999, Inoue and colleagues showed that when primary neuronal cultures from rat embryos were treated with three typical agonists of ionotropic glutamate receptors, namely kainic acid (KA), AMPA and NMDA, a remarkable increase in the activity of α2 and α3 isoforms and a slight decreased activity of α1 was observed, suggesting that glutamate effects on NKA may be mainly mediated by ionotropic glutamate receptors (Inoue et al., <xref ref-type="bibr" rid="B130">1999</xref>; Kawamoto et al., <xref ref-type="bibr" rid="B144">2012</xref>), with the neuronal NKA isoforms differing in physiological functions and playing a crucial role in restoring ion gradients after neuronal excitation (Inoue et al., <xref ref-type="bibr" rid="B130">1999</xref>). Meanwhile, Brines and Robbins (<xref ref-type="bibr" rid="B44">1992</xref>) observed that prolonged inhibition of α2 and α3 could lead to the potentiation of glutamate neurotoxicity, with NKA activity also regulating the cell surface expression and turnover of AMPA receptors (Zhang et al., <xref ref-type="bibr" rid="B328">2009</xref>). Interestingly, when primary cultured cerebellar neurons were treated with 0.1 μM glutamate a 37% increase in NKA activity was observed, while a concentration of 100 μM glutamate was able to increase NKA activity by 85%. However, when pre-treated with the NMDA receptor antagonist, MK-801, NKA activity increase was abrogated, suggesting that glutamate-driven NKA activation is mediated by NMDA receptors (Marcaida et al., <xref ref-type="bibr" rid="B179">1996</xref>). Once NMDA receptors are activated, the subsequent Ca<sup>2+</sup> influx can activate calcineurin, a calcium/calmodulin-dependent protein phosphatase (Marcaida et al., <xref ref-type="bibr" rid="B179">1996</xref>; Rambo et al., <xref ref-type="bibr" rid="B233">2012</xref>; Unoki et al., <xref ref-type="bibr" rid="B293">2012</xref>; de Lores Arnaiz and Bersier, <xref ref-type="bibr" rid="B73">2014</xref>), which, through NKA dephosphorylation, restores NKA enzyme activity (Bertorello et al., <xref ref-type="bibr" rid="B28">1991</xref>; Aperia et al., <xref ref-type="bibr" rid="B12">1992</xref>; Marcaida et al., <xref ref-type="bibr" rid="B179">1996</xref>). It is well proven that protein kinase C (PKC) phosphorylates the α subunit, leading to a decrease in its enzyme activity (Bertorello and Aperia, <xref ref-type="bibr" rid="B27">1989</xref>; Fukuda et al., <xref ref-type="bibr" rid="B100">1991</xref>; Beguin et al., <xref ref-type="bibr" rid="B22">1994</xref>; Marcaida et al., <xref ref-type="bibr" rid="B179">1996</xref>; Cheng et al., <xref ref-type="bibr" rid="B55">1997</xref>; Chibalin et al., <xref ref-type="bibr" rid="B57">1998</xref>; Nishi et al., <xref ref-type="bibr" rid="B200">1999</xref>; Taub et al., <xref ref-type="bibr" rid="B283">2010</xref>; Liu et al., <xref ref-type="bibr" rid="B172">2016</xref>). Calcineurin can desensitize NMDA receptors (Lieberman and Mody, <xref ref-type="bibr" rid="B167">1994</xref>) <italic>via</italic> the C-terminus of the NR2A subunit (Krupp et al., <xref ref-type="bibr" rid="B156">2002</xref>) and regulates calmodulin effects, reducing the open time of the channel (Rycroft and Gibb, <xref ref-type="bibr" rid="B250">2004</xref>).</p>
<p>During learning processes PKC is active and phosphorylates some Src family kinases (SFK), which in turn induces tyrosine phosphorylation of NMDA receptors, leading to a rapid up-regulation of NMDA receptor membrane expression (Groveman et al., <xref ref-type="bibr" rid="B113">2012</xref>). Some studies have proposed that Src protein forms a complex with the NMDA receptor through the binding of its SH2 domain with the N-terminal region of postsynaptic density protein 95 (PSD-95). Furthermore, PSD-95 seems to negatively regulate Src (Kalia et al., <xref ref-type="bibr" rid="B141">2006</xref>; Groveman et al., <xref ref-type="bibr" rid="B113">2012</xref>). Indeed, co-activation of mGluR5 and the NMDA receptor with low concentrations of their agonists (CHPG and NMDA, respectively), in rat hippocampal slices, leads to the phosphorylation of NR2B (Tyr1472) by Src kinase (Sarantis et al., <xref ref-type="bibr" rid="B252">2015</xref>), in turn increasing NMDA-mediated excitability.</p>
<p>It is important to note that NKA acts as a specific receptor for CTS. The interplay between the NKA and NMDA receptors is proposed to arise from the initial administration of CTS leading to conformational changes that enhance NMDA subunit expression as a compensatory mechanism (de Lores Arnaiz and Bersier, <xref ref-type="bibr" rid="B73">2014</xref>). OUA is also able to regulate NMDA binding and receptor activity in the adult rat brain (Reines et al., <xref ref-type="bibr" rid="B236">2001</xref>, <xref ref-type="bibr" rid="B237">2004</xref>; Bersier and Rodríguez de Lores Arnaiz, <xref ref-type="bibr" rid="B26">2009</xref>), in a concentration-dependent manner (Bersier and Rodríguez de Lores Arnaiz, <xref ref-type="bibr" rid="B26">2009</xref>). Akkuratov et al. (<xref ref-type="bibr" rid="B5">2015</xref>), in rat cerebellar neurons, showed that both α1 and α3 subunits can functionally interact with NMDA receptors whereas Sibarov and colleagues demonstrated by patch-clamp and Ca<sup>2+</sup> imaging experiments that rat cortical neurons treated with 30 μM NMDA or KA with 1 nM OUA or digoxin for 4 or 6 h, were protected from apoptosis (Sibarov et al., <xref ref-type="bibr" rid="B267">2012</xref>; Abushik et al., <xref ref-type="bibr" rid="B1">2013</xref>). Similar protection was observed <italic>in vivo</italic> (Golden and Martin, <xref ref-type="bibr" rid="B110">2006</xref>). One possible explanation is that an up-regulation of the plasma membrane NCX leads to more Ca<sup>2+</sup> extrusion preventing the increase of sEPSC frequency, which is typically found in excitotoxicity process. This up-regulation of NCX activity seems to be due to an interaction between NKA and NCX (Sibarov et al., <xref ref-type="bibr" rid="B267">2012</xref>).</p>
<p>Furthermore, a study published in 2013, in primary cerebellar cell culture treated with OUA in different concentrations (1, 10, and 100 mM) for different times (1, 2, and 4 h), suggested nuclear factor-kappaB (NF-κB) activation in a time and concentration-dependent manner. However, this effect was not observed when neurons were pre-treated with MK-801, PP1 (Src-family tyrosine kinase inhibitor), manumycin A (farnesyltransferase inhibitor), and PD98059 (mitogen-activated protein kinase (MAPK) inhibitor). As such, this study described a pathway whereby OUA activates NF-κB through the NMDA receptor-Src-Ras-MAPK pathways (de Sá Lima et al., <xref ref-type="bibr" rid="B79">2013</xref>). Strong evidence indicates that NMDA can activate NF-κB in the rat hippocampus (Lipsky et al., <xref ref-type="bibr" rid="B170">2001</xref>; Kawamoto et al., <xref ref-type="bibr" rid="B144">2012</xref>), with intra-hippocampal injection of 1 μM NMDA 1 h before the injection of 10 nM OUA potentiating NF-κB activity (Kawamoto et al., <xref ref-type="bibr" rid="B144">2012</xref>). This activation was reduced when cells were pre-treated with an NMDA receptor antagonist (MK-801), suggesting that NF-κB activation by OUA, in part, arises from NMDA receptor modulation (Kawamoto et al., <xref ref-type="bibr" rid="B144">2012</xref>). Overall, the above results indicate that OUA, through the action of NKA as a pump or as a receptor, can modulate many signals important in neurotransmission.</p>
</sec>
<sec>
<title>NKA-glutamatergic signaling: aging and neurodegenerative diseases</title>
<p>Several studies have shown age-related modifications in the NMDA receptor-NO-cGMP cascade in the CNS (Peterson and Cotman, <xref ref-type="bibr" rid="B218">1989</xref>; Tamaru et al., <xref ref-type="bibr" rid="B281">1991</xref>; Wenk et al., <xref ref-type="bibr" rid="B311">1991</xref>; Vallebuona and Raiteri, <xref ref-type="bibr" rid="B297">1995</xref>; Wardas et al., <xref ref-type="bibr" rid="B307">1997</xref>; Ossowska et al., <xref ref-type="bibr" rid="B207">2001</xref>; Chepkova et al., <xref ref-type="bibr" rid="B56">2015</xref>). In addition, the aging process is associated with a progressive decline in NKA activity, both centrally and peripherally (Scavone et al., <xref ref-type="bibr" rid="B254">2000</xref>; Kawamoto et al., <xref ref-type="bibr" rid="B145">2008</xref>; Vasconcelos et al., <xref ref-type="bibr" rid="B298">2015</xref>). In the CNS, this reduction is due to the modulation of α2 and α3 isoforms with no change in α1 and Mg<sup>2+</sup>-ATPase activities, as reported in the rat cerebellum and hippocampus (Kawamoto et al., <xref ref-type="bibr" rid="B145">2008</xref>; Vasconcelos et al., <xref ref-type="bibr" rid="B298">2015</xref>). As no differences in the α2 and α3 protein levels are evident, the age-related decrease in NKA activity is linked to modifications in glutamate-cGMP-PKG pathway (Kawamoto et al., <xref ref-type="bibr" rid="B145">2008</xref>). The age-related failure of NKA modulation by glutamate through cGMP-PKG signaling may be connected to ionic disturbances during senescence, which may predispose to neurodegenerative diseases (Scavone et al., <xref ref-type="bibr" rid="B255">2005</xref>). Interestingly, while inflammation, closely associated with aging and neurodegeneration, worsens aging-associated glutamate signaling and NKA defects, intermittent fasting counteracts this effect (Vasconcelos et al., <xref ref-type="bibr" rid="B298">2015</xref>) (Figure <xref ref-type="fig" rid="F2">2</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p><bold>Schematic model for molecular mechanisms underlying aging modulatory effects on NKA isoforms</bold>. Aging can either increase the production of ROS, such as superoxide radical and hydrogen peroxide, or induce NO<sup>•</sup> release by impairing Ca<sup>2+</sup> homeostasis and subsequently increasing intracellular Ca<sup>2+</sup> (nNOS-mediated NO<sup>•</sup> production). NO<sup>•</sup> is a free radical and can generate peroxynitrite, which may cause neurotoxicity by lipid peroxidation, mitochondria disruption, mutations of DNA and proteins, apoptosis and impairment of α1 activity. Strategies that induce NMDA activation can also activate the cGMP pathway, which, in turn, may lead to neuroprotective signaling, partly by upregulating α2 and α3 (cGMP, cyclic GMP; GLU, glutamate; NKA, Na<sup>+</sup>,K<sup>+</sup>-ATPase).</p>
</caption>
<graphic xlink:href="fphys-07-00195-g0002"></graphic>
</fig>
<p>DNA repair defects (Garinis et al., <xref ref-type="bibr" rid="B103">2008</xref>; Schumacher et al., <xref ref-type="bibr" rid="B259">2008</xref>; Végh et al., <xref ref-type="bibr" rid="B299">2012</xref>), and consequent mitochondrial dysfunction (Zahn et al., <xref ref-type="bibr" rid="B324">2007</xref>; Yankner et al., <xref ref-type="bibr" rid="B321">2008</xref>), are considered important causes of aging and, in turn, with neurodegenerative disorders (Lin and Beal, <xref ref-type="bibr" rid="B169">2006</xref>; Johri and Beal, <xref ref-type="bibr" rid="B135">2012</xref>). Likewise, ROS-induced mitochondria impairment may contribute to the etiology of neurodegenerative disorders (Lin and Beal, <xref ref-type="bibr" rid="B169">2006</xref>). Compromised mitochondria lead to impaired energy supply, producing less ATP and even more free radicals, as a consequence of inefficient oxidative phosphorylation, which, in turn, can directly or indirectly affect NKA activity (Nathanson et al., <xref ref-type="bibr" rid="B195">1995</xref>). In support of this, a number of studies show the α subunit to be sensitive to free radical attack (Kim and Akera, <xref ref-type="bibr" rid="B147">1987</xref>; Mense et al., <xref ref-type="bibr" rid="B188">1997</xref>; Xie and Xie, <xref ref-type="bibr" rid="B318">2005</xref>), with the oxidized α subunit being degraded (Zolotarjova et al., <xref ref-type="bibr" rid="B332">1994</xref>; Thevenod and Friedmann, <xref ref-type="bibr" rid="B284">1999</xref>). Furthermore, age-related increases in the levels of the free radical superoxide (<inline-formula><mml:math id="M5"><mml:mrow><mml:msubsup><mml:mtext>O</mml:mtext><mml:mn>2</mml:mn><mml:mo>−</mml:mo></mml:msubsup></mml:mrow></mml:math></inline-formula>) lead to ONOO<sup>−</sup> formation <italic>via</italic> reaction with the NO generated by glutamate signaling (Wink et al., <xref ref-type="bibr" rid="B314">1996</xref>). ONOO<sup>−</sup> also impairs NKA activity (Boldyrev et al., <xref ref-type="bibr" rid="B39">1997</xref>; Sato et al., <xref ref-type="bibr" rid="B253">1997</xref>; Muriel and Sandoval, <xref ref-type="bibr" rid="B193">2000</xref>; Kocak-Toker et al., <xref ref-type="bibr" rid="B153">2005</xref>; Reifenberger et al., <xref ref-type="bibr" rid="B235">2008</xref>). NKA inhibition also increases neuronal susceptibility to glutamate excitotoxicity, at least in part by reducing the Na<sup>+</sup> gradient necessary for glutamate transport and clearance from the synapse cleft, leading to a positive feedback loop (Lees et al., <xref ref-type="bibr" rid="B162">1990</xref>; Brines and Robbins, <xref ref-type="bibr" rid="B44">1992</xref>). Both cGMP and PKG are well-established as important mediators of LTP, which NKA also modulates (Stevens and Wang, <xref ref-type="bibr" rid="B272">1993</xref>; Zhuo et al., <xref ref-type="bibr" rid="B331">1994</xref>; Nathanson et al., <xref ref-type="bibr" rid="B195">1995</xref>). Moreover, NKA impairment downregulates the synaptic AMPA receptor, contributing to synaptic transmission defects, and consequently cognitive decline (Zhang et al., <xref ref-type="bibr" rid="B328">2009</xref>). Since cognitive impairment is a hallmark of aging and neurodegenerative diseases, NKA-mediated glutamate signaling dysfunction may be an important contributory factor to neurodegenerative disorders (Végh et al., <xref ref-type="bibr" rid="B299">2012</xref>).</p>
<p>EAAT downregulation has been associated with many neurodegenerative diseases (Sheldon and Robinson, <xref ref-type="bibr" rid="B264">2007</xref>). As described above, the resulting elevation in glutamate levels in the synapse cleft and consequent excitotoxicity may interfere in NKA functioning by increasing NO release and free-radical production (Dawson et al., <xref ref-type="bibr" rid="B68">1991</xref>).</p>
<p>Glutamatergic signaling dysfunction and its associated consequences are critical contributors to the pathophysiological underpinnings of Alzheimer's disease (AD) (Lewerenz and Maher, <xref ref-type="bibr" rid="B165">2015</xref>). AD is the most frequent form of dementia, being characterized by memory and cognitive impairments. The AD brain shows two classical changes: increased Aβ peptide deposition in senile plaques; and tau hyperphosphorylation that leads to neurofibrillary tangles (Khachaturian, <xref ref-type="bibr" rid="B146">1985</xref>; Mattson, <xref ref-type="bibr" rid="B184">2004</xref>). AD is also associated with increased ROS production (Butterfield et al., <xref ref-type="bibr" rid="B48">2001</xref>), compromised glutamate clearance (Lauderback et al., <xref ref-type="bibr" rid="B160">2001</xref>; Vitvitsky et al., <xref ref-type="bibr" rid="B304">2012</xref>) and increased immune-inflammatory activity, in association with raised levels of glutamate, which regulates tryptophan catabolites (Maes and Anderson, <xref ref-type="bibr" rid="B176">2016</xref>).</p>
<p>ATPase activities play a key role in protecting neurons from excitotoxic insults (Hattori et al., <xref ref-type="bibr" rid="B118">1998</xref>). Hattori and colleagues showed reduced NKA activity in postmortem AD patients' brains (77.2% of the controls) with no change in Mg<sup>2+</sup>-ATPase activities (Hattori et al., <xref ref-type="bibr" rid="B118">1998</xref>). The protein levels of alpha and beta subunits were also decreased in AD brains (Hattori et al., <xref ref-type="bibr" rid="B118">1998</xref>). However, although this study showed a clear reduction of NKA activity in the frontal lobes of AD brains (Hattori et al., <xref ref-type="bibr" rid="B118">1998</xref>), a previous study found no change in NKA enzyme activity in 4 AD brains vs. 5 control brains (Liguri et al., <xref ref-type="bibr" rid="B168">1990</xref>).</p>
<p>In an <italic>in vitro</italic> study, the acute administration of Aβ<sub>25−35</sub> or Aβ<sub>1−40</sub> oligomers in rat hippocampal neurons resulted in lower NKA activity (Mark et al., <xref ref-type="bibr" rid="B180">1995</xref>), suggesting a role of Aβ toxicity in the NKA activity impairment. Also, a disruption in NKA activity leads to Na<sup>+</sup> intracellular accumulation, increasing the influx of calcium through voltage-dependent calcium channels (Mark et al., <xref ref-type="bibr" rid="B180">1995</xref>), suggesting an NKA role in AD cellular toxicity and apoptosis (Hattori et al., <xref ref-type="bibr" rid="B118">1998</xref>). In an AD model, the APP+PS1 transgenic mouse, a decrease in hippocampal NKA activity and protein levels is also evident (Dickey et al., <xref ref-type="bibr" rid="B83">2005</xref>), further implicating a role for Aβ regulation of NKA in AD.</p>
<p>Supporting the NKA dysfunction in AD, Vitvitsky and colleagues showed an imbalance of Na<sup>+</sup> and K<sup>+</sup> ion concentrations in both postmortem AD brain tissue and <italic>in vitro</italic> primary astrocytes treated with Aβ<sub>25−35</sub> or Aβ<sub>1−40</sub>peptides (Vitvitsky et al., <xref ref-type="bibr" rid="B304">2012</xref>). The electrochemical Na<sup>+</sup> gradient maintained by NKA is the driving force for glutamate re-uptake by EAATs (Rose et al., <xref ref-type="bibr" rid="B243">2009</xref>). In the astrocyte cell culture, ion homeostasis disruption was associated with reduced levels of NKA and Na<sup>+</sup>-dependent EAATs (Vitvitsky et al., <xref ref-type="bibr" rid="B304">2012</xref>). Furthermore, homocysteine, a protein involved in many CNS disorders, including Parkinson's disease (Kuhn et al., <xref ref-type="bibr" rid="B157">1998</xref>) and AD (Gallucci et al., <xref ref-type="bibr" rid="B102">2004</xref>), was shown to reduce NKA activity and consequently impair glutamate reuptake in the rat hippocampus (Machado et al., <xref ref-type="bibr" rid="B175">2011</xref>). Hence, NKA impairment associated with glutamate signaling imbalance may contribute to the pathophysiology of AD and other neurodegenerative diseases by significantly deregulating membrane transport, brain electrophysiological activity and other important cellular processes (Vitvitsky et al., <xref ref-type="bibr" rid="B304">2012</xref>). Huntington's disease (HD) is another neurodegenerative disorder associated with cognitive decline and synapse impairment (DiFiglia et al., <xref ref-type="bibr" rid="B84">1995</xref>; Smith et al., <xref ref-type="bibr" rid="B270">2005</xref>; Rozas et al., <xref ref-type="bibr" rid="B248">2010</xref>; Nithianantharajah and Hannan, <xref ref-type="bibr" rid="B201">2013</xref>; Valencia et al., <xref ref-type="bibr" rid="B296">2013</xref>). Many studies show glutamate signaling to be defective in HD, which is proposed to play a role in its pathophysiology (Coyle and Schwarcz, <xref ref-type="bibr" rid="B63">1976</xref>; Beal et al., <xref ref-type="bibr" rid="B21">1986</xref>; Zeron et al., <xref ref-type="bibr" rid="B327">2002</xref>; Shehadeh et al., <xref ref-type="bibr" rid="B263">2006</xref>). In Hdh<sup>140Q∕140Q</sup>, a knock-in mouse model of HD, a reduction of NKA and glutamate transporters, VGlut1 and Vglut2, by more than 30% is evident at 12 months vs. controls (Valencia et al., <xref ref-type="bibr" rid="B295">2010</xref>, <xref ref-type="bibr" rid="B296">2013</xref>).</p>
<p>Amyotrophic lateral sclerosis (ALS) is an age-related fatal disease characterized by progressive motoneuron degeneration. The loss of Cu/Zn superoxide dismutase 1 (SOD1) activity, an antioxidant enzyme, following increased oxidative stress, is widely thought to have a role in the etiology and/or course of ALS (Julien, <xref ref-type="bibr" rid="B138">2001</xref>). Other possible contributing factors include increases in iNOS (Almer et al., <xref ref-type="bibr" rid="B6">1999</xref>), glutamate excitotoxicity due to EAATs dysfunction (Rothstein et al., <xref ref-type="bibr" rid="B246">1995</xref>; Bruijn et al., <xref ref-type="bibr" rid="B47">1997</xref>; Trotti et al., <xref ref-type="bibr" rid="B290">1999</xref>) and mitochondrial defect (Beal, <xref ref-type="bibr" rid="B20">1995</xref>). Importantly, Ellis et al. showed that the NO-sGC-cGMP pathway was significantly impaired in the transgenic SOD1 ALS murine model, with this cascade being unable to modulate NKA activity (Ellis et al., <xref ref-type="bibr" rid="B94">2003</xref>). Furthermore, in this study, a marked reduction in NKA activity accompanied by a decrease in the protein levels of the α subunits was evident. As to whether such changes are causal or a consequence of other pathophysiological processes in ALS requires further investigation (Ellis et al., <xref ref-type="bibr" rid="B94">2003</xref>).</p>
</sec>
</sec>
<sec id="s2">
<title>Conclusions and future perspective</title>
<p>NKA is present in the membranes of most eukaryotic cells and acts as ion pump. NKA can be modulated by hormones and neurotransmitters, allowing these factors to regulate NKA's diverse important effects, including in the regulation of neurotransmission. NKA can also act as a receptor for steroids, as typified by the effects of OUA, with this being another mechanism whereby it contributes to the regulation of many essential cellular functions, centrally and peripherally. Changes in NKA activity, as occurs in aging as well as when arising from mutations, will play a role in a host of CNS diseases, partly via deficits in energy and glutamatergic regulation. Central energy deficiency has been proposed to be a key factor in many, currently poorly managed, neurodegenerative diseases, which are linked to changes in brain metabolism and increased levels of apoptosis. Given that NKA is fundamental for optimizing central synaptic functioning, as well as energy regulation, its further study, including its environmental, epigenetic and genetic regulation, are likely to be important in the development of new pharmacological and non-pharmaceutical treatments for a host of medical conditions that are currently poorly managed, as well as for the study and regulation of aging <italic>per se</italic>.</p>
</sec>
<sec id="s3">
<title>Author contributions</title>
<p>Conceived and designed the manuscript: EK, LQ, and CS. Wrote the manuscript: AO, AV, PK, JL, and LQ have contributed equally to this work. Final revision: LQ, EK, CS, AO, PK, AV, JL.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</sec>
</body>
<back>
<ack>
<p>AO, AV, JL, and PK are supported by Ph.D. fellowship from Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP). CS and LQ are research fellows of Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq). This publication was made possible by Grants from FAPESP to CS; FAPESP Young Investigators Grants to EK; CNPq to CS and LQ; and the Neuroscience Research Suport Centers (NAPNA). We thank George Anderson, CRC Scotland and London for English Editing.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abushik</surname><given-names>P. A.</given-names></name><name><surname>Sibarov</surname><given-names>D. A.</given-names></name><name><surname>Eaton</surname><given-names>M. J.</given-names></name><name><surname>Skatchkov</surname><given-names>S. N.</given-names></name><name><surname>Antonov</surname><given-names>S. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Kainate-induced calcium overload of cortical neurons <italic>in vitro</italic>: dependence on expression of AMPAR GluA2-subunit and down-regulation by subnanomolar ouabain</article-title>. <source/>Cell Calcium
<volume>54</volume>, <fpage>95</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceca.2013.05.002</pub-id><pub-id pub-id-type="pmid">23721822</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aitta-aho</surname><given-names>T.</given-names></name><name><surname>Möykkynen</surname><given-names>T. P.</given-names></name><name><surname>Panhelainen</surname><given-names>A. E.</given-names></name><name><surname>Vekovischeva</surname><given-names>O. Y.</given-names></name><name><surname>Bäckström</surname><given-names>P.</given-names></name><name><surname>Korpi</surname><given-names>E. R.</given-names></name></person-group> (<year>2012</year>). <article-title>Importance of GluA1 subunit-containing AMPA glutamate receptors for morphine state-dependency</article-title>. <source/>PLoS ONE
<volume>7</volume>:<fpage>e38325</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0038325</pub-id><pub-id pub-id-type="pmid">22675452</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akera</surname><given-names>T.</given-names></name><name><surname>Brody</surname><given-names>T. M.</given-names></name></person-group> (<year>1977</year>). <article-title>The role of Na<sup>+</sup>, K<sup>+</sup>-ATPase in the inotropic action of digitalis</article-title>. <source/>Pharmacol. Rev.
<volume>29</volume>, <fpage>187</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="pmid">150607</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akera</surname><given-names>T.</given-names></name><name><surname>Hook</surname><given-names>J. B.</given-names></name><name><surname>Tobin</surname><given-names>T.</given-names></name><name><surname>Brody</surname><given-names>T. M.</given-names></name></person-group> (<year>1972</year>). <article-title>Cardiac glycoside sensitivity of (Na + +K +)-activated ATPase in new-born rats</article-title>. <source/>Res. Commun. Chem. Pathol. Pharmacol.
<volume>4</volume>, <fpage>699</fpage>–<lpage>706</lpage>. <pub-id pub-id-type="pmid">4264311</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Akkuratov</surname><given-names>E. E.</given-names></name><name><surname>Lopacheva</surname><given-names>O. M.</given-names></name><name><surname>Kruusmägi</surname><given-names>M.</given-names></name><name><surname>Lopachev</surname><given-names>A. V.</given-names></name><name><surname>Shah</surname><given-names>Z. A.</given-names></name><name><surname>Boldyrev</surname><given-names>A. A.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Functional interaction between Na/K-ATPase and NMDA receptor in cerebellar neurons</article-title>. <source/>Mol. Neurobiol.
<volume>52</volume>, <fpage>1726</fpage>–<lpage>1734</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-014-8975-3</pub-id><pub-id pub-id-type="pmid">25381029</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Almer</surname><given-names>G.</given-names></name><name><surname>Vukosavic</surname><given-names>S.</given-names></name><name><surname>Romero</surname><given-names>N.</given-names></name><name><surname>Przedborski</surname><given-names>S.</given-names></name></person-group> (<year>1999</year>). <article-title>Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis</article-title>. <source/>J. Neurochem.
<volume>72</volume>, <fpage>2415</fpage>–<lpage>2425</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.1999.0722415.x</pub-id><pub-id pub-id-type="pmid">10349851</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alvarsson</surname><given-names>A.</given-names></name><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Stan</surname><given-names>T. L.</given-names></name><name><surname>Schintu</surname><given-names>N.</given-names></name><name><surname>Kadkhodaei</surname><given-names>B.</given-names></name><name><surname>Millan</surname><given-names>M. J.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Modulation by trace amine-associated receptor 1 of experimental Parkinsonism, L-DOPA responsivity, and glutamatergic neurotransmission</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>14057</fpage>–<lpage>14069</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1312-15.2015</pub-id><pub-id pub-id-type="pmid">26468205</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amara</surname><given-names>S. G.</given-names></name><name><surname>Fontana</surname><given-names>A. C.</given-names></name></person-group> (<year>2002</year>). <article-title>Excitatory amino acid transporters: keeping up with glutamate</article-title>. <source/>Neurochem. Int.
<volume>41</volume>, <fpage>313</fpage>–<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1016/S0197-0186(02)00018-9</pub-id><pub-id pub-id-type="pmid">12176072</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>C. M.</given-names></name><name><surname>Swanson</surname><given-names>R. A.</given-names></name></person-group> (<year>2000</year>). <article-title>Astrocyte glutamate transport: review of properties, regulation, and physiological functions</article-title>. <source/>Glia
<volume>32</volume>, <fpage>1</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1002/1098-1136(200010)32:1&lt;1::AID-GLIA10&gt;3.0.CO;2-W</pub-id><pub-id pub-id-type="pmid">10975906</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anselm</surname><given-names>I. A.</given-names></name><name><surname>Sweadner</surname><given-names>K. J.</given-names></name><name><surname>Gollamudi</surname><given-names>S.</given-names></name><name><surname>Ozelius</surname><given-names>L. J.</given-names></name><name><surname>Darras</surname><given-names>B. T.</given-names></name></person-group> (<year>2009</year>). <article-title>Rapid-onset dystonia-parkinsonism in a child with a novel atp1a3 gene mutation</article-title>. <source/>Neurology
<volume>73</volume>, <fpage>400</fpage>–<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0b013e3181b04acd</pub-id><pub-id pub-id-type="pmid">19652145</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aperia</surname><given-names>A. C.</given-names></name><name><surname>Akkuratov</surname><given-names>E. E.</given-names></name><name><surname>Fontana</surname><given-names>J. M.</given-names></name><name><surname>Brismar</surname><given-names>H.</given-names></name></person-group> (<year>2016</year>). <article-title>Na<sup>+</sup>-K<sup>+</sup>-ATPase, a new class of plasma membrane receptors</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>310</volume>, <fpage>C491</fpage>–<lpage>C495</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00359.2015</pub-id><pub-id pub-id-type="pmid">26791490</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aperia</surname><given-names>A.</given-names></name><name><surname>Ibarra</surname><given-names>F.</given-names></name><name><surname>Svensson</surname><given-names>L. B.</given-names></name><name><surname>Klee</surname><given-names>C.</given-names></name><name><surname>Greengard</surname><given-names>P.</given-names></name></person-group> (<year>1992</year>). <article-title>Calcineurin mediates alpha-adrenergic stimulation of Na+, K(+)-ATPase activity in renal tubule cells</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>89</volume>, <fpage>7394</fpage>–<lpage>7397</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.89.16.7394</pub-id><pub-id pub-id-type="pmid">1380157</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arnaud-Batista</surname><given-names>F. J.</given-names></name><name><surname>Costa</surname><given-names>G. T.</given-names></name><name><surname>Oliveira</surname><given-names>I. M.</given-names></name><name><surname>Costa</surname><given-names>P. P.</given-names></name><name><surname>Santos</surname><given-names>C. F.</given-names></name><name><surname>Fonteles</surname><given-names>M. C.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Natriuretic effect of bufalin in isolated rat kidneys involves activation of the Na+-K+-ATPase-Src kinase pathway</article-title>. <source/>Am. J. Physiol. Renal Physiol.
<volume>302</volume>, <fpage>F959</fpage>–<lpage>F966</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.00130.2011</pub-id><pub-id pub-id-type="pmid">22237798</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aroniadou-Anderjaska</surname><given-names>V.</given-names></name><name><surname>Fritsch</surname><given-names>B.</given-names></name><name><surname>Qashu</surname><given-names>F.</given-names></name><name><surname>Braga</surname><given-names>M. F.</given-names></name></person-group> (<year>2008</year>). <article-title>Pathology and pathophysiology of the amygdala in epileptogenesis and epilepsy</article-title>. <source/>Epilepsy Res.
<volume>78</volume>, <fpage>102</fpage>–<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2007.11.011</pub-id><pub-id pub-id-type="pmid">18226499</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asmus</surname><given-names>F.</given-names></name><name><surname>Gasser</surname><given-names>T.</given-names></name></person-group> (<year>2010</year>). <article-title>Dystonia-plus syndromes</article-title>. <source/>Eur. J. Neurol.
<volume>17</volume> (<issue>Suppl. 1</issue>), <fpage>37</fpage>–<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1111/j.1468-1331.2010.03049.x</pub-id><pub-id pub-id-type="pmid">20590807</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Azizan</surname><given-names>E. A.</given-names></name><name><surname>Poulsen</surname><given-names>H.</given-names></name><name><surname>Tuluc</surname><given-names>P.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Clausen</surname><given-names>M. V.</given-names></name><name><surname>Lieb</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension</article-title>. <source/>Nat. Genet.
<volume>45</volume>, <fpage>1055</fpage>–<lpage>1060</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2716</pub-id><pub-id pub-id-type="pmid">23913004</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbano</surname><given-names>R. L.</given-names></name><name><surname>Hill</surname><given-names>D. F.</given-names></name><name><surname>Snively</surname><given-names>B. M.</given-names></name><name><surname>Light</surname><given-names>L. S.</given-names></name><name><surname>Boggs</surname><given-names>N.</given-names></name><name><surname>McCall</surname><given-names>W. V.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>New triggers and non-motor findings in a family with rapid-onset dystonia-parkinsonism</article-title>. <source/>Parkinsonism Relat. Disord.
<volume>18</volume>, <fpage>737</fpage>–<lpage>741</lpage>. <pub-id pub-id-type="doi">10.1016/j.parkreldis.2012.03.020</pub-id><pub-id pub-id-type="pmid">22534615</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassan</surname><given-names>M.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Madsen</surname><given-names>K. L.</given-names></name><name><surname>Armsen</surname><given-names>W.</given-names></name><name><surname>Zhou</surname><given-names>J.</given-names></name><name><surname>Desilva</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Interaction between the glutamate transporter GLT1b and the synaptic PDZ domain protein PICK1</article-title>. <source/>Eur. J. Neurosci.
<volume>27</volume>, <fpage>66</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2007.05986.x</pub-id><pub-id pub-id-type="pmid">18184314</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bauer</surname><given-names>D. E.</given-names></name><name><surname>Jackson</surname><given-names>J. G.</given-names></name><name><surname>Genda</surname><given-names>E. N.</given-names></name><name><surname>Montoya</surname><given-names>M. M.</given-names></name><name><surname>Yudkoff</surname><given-names>M.</given-names></name><name><surname>Robinson</surname><given-names>M. B.</given-names></name></person-group> (<year>2012</year>). <article-title>The glutamate transporter, GLAST, participates in a macromolecular complex that supports glutamate metabolism</article-title>. <source/>Neurochem. Int.
<volume>61</volume>, <fpage>566</fpage>–<lpage>574</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2012.01.013</pub-id><pub-id pub-id-type="pmid">22306776</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beal</surname><given-names>M. F.</given-names></name></person-group> (<year>1995</year>). <article-title>Aging, energy, and oxidative stress in neurodegenerative diseases</article-title>. <source/>Ann. Neurol.
<volume>38</volume>, <fpage>357</fpage>–<lpage>366</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410380304</pub-id><pub-id pub-id-type="pmid">7668820</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beal</surname><given-names>M. F.</given-names></name><name><surname>Kowall</surname><given-names>N. W.</given-names></name><name><surname>Ellison</surname><given-names>D. W.</given-names></name><name><surname>Mazurek</surname><given-names>M. F.</given-names></name><name><surname>Swartz</surname><given-names>K. J.</given-names></name><name><surname>Martin</surname><given-names>J. B.</given-names></name></person-group> (<year>1986</year>). <article-title>Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid</article-title>. <source/>Nature
<volume>321</volume>, <fpage>168</fpage>–<lpage>171</lpage>. <pub-id pub-id-type="doi">10.1038/321168a0</pub-id><pub-id pub-id-type="pmid">2422561</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beguin</surname><given-names>P.</given-names></name><name><surname>Beggah</surname><given-names>A. T.</given-names></name><name><surname>Chibalin</surname><given-names>A. V.</given-names></name><name><surname>Burgener-Kairuz</surname><given-names>P.</given-names></name><name><surname>Jaisser</surname><given-names>F.</given-names></name><name><surname>Mathews</surname><given-names>P. M.</given-names></name><etal></etal></person-group>. (<year>1994</year>). <article-title>Phosphorylation of the Na,K-ATPase alpha-subunit by protein kinase A and C <italic>in vitro</italic> and in intact cells. Identification of a novel motif for PKC-mediated phosphorylation</article-title>. <source/>J. Biol. Chem.
<volume>269</volume>, <fpage>24437</fpage>–<lpage>24445</lpage>. <pub-id pub-id-type="pmid">7929106</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Behrens</surname><given-names>P. F.</given-names></name><name><surname>Franz</surname><given-names>P.</given-names></name><name><surname>Woodman</surname><given-names>B.</given-names></name><name><surname>Lindenberg</surname><given-names>K. S.</given-names></name><name><surname>Landwehrmeyer</surname><given-names>G. B.</given-names></name></person-group> (<year>2002</year>). <article-title>Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation</article-title>. <source/>Brain
<volume>125(Pt 8)</volume>, <fpage>1908</fpage>–<lpage>1922</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awf180</pub-id><pub-id pub-id-type="pmid">12135980</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berl</surname><given-names>S.</given-names></name><name><surname>Lajtha</surname><given-names>A.</given-names></name><name><surname>Waelsch</surname><given-names>H.</given-names></name></person-group> (<year>1961</year>). <article-title>Amino acid and protein metabolism. VI. Cerebral compartments of glutamic acid metabolism</article-title>. <source/>J. Neurochem.
<volume>7</volume>, <fpage>186</fpage>–<lpage>197</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.1961.tb13503.x</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berman</surname><given-names>R. M.</given-names></name><name><surname>Cappiello</surname><given-names>A.</given-names></name><name><surname>Anand</surname><given-names>A.</given-names></name><name><surname>Oren</surname><given-names>D. A.</given-names></name><name><surname>Heninger</surname><given-names>G. R.</given-names></name><name><surname>Charney</surname><given-names>D. S.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Antidepressant effects of ketamine in depressed patients</article-title>. <source/>Biol. Psychiatry
<volume>47</volume>, <fpage>351</fpage>–<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-3223(99)00230-9</pub-id><pub-id pub-id-type="pmid">10686270</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bersier</surname><given-names>M. G.</given-names></name><name><surname>Rodríguez de Lores Arnaiz</surname><given-names>G.</given-names></name></person-group> (<year>2009</year>). <article-title>Intracerebroventricular administration of ouabain to rats changes the expression of NMDA receptor subunits in cerebral cortex and hippocampus</article-title>. <source/>Neurochem. Res.
<volume>34</volume>, <fpage>1650</fpage>–<lpage>1657</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-009-9956-1</pub-id><pub-id pub-id-type="pmid">19322657</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertorello</surname><given-names>A.</given-names></name><name><surname>Aperia</surname><given-names>A.</given-names></name></person-group> (<year>1989</year>). <article-title>Na+-K+-ATPase is an effector protein for protein kinase C in renal proximal tubule cells</article-title>. <source/>Am. J. Physiol.
<volume>256</volume><issue>(2 Pt 2)</issue>, <fpage>F370</fpage>–<lpage>F373</lpage>. <pub-id pub-id-type="pmid">2537029</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bertorello</surname><given-names>A. M.</given-names></name><name><surname>Aperia</surname><given-names>A.</given-names></name><name><surname>Walaas</surname><given-names>S. I.</given-names></name><name><surname>Nairn</surname><given-names>A. C.</given-names></name><name><surname>Greengard</surname><given-names>P.</given-names></name></person-group> (<year>1991</year>). <article-title>Phosphorylation of the catalytic subunit of Na+, K(+)-ATPase inhibits the activity of the enzyme</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>88</volume>, <fpage>11359</fpage>–<lpage>11362</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.88.24.11359</pub-id><pub-id pub-id-type="pmid">1662394</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beuschlein</surname><given-names>F.</given-names></name><name><surname>Boulkroun</surname><given-names>S.</given-names></name><name><surname>Osswald</surname><given-names>A.</given-names></name><name><surname>Wieland</surname><given-names>T.</given-names></name><name><surname>Nielsen</surname><given-names>H. N.</given-names></name><name><surname>Lichtenauer</surname><given-names>U. D.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension</article-title>. <source/>Nat. Genet.
<volume>45</volume>, <fpage>440</fpage>–<lpage>4</lpage>, 4e1–2. <pub-id pub-id-type="doi">10.1038/ng.2550</pub-id><pub-id pub-id-type="pmid">23416519</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bianchin</surname><given-names>M. M.</given-names></name><name><surname>Londero</surname><given-names>R. G.</given-names></name><name><surname>Lima</surname><given-names>J. E.</given-names></name><name><surname>Bigal</surname><given-names>M. E.</given-names></name></person-group> (<year>2010</year>). <article-title>Migraine and epilepsy: a focus on overlapping clinical, pathophysiological, molecular, and therapeutic aspects</article-title>. <source/>Curr. Pain Headache Rep.
<volume>14</volume>, <fpage>276</fpage>–<lpage>283</lpage>. <pub-id pub-id-type="doi">10.1007/s11916-010-0121-y</pub-id><pub-id pub-id-type="pmid">20495966</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname><given-names>G.</given-names></name></person-group> (<year>2005</year>). <article-title>Na,K-ATPase subunit heterogeneity as a mechanism for tissue-specific ion regulation</article-title>. <source/>Semin. Nephrol.
<volume>25</volume>, <fpage>292</fpage>–<lpage>303</lpage>. <pub-id pub-id-type="doi">10.1016/j.semnephrol.2005.03.004</pub-id><pub-id pub-id-type="pmid">16139684</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname><given-names>G.</given-names></name><name><surname>DeTomaso</surname><given-names>A. W.</given-names></name><name><surname>Koster</surname><given-names>J.</given-names></name><name><surname>Xie</surname><given-names>Z. J.</given-names></name><name><surname>Mercer</surname><given-names>R. W.</given-names></name></person-group> (<year>1994</year>). <article-title>The alpha-subunit of the Na, K-ATPase has catalytic activity independent of the beta-subunit</article-title>. <source/>J. Biol. Chem.
<volume>269</volume>, <fpage>23420</fpage>–<lpage>23425</lpage>. <pub-id pub-id-type="pmid">8089106</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname><given-names>G.</given-names></name><name><surname>Mercer</surname><given-names>R. W.</given-names></name></person-group> (<year>1998</year>). <article-title>Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function</article-title>. <source/>Am. J. Physiol.
<volume>275</volume><issue>(5 Pt 2)</issue>, <fpage>F633</fpage>–<lpage>F650</lpage>. <pub-id pub-id-type="pmid">9815123</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco</surname><given-names>G.</given-names></name><name><surname>Sánchez</surname><given-names>G.</given-names></name><name><surname>Melton</surname><given-names>R. J.</given-names></name><name><surname>Tourtellotte</surname><given-names>W. G.</given-names></name><name><surname>Mercer</surname><given-names>R. W.</given-names></name></person-group> (<year>2000</year>). <article-title>The alpha4 isoform of the Na,K-ATPase is expressed in the germ cells of the testes</article-title>. <source/>J. Histochem. Cytochem.
<volume>48</volume>, <fpage>1023</fpage>–<lpage>1032</lpage>. <pub-id pub-id-type="doi">10.1177/002215540004800801</pub-id><pub-id pub-id-type="pmid">10898797</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blanco-Arias</surname><given-names>P.</given-names></name><name><surname>Einholm</surname><given-names>A. P.</given-names></name><name><surname>Mamsa</surname><given-names>H.</given-names></name><name><surname>Concheiro</surname><given-names>C.</given-names></name><name><surname>Gutiérrez-de-Terán</surname><given-names>H.</given-names></name><name><surname>Romero</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>A C-terminal mutation of ATP1A3 underscores the crucial role of sodium affinity in the pathophysiology of rapid-onset dystonia-parkinsonism</article-title>. <source/>Hum. Mol. Genet.
<volume>18</volume>, <fpage>2370</fpage>–<lpage>2377</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddp170</pub-id><pub-id pub-id-type="pmid">19351654</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bliss</surname><given-names>T. V.</given-names></name><name><surname>Collingridge</surname><given-names>G. L.</given-names></name></person-group> (<year>1993</year>). <article-title>A synaptic model of memory: long-term potentiation in the hippocampus</article-title>. <source/>Nature
<volume>361</volume>, <fpage>31</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1038/361031a0</pub-id><pub-id pub-id-type="pmid">8421494</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boelman</surname><given-names>C.</given-names></name><name><surname>Lagman-Bartolome</surname><given-names>A. M.</given-names></name><name><surname>MacGregor</surname><given-names>D. L.</given-names></name><name><surname>McCabe</surname><given-names>J.</given-names></name><name><surname>Logan</surname><given-names>W. J.</given-names></name><name><surname>Minassian</surname><given-names>B. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Identical ATP1A3 mutation causes alternating hemiplegia of childhood and rapid-onset dystonia parkinsonism phenotypes</article-title>. <source/>Pediatr. Neurol.
<volume>51</volume>, <fpage>850</fpage>–<lpage>853</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2014.08.015</pub-id><pub-id pub-id-type="pmid">25439493</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolay</surname><given-names>H.</given-names></name><name><surname>Reuter</surname><given-names>U.</given-names></name><name><surname>Dunn</surname><given-names>A. K.</given-names></name><name><surname>Huang</surname><given-names>Z.</given-names></name><name><surname>Boas</surname><given-names>D. A.</given-names></name><name><surname>Moskowitz</surname><given-names>M. A.</given-names></name></person-group> (<year>2002</year>). <article-title>Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model</article-title>. <source/>Nat. Med.
<volume>8</volume>, <fpage>136</fpage>–<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1038/nm0202-136</pub-id><pub-id pub-id-type="pmid">11821897</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boldyrev</surname><given-names>A. A.</given-names></name><name><surname>Bulygina</surname><given-names>E. R.</given-names></name><name><surname>Kramarenko</surname><given-names>G. G.</given-names></name><name><surname>Vanin</surname><given-names>A. F.</given-names></name></person-group> (<year>1997</year>). <article-title>Effect of nitroso compounds on Na/K-ATPase</article-title>. <source/>Biochim. Biophys. Acta
<volume>1321</volume>, <fpage>243</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1016/S0005-2728(97)00053-4</pub-id><pub-id pub-id-type="pmid">9393642</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bonnet</surname><given-names>C. S.</given-names></name><name><surname>Williams</surname><given-names>A. S.</given-names></name><name><surname>Gilbert</surname><given-names>S. J.</given-names></name><name><surname>Harvey</surname><given-names>A. K.</given-names></name><name><surname>Evans</surname><given-names>B. A.</given-names></name><name><surname>Mason</surname><given-names>D. J.</given-names></name></person-group> (<year>2015</year>). <article-title>AMPA/kainate glutamate receptors contribute to inflammation, degeneration and pain related behaviour in inflammatory stages of arthritis</article-title>. <source/>Ann. Rheum. Dis.
<volume>74</volume>, <fpage>242</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1136/annrheumdis-2013-203670</pub-id><pub-id pub-id-type="pmid">24130267</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bøttger</surname><given-names>P.</given-names></name><name><surname>Glerup</surname><given-names>S.</given-names></name><name><surname>Gesslein</surname><given-names>B.</given-names></name><name><surname>Illarionova</surname><given-names>N. B.</given-names></name><name><surname>Isaksen</surname><given-names>T. J.</given-names></name><name><surname>Heuck</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Glutamate-system defects behind psychiatric manifestations in a familial hemiplegic migraine type 2 disease-mutation mouse model</article-title>. <source/>Sci. Rep.
<volume>6</volume>, <fpage>22047</fpage>. <pub-id pub-id-type="doi">10.1038/srep22047</pub-id><pub-id pub-id-type="pmid">26911348</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowyer</surname><given-names>S. M.</given-names></name><name><surname>Aurora</surname><given-names>K. S.</given-names></name><name><surname>Moran</surname><given-names>J. E.</given-names></name><name><surname>Tepley</surname><given-names>N.</given-names></name><name><surname>Welch</surname><given-names>K. M.</given-names></name></person-group> (<year>2001</year>). <article-title>Magnetoencephalographic fields from patients with spontaneous and induced migraine aura</article-title>. <source/>Ann. Neurol.
<volume>50</volume>, <fpage>582</fpage>–<lpage>587</lpage>. <pub-id pub-id-type="doi">10.1002/ana.1293</pub-id><pub-id pub-id-type="pmid">11706963</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brashear</surname><given-names>A.</given-names></name><name><surname>Mink</surname><given-names>J. W.</given-names></name><name><surname>Hill</surname><given-names>D. F.</given-names></name><name><surname>Boggs</surname><given-names>N.</given-names></name><name><surname>McCall</surname><given-names>W. V.</given-names></name><name><surname>Stacy</surname><given-names>M. A.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>ATP1A3 mutations in infants: a new rapid-onset dystonia-Parkinsonism phenotype characterized by motor delay and ataxia</article-title>. <source/>Dev. Med. Child Neurol.
<volume>54</volume>, <fpage>1065</fpage>–<lpage>1067</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-8749.2012.04421.x</pub-id><pub-id pub-id-type="pmid">22924536</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brines</surname><given-names>M. L.</given-names></name><name><surname>Robbins</surname><given-names>R. J.</given-names></name></person-group> (<year>1992</year>). <article-title>Inhibition of alpha 2/alpha 3 sodium pump isoforms potentiates glutamate neurotoxicity</article-title>. <source/>Brain Res.
<volume>591</volume>, <fpage>94</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(92)90982-F</pub-id><pub-id pub-id-type="pmid">1359920</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bristot Silvestrin</surname><given-names>R.</given-names></name><name><surname>Bambini-Junior</surname><given-names>V.</given-names></name><name><surname>Galland</surname><given-names>F.</given-names></name><name><surname>Daniele Bobermim</surname><given-names>L.</given-names></name><name><surname>Quincozes-Santos</surname><given-names>A.</given-names></name><name><surname>Torres Abib</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Animal model of autism induced by prenatal exposure to valproate: altered glutamate metabolism in the hippocampus</article-title>. <source/>Brain Res.
<volume>1495</volume>, <fpage>52</fpage>–<lpage>60</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2012.11.048</pub-id><pub-id pub-id-type="pmid">23219577</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broude</surname><given-names>N. E.</given-names></name><name><surname>Modyanov</surname><given-names>N. N.</given-names></name><name><surname>Monastyrskaya</surname><given-names>G. S.</given-names></name><name><surname>Sverdlov</surname><given-names>E. D.</given-names></name></person-group> (<year>1989</year>). <article-title>Advances in Na+, K+-ATPase studies: from protein to gene and back to protein</article-title>. <source/>FEBS Lett.
<volume>257</volume>, <fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/0014-5793(89)81773-9</pub-id><pub-id pub-id-type="pmid">2553482</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bruijn</surname><given-names>L. I.</given-names></name><name><surname>Becher</surname><given-names>M. W.</given-names></name><name><surname>Lee</surname><given-names>M. K.</given-names></name><name><surname>Anderson</surname><given-names>K. L.</given-names></name><name><surname>Jenkins</surname><given-names>N. A.</given-names></name><name><surname>Copeland</surname><given-names>N. G.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions</article-title>. <source/>Neuron
<volume>18</volume>, <fpage>327</fpage>–<lpage>338</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80272-X</pub-id><pub-id pub-id-type="pmid">9052802</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butterfield</surname><given-names>D. A.</given-names></name><name><surname>Drake</surname><given-names>J.</given-names></name><name><surname>Pocernich</surname><given-names>C.</given-names></name><name><surname>Castegna</surname><given-names>A.</given-names></name></person-group> (<year>2001</year>). <article-title>Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide</article-title>. <source/>Trends Mol. Med.
<volume>7</volume>, <fpage>548</fpage>–<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1016/S1471-4914(01)02173-6</pub-id><pub-id pub-id-type="pmid">11733217</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>T.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Gunning</surname><given-names>W. T.</given-names></name><name><surname>Quintas</surname><given-names>L. E.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Regulation of caveolin-1 membrane trafficking by the Na/K-ATPase</article-title>. <source/>J. Cell Biol.
<volume>182</volume>, <fpage>1153</fpage>–<lpage>1169</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.200712022</pub-id><pub-id pub-id-type="pmid">18794328</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campos</surname><given-names>F.</given-names></name><name><surname>Sobrino</surname><given-names>T.</given-names></name><name><surname>Pérez-Mato</surname><given-names>M.</given-names></name><name><surname>Rodríguez-Osorio</surname><given-names>X.</given-names></name><name><surname>Leira</surname><given-names>R.</given-names></name><name><surname>Blanco</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Glutamate oxaloacetate transaminase: a new key in the dysregulation of glutamate in migraine patients</article-title>. <source/>Cephalalgia
<volume>33</volume>, <fpage>1148</fpage>–<lpage>1154</lpage>. <pub-id pub-id-type="doi">10.1177/0333102413487444</pub-id><pub-id pub-id-type="pmid">23674828</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cereijido</surname><given-names>M.</given-names></name><name><surname>Contreras</surname><given-names>R. G.</given-names></name><name><surname>Shoshani</surname><given-names>L.</given-names></name><name><surname>Larre</surname><given-names>I.</given-names></name></person-group> (<year>2012</year>). <article-title>The Na+-K+-ATPase as self-adhesion molecule and hormone receptor</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>302</volume>, <fpage>C473</fpage>–<lpage>C481</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00083.2011</pub-id><pub-id pub-id-type="pmid">22049208</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charlesworth</surname><given-names>G.</given-names></name><name><surname>Bhatia</surname><given-names>K. P.</given-names></name><name><surname>Wood</surname><given-names>N. W.</given-names></name></person-group> (<year>2013</year>). <article-title>The genetics of dystonia: new twists in an old tale</article-title>. <source/>Brain
<volume>136(Pt 7)</volume>, <fpage>2017</fpage>–<lpage>2037</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awt138</pub-id><pub-id pub-id-type="pmid">23775978</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chatton</surname><given-names>J. Y.</given-names></name><name><surname>Marquet</surname><given-names>P.</given-names></name><name><surname>Magistretti</surname><given-names>P. J.</given-names></name></person-group> (<year>2000</year>). <article-title>A quantitative analysis of L-glutamate-regulated Na+ dynamics in mouse cortical astrocytes: implications for cellular bioenergetics</article-title>. <source/>Eur. J. Neurosci.
<volume>12</volume>, <fpage>3843</fpage>–<lpage>3853</lpage>. <pub-id pub-id-type="doi">10.1046/j.1460-9568.2000.00269.x</pub-id><pub-id pub-id-type="pmid">11069579</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>W.</given-names></name><name><surname>Mahadomrongkul</surname><given-names>V.</given-names></name><name><surname>Berger</surname><given-names>U. V.</given-names></name><name><surname>Bassan</surname><given-names>M.</given-names></name><name><surname>DeSilva</surname><given-names>T.</given-names></name><name><surname>Tanaka</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>The glutamate transporter GLT1a is expressed in excitatory axon terminals of mature hippocampal neurons</article-title>. <source/>J. Neurosci.
<volume>24</volume>, <fpage>1136</fpage>–<lpage>1148</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1586-03.2004</pub-id><pub-id pub-id-type="pmid">14762132</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>X. J.</given-names></name><name><surname>Höög</surname><given-names>J. O.</given-names></name><name><surname>Nairn</surname><given-names>A. C.</given-names></name><name><surname>Greengard</surname><given-names>P.</given-names></name><name><surname>Aperia</surname><given-names>A.</given-names></name></person-group> (<year>1997</year>). <article-title>Regulation of rat Na(+)-K(+)-ATPase activity by PKC is modulated by state of phosphorylation of Ser-943 by PKA</article-title>. <source/>Am. J. Physiol.
<volume>273</volume><issue>(6 Pt 1)</issue>, <fpage>C1981</fpage>–<lpage>C1986</lpage>. <pub-id pub-id-type="pmid">9435504</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chepkova</surname><given-names>A. N.</given-names></name><name><surname>Schönfeld</surname><given-names>S.</given-names></name><name><surname>Sergeeva</surname><given-names>O. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Age-related alterations in the expression of genes and synaptic plasticity associated with nitric oxide signaling in the mouse dorsal striatum</article-title>. <source/>Neural Plast.
<volume>2015</volume>, <fpage>458123</fpage>. <pub-id pub-id-type="doi">10.1155/2015/458123</pub-id><pub-id pub-id-type="pmid">25821602</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chibalin</surname><given-names>A. V.</given-names></name><name><surname>Pedemonte</surname><given-names>C. H.</given-names></name><name><surname>Katz</surname><given-names>A. I.</given-names></name><name><surname>Féraille</surname><given-names>E.</given-names></name><name><surname>Berggren</surname><given-names>P. O.</given-names></name><name><surname>Bertorello</surname><given-names>A. M.</given-names></name></person-group> (<year>1998</year>). <article-title>Phosphorylation of the catalyic alpha-subunit constitutes a triggering signal for Na+, K+-ATPase endocytosis</article-title>. <source/>J. Biol. Chem.
<volume>273</volume>, <fpage>8814</fpage>–<lpage>8819</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.273.15.8814</pub-id><pub-id pub-id-type="pmid">9535860</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cholet</surname><given-names>N.</given-names></name><name><surname>Pellerin</surname><given-names>L.</given-names></name><name><surname>Magistretti</surname><given-names>P. J.</given-names></name><name><surname>Hamel</surname><given-names>E.</given-names></name></person-group> (<year>2002</year>). <article-title>Similar perisynaptic glial localization for the Na+, K+-ATPase alpha 2 subunit and the glutamate transporters GLAST and GLT-1 in the rat somatosensory cortex</article-title>. <source/>Cereb. Cortex
<volume>12</volume>, <fpage>515</fpage>–<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/12.5.515</pub-id><pub-id pub-id-type="pmid">11950769</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clapcote</surname><given-names>S. J.</given-names></name><name><surname>Duffy</surname><given-names>S.</given-names></name><name><surname>Xie</surname><given-names>G.</given-names></name><name><surname>Kirshenbaum</surname><given-names>G.</given-names></name><name><surname>Bechard</surname><given-names>A. R.</given-names></name><name><surname>Rodacker Schack</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Mutation I810N in the alpha3 isoform of Na+, K+-ATPase causes impairments in the sodium pump and hyperexcitability in the CNS</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>106</volume>, <fpage>14085</fpage>–<lpage>14090</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0904817106</pub-id><pub-id pub-id-type="pmid">19666602</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coesmans</surname><given-names>M.</given-names></name><name><surname>Smitt</surname><given-names>P. A.</given-names></name><name><surname>Linden</surname><given-names>D. J.</given-names></name><name><surname>Shigemoto</surname><given-names>R.</given-names></name><name><surname>Hirano</surname><given-names>T.</given-names></name><name><surname>Yamakawa</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Mechanisms underlying cerebellar motor deficits due to mGluR1-autoantibodies</article-title>. <source/>Ann. Neurol.
<volume>53</volume>, <fpage>325</fpage>–<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1002/ana.10451</pub-id><pub-id pub-id-type="pmid">12601700</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conquet</surname><given-names>F.</given-names></name><name><surname>Bashir</surname><given-names>Z. I.</given-names></name><name><surname>Davies</surname><given-names>C. H.</given-names></name><name><surname>Daniel</surname><given-names>H.</given-names></name><name><surname>Ferraguti</surname><given-names>F.</given-names></name><name><surname>Bordi</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>1994</year>). <article-title>Motor deficit and impairment of synaptic plasticity in mice lacking mGluR1</article-title>. <source/>Nature
<volume>372</volume>, <fpage>237</fpage>–<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1038/372237a0</pub-id><pub-id pub-id-type="pmid">7969468</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cook</surname><given-names>J. F.</given-names></name><name><surname>Hill</surname><given-names>D. F.</given-names></name><name><surname>Snively</surname><given-names>B. M.</given-names></name><name><surname>Boggs</surname><given-names>N.</given-names></name><name><surname>Suerken</surname><given-names>C. K.</given-names></name><name><surname>Haq</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Cognitive impairment in rapid-onset dystonia-parkinsonism</article-title>. <source/>Movem. Disorders
<volume>29</volume>, <fpage>344</fpage>–<lpage>350</lpage>. <pub-id pub-id-type="doi">10.1002/mds.25790</pub-id><pub-id pub-id-type="pmid">24436111</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coyle</surname><given-names>J. T.</given-names></name><name><surname>Schwarcz</surname><given-names>R.</given-names></name></person-group> (<year>1976</year>). <article-title>Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea</article-title>. <source/>Nature
<volume>263</volume>, <fpage>244</fpage>–<lpage>246</lpage>. <pub-id pub-id-type="doi">10.1038/263244a0</pub-id><pub-id pub-id-type="pmid">8731</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname><given-names>W. S.</given-names></name><name><surname>Kyte</surname><given-names>J.</given-names></name></person-group> (<year>1980</year>). <article-title>Stoichiometry and molecular weight of the minimum asymmetric unit of canine renal sodium and potassium ion-activated adenosine triphosphatase</article-title>. <source/>J. Biol. Chem.
<volume>255</volume>, <fpage>6262</fpage>–<lpage>6269</lpage>. <pub-id pub-id-type="pmid">6248516</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cutrer</surname><given-names>F. M.</given-names></name><name><surname>Sorensen</surname><given-names>A. G.</given-names></name><name><surname>Weisskoff</surname><given-names>R. M.</given-names></name><name><surname>Ostergaard</surname><given-names>L.</given-names></name><name><surname>Sanchez del Rio</surname><given-names>M.</given-names></name><name><surname>Lee</surname><given-names>E. J.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Perfusion-weighted imaging defects during spontaneous migrainous aura</article-title>. <source/>Ann. Neurol.
<volume>43</volume>, <fpage>25</fpage>–<lpage>31</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410430108</pub-id><pub-id pub-id-type="pmid">9450765</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dalkara</surname><given-names>T.</given-names></name><name><surname>Zervas</surname><given-names>N. T.</given-names></name><name><surname>Moskowitz</surname><given-names>M. A.</given-names></name></person-group> (<year>2006</year>). <article-title>From spreading depression to the trigeminovascular system</article-title>. <source/>Neurol. Sci.
<volume>27</volume> (<issue>Suppl. 2</issue>), <fpage>S86</fpage>–<lpage>S90</lpage>. <pub-id pub-id-type="doi">10.1007/s10072-006-0577-z</pub-id><pub-id pub-id-type="pmid">16688636</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D'Ambrosio</surname><given-names>R.</given-names></name><name><surname>Gordon</surname><given-names>D. S.</given-names></name><name><surname>Winn</surname><given-names>H. R.</given-names></name></person-group> (<year>2002</year>). <article-title>Differential role of KIR channel and Na(+)/K(+)-pump in the regulation of extracellular K(+) in rat hippocampus</article-title>. <source/>J. Neurophysiol.
<volume>87</volume>, <fpage>87</fpage>–<lpage>102</lpage>. <pub-id pub-id-type="doi">10.1152/jn.00240.2001</pub-id><pub-id pub-id-type="pmid">11784732</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dawson</surname><given-names>V. L.</given-names></name><name><surname>Dawson</surname><given-names>T. M.</given-names></name><name><surname>London</surname><given-names>E. D.</given-names></name><name><surname>Bredt</surname><given-names>D. S.</given-names></name><name><surname>Snyder</surname><given-names>S. H.</given-names></name></person-group> (<year>1991</year>). <article-title>Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>88</volume>, <fpage>6368</fpage>–<lpage>6371</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.88.14.6368</pub-id><pub-id pub-id-type="pmid">1648740</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeAndrade</surname><given-names>M. P.</given-names></name><name><surname>Yokoi</surname><given-names>F.</given-names></name><name><surname>van Groen</surname><given-names>T.</given-names></name><name><surname>Lingrel</surname><given-names>J. B.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name></person-group> (<year>2011</year>). <article-title>Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonism</article-title>. <source/>Behav. Brain Res.
<volume>216</volume>, <fpage>659</fpage>–<lpage>665</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2010.09.009</pub-id><pub-id pub-id-type="pmid">20850480</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Carvalho Aguiar</surname><given-names>P.</given-names></name><name><surname>Sweadner</surname><given-names>K. J.</given-names></name><name><surname>Penniston</surname><given-names>J. T.</given-names></name><name><surname>Zaremba</surname><given-names>J.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Caton</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Mutations in the Na+/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism</article-title>. <source/>Neuron
<volume>43</volume>, <fpage>169</fpage>–<lpage>175</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2004.06.028</pub-id><pub-id pub-id-type="pmid">15260953</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Fusco</surname><given-names>M.</given-names></name><name><surname>Marconi</surname><given-names>R.</given-names></name><name><surname>Silvestri</surname><given-names>L.</given-names></name><name><surname>Atorino</surname><given-names>L.</given-names></name><name><surname>Rampoldi</surname><given-names>L.</given-names></name><name><surname>Morgante</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2</article-title>. <source/>Nat. Genet.
<volume>33</volume>, <fpage>192</fpage>–<lpage>196</lpage>. <pub-id pub-id-type="doi">10.1038/ng1081</pub-id><pub-id pub-id-type="pmid">12539047</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deisseroth</surname><given-names>K.</given-names></name><name><surname>Singla</surname><given-names>S.</given-names></name><name><surname>Toda</surname><given-names>H.</given-names></name><name><surname>Monje</surname><given-names>M.</given-names></name><name><surname>Palmer</surname><given-names>T. D.</given-names></name><name><surname>Malenka</surname><given-names>R. C.</given-names></name></person-group> (<year>2004</year>). <article-title>Excitation-neurogenesis coupling in adult neural stem/progenitor cells</article-title>. <source/>Neuron
<volume>42</volume>, <fpage>535</fpage>–<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(04)00266-1</pub-id><pub-id pub-id-type="pmid">15157417</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Lores Arnaiz</surname><given-names>G. R.</given-names></name><name><surname>Bersier</surname><given-names>M. G.</given-names></name></person-group> (<year>2014</year>). <article-title>Relationship between Na+, K+-ATPase and NMDA receptor at central synapses</article-title>. <source/>Curr. Protein Pept. Sci.
<volume>15</volume>, <fpage>761</fpage>–<lpage>777</lpage>. <pub-id pub-id-type="doi">10.2174/1389203715666140903145608</pub-id><pub-id pub-id-type="pmid">25135486</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demos</surname><given-names>M. K.</given-names></name><name><surname>van Karnebeek</surname><given-names>C. D.</given-names></name><name><surname>Ross</surname><given-names>C. J.</given-names></name><name><surname>Adam</surname><given-names>S.</given-names></name><name><surname>Shen</surname><given-names>Y.</given-names></name><name><surname>Zhan</surname><given-names>S. H.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>A novel recurrent mutation in ATP1A3 causes CAPOS syndrome</article-title>. <source/>Orphanet J. Rare Dis.
<volume>9</volume>, <fpage>15</fpage>. <pub-id pub-id-type="doi">10.1186/1750-1172-9-15</pub-id><pub-id pub-id-type="pmid">24468074</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Oliveira Elias</surname><given-names>M.</given-names></name><name><surname>Tavares de Lima</surname><given-names>W.</given-names></name><name><surname>Vannuchi</surname><given-names>Y. B.</given-names></name><name><surname>Marcourakis</surname><given-names>T.</given-names></name><name><surname>da Silva</surname><given-names>Z. L.</given-names></name><name><surname>Trezena</surname><given-names>A. G.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Nitric oxide modulates Na+, K+-ATPase activity through cyclic GMP pathway in proximal rat trachea</article-title>. <source/>Eur. J. Pharmacol.
<volume>367</volume>, <fpage>307</fpage>–<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-2999(98)00928-5</pub-id><pub-id pub-id-type="pmid">10079006</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Pover</surname><given-names>A.</given-names></name><name><surname>Godfraind</surname><given-names>T.</given-names></name></person-group> (<year>1976</year>). <article-title>Sensitivity to cardiac glycosides of (Na + K) ATPase prepared from human heart, guinea-pig heart and guinea-pig brain</article-title>. <source/>Arch. Int. Pharmacodyn. Ther.
<volume>221</volume>, <fpage>339</fpage>–<lpage>341</lpage>. <pub-id pub-id-type="pmid">134678</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Pover</surname><given-names>A.</given-names></name><name><surname>Godfraind</surname><given-names>T.</given-names></name></person-group> (<year>1979</year>). <article-title>Interaction of ouabain with (Na+ + K+)ATPase from human heart and from guinea-pig heart</article-title>. <source/>Biochem. Pharmacol.
<volume>28</volume>, <fpage>3051</fpage>–<lpage>3056</lpage>. <pub-id pub-id-type="doi">10.1016/0006-2952(79)90612-9</pub-id><pub-id pub-id-type="pmid">229866</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deprez</surname><given-names>L.</given-names></name><name><surname>Weckhuysen</surname><given-names>S.</given-names></name><name><surname>Peeters</surname><given-names>K.</given-names></name><name><surname>Deconinck</surname><given-names>T.</given-names></name><name><surname>Claeys</surname><given-names>K. G.</given-names></name><name><surname>Claes</surname><given-names>L. R.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Epilepsy as part of the phenotype associated with ATP1A2 mutations</article-title>. <source/>Epilepsia
<volume>49</volume>, <fpage>500</fpage>–<lpage>508</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2007.01415.x</pub-id><pub-id pub-id-type="pmid">18028407</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Sá Lima</surname><given-names>L.</given-names></name><name><surname>Kawamoto</surname><given-names>E. M.</given-names></name><name><surname>Munhoz</surname><given-names>C. D.</given-names></name><name><surname>Kinoshita</surname><given-names>P. F.</given-names></name><name><surname>Orellana</surname><given-names>A. M.</given-names></name><name><surname>Curi</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Ouabain activates NFkappaB through an NMDA signaling pathway in cultured cerebellar cells</article-title>. <source/>Neuropharmacology
<volume>73</volume>, <fpage>327</fpage>–<lpage>336</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2013.06.006</pub-id><pub-id pub-id-type="pmid">23774137</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DeSilva</surname><given-names>T. M.</given-names></name><name><surname>Borenstein</surname><given-names>N. S.</given-names></name><name><surname>Volpe</surname><given-names>J. J.</given-names></name><name><surname>Kinney</surname><given-names>H. C.</given-names></name><name><surname>Rosenberg</surname><given-names>P. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Expression of EAAT2 in neurons and protoplasmic astrocytes during human cortical development</article-title>. <source/>J. Comp. Neurol.
<volume>520</volume>, <fpage>3912</fpage>–<lpage>3932</lpage>. <pub-id pub-id-type="doi">10.1002/cne.23130</pub-id><pub-id pub-id-type="pmid">22522966</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhami</surname><given-names>K. S.</given-names></name><name><surname>Churchward</surname><given-names>M. A.</given-names></name><name><surname>Baker</surname><given-names>G. B.</given-names></name><name><surname>Todd</surname><given-names>K. G.</given-names></name></person-group> (<year>2013</year>). <article-title>Fluoxetine and citalopram decrease microglial release of glutamate and D-serine to promote cortical neuronal viability following ischemic insult</article-title>. <source/>Mol. Cell. Neurosci.
<volume>56</volume>, <fpage>365</fpage>–<lpage>374</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2013.07.006</pub-id><pub-id pub-id-type="pmid">23876875</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dichgans</surname><given-names>M.</given-names></name><name><surname>Freilinger</surname><given-names>T.</given-names></name><name><surname>Eckstein</surname><given-names>G.</given-names></name><name><surname>Babini</surname><given-names>E.</given-names></name><name><surname>Lorenz-Depiereux</surname><given-names>B.</given-names></name><name><surname>Biskup</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine</article-title>. <source/>Lancet
<volume>366</volume>, <fpage>371</fpage>–<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(05)66786-4</pub-id><pub-id pub-id-type="pmid">16054936</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dickey</surname><given-names>C. A.</given-names></name><name><surname>Gordon</surname><given-names>M. N.</given-names></name><name><surname>Wilcock</surname><given-names>D. M.</given-names></name><name><surname>Herber</surname><given-names>D. L.</given-names></name><name><surname>Freeman</surname><given-names>M. J.</given-names></name><name><surname>Morgan</surname><given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>Dysregulation of Na+/K+ ATPase by amyloid in APP+PS1 transgenic mice</article-title>. <source/>BMC Neurosci.
<volume>6</volume>:<fpage>7</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2202-6-7</pub-id><pub-id pub-id-type="pmid">15689237</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiFiglia</surname><given-names>M.</given-names></name><name><surname>Sapp</surname><given-names>E.</given-names></name><name><surname>Chase</surname><given-names>K.</given-names></name><name><surname>Schwarz</surname><given-names>C.</given-names></name><name><surname>Meloni</surname><given-names>A.</given-names></name><name><surname>Young</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>1995</year>). <article-title>Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons</article-title>. <source/>Neuron
<volume>14</volume>, <fpage>1075</fpage>–<lpage>1081</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(95)90346-1</pub-id><pub-id pub-id-type="pmid">7748555</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Michele</surname><given-names>M.</given-names></name><name><surname>Goubau</surname><given-names>C.</given-names></name><name><surname>Waelkens</surname><given-names>E.</given-names></name><name><surname>Thys</surname><given-names>C.</given-names></name><name><surname>De Vos</surname><given-names>R.</given-names></name><name><surname>Overbergh</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Functional studies and proteomics in platelets and fibroblasts reveal a lysosomal defect with increased cathepsin-dependent apoptosis in ATP1A3 defective alternating hemiplegia of childhood</article-title>. <source/>J. Proteomics
<volume>86</volume>, <fpage>53</fpage>–<lpage>69</lpage>. <pub-id pub-id-type="doi">10.1016/j.jprot.2013.05.005</pub-id><pub-id pub-id-type="pmid">23681173</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dobretsov</surname><given-names>M.</given-names></name><name><surname>Stimers</surname><given-names>J. R.</given-names></name></person-group> (<year>2005</year>). <article-title>Neuronal function and alpha3 isoform of the Na/K-ATPase</article-title>. <source/>Front. Biosci.
<volume>10</volume>, <fpage>2373</fpage>–<lpage>2396</lpage>. <pub-id pub-id-type="doi">10.2741/1704</pub-id><pub-id pub-id-type="pmid">15970502</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>Z.</given-names></name><name><surname>Bai</surname><given-names>Y.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Gong</surname><given-names>B.</given-names></name><name><surname>Howland</surname><given-names>J. G.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Hippocampal long-term depression mediates spatial reversal learning in the Morris water maze</article-title>. <source/>Neuropharmacology
<volume>64</volume>, <fpage>65</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2012.06.027</pub-id><pub-id pub-id-type="pmid">22732443</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Drouin-Ouellet</surname><given-names>J.</given-names></name><name><surname>Brownell</surname><given-names>A. L.</given-names></name><name><surname>Saint-Pierre</surname><given-names>M.</given-names></name><name><surname>Fasano</surname><given-names>C.</given-names></name><name><surname>Emond</surname><given-names>V.</given-names></name><name><surname>Trudeau</surname><given-names>L. E.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Neuroinflammation is associated with changes in glial mGluR5 expression and the development of neonatal excitotoxic lesions</article-title>. <source/>Glia
<volume>59</volume>, <fpage>188</fpage>–<lpage>199</lpage>. <pub-id pub-id-type="doi">10.1002/glia.21086</pub-id><pub-id pub-id-type="pmid">21125661</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duan</surname><given-names>K.</given-names></name><name><surname>Mete</surname><given-names>O.</given-names></name></person-group> (<year>2015</year>). <article-title>Clinicopathologic correlates of primary aldosteronism</article-title>. <source/>Arch. Pathol. Lab. Med.
<volume>139</volume>, <fpage>948</fpage>–<lpage>954</lpage>. <pub-id pub-id-type="doi">10.5858/arpa.2014-0156-RS</pub-id><pub-id pub-id-type="pmid">26125435</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ducros</surname><given-names>A.</given-names></name><name><surname>Joutel</surname><given-names>A.</given-names></name><name><surname>Vahedi</surname><given-names>K.</given-names></name><name><surname>Cecillon</surname><given-names>M.</given-names></name><name><surname>Ferreira</surname><given-names>A.</given-names></name><name><surname>Bernard</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>1997</year>). <article-title>Mapping of a second locus for familial hemiplegic migraine to 1q21-q23 and evidence of further heterogeneity</article-title>. <source/>Ann. Neurol.
<volume>42</volume>, <fpage>885</fpage>–<lpage>890</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410420610</pub-id><pub-id pub-id-type="pmid">9403481</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dudek</surname><given-names>S. M.</given-names></name><name><surname>Bear</surname><given-names>M. F.</given-names></name></person-group> (<year>1992</year>). <article-title>Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>89</volume>, <fpage>4363</fpage>–<lpage>4367</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.89.10.4363</pub-id><pub-id pub-id-type="pmid">1350090</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dunlop</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>Glutamate-based therapeutic approaches: targeting the glutamate transport system</article-title>. <source/>Curr. Opin. Pharmacol.
<volume>6</volume>, <fpage>103</fpage>–<lpage>107</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2005.09.004</pub-id><pub-id pub-id-type="pmid">16368269</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duric</surname><given-names>V.</given-names></name><name><surname>Banasr</surname><given-names>M.</given-names></name><name><surname>Stockmeier</surname><given-names>C. A.</given-names></name><name><surname>Simen</surname><given-names>A. A.</given-names></name><name><surname>Newton</surname><given-names>S. S.</given-names></name><name><surname>Overholser</surname><given-names>J. C.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Altered expression of synapse and glutamate related genes in post-mortem hippocampus of depressed subjects</article-title>. <source/>Int. J. Neuropsychopharmacol.
<volume>16</volume>, <fpage>69</fpage>–<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1017/S1461145712000016</pub-id><pub-id pub-id-type="pmid">22339950</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname><given-names>D. Z.</given-names></name><name><surname>Rabe</surname><given-names>J.</given-names></name><name><surname>Sweadner</surname><given-names>K. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Global loss of Na, K-ATPase and its nitric oxide-mediated regulation in a transgenic mouse model of amyotrophic lateral sclerosis</article-title>. <source/>J. Neurosci.
<volume>23</volume>, <fpage>43</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="pmid">12514200</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Erecinska</surname><given-names>M.</given-names></name><name><surname>Silver</surname><given-names>I. A.</given-names></name></person-group> (<year>1990</year>). <article-title>Metabolism and role of glutamate in mammalian brain</article-title>. <source/>Progress Neurobiol.
<volume>35</volume>, <fpage>245</fpage>–<lpage>296</lpage>. <pub-id pub-id-type="doi">10.1016/0301-0082(90)90013-7</pub-id><pub-id pub-id-type="pmid">1980745</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Estrada-Sánchez</surname><given-names>A. M.</given-names></name><name><surname>Montiel</surname><given-names>T.</given-names></name><name><surname>Segovia</surname><given-names>J.</given-names></name><name><surname>Massieu</surname><given-names>L.</given-names></name></person-group> (<year>2009</year>). <article-title>Glutamate toxicity in the striatum of the R6/2 Huntington's disease transgenic mice is age-dependent and correlates with decreased levels of glutamate transporters</article-title>. <source/>Neurobiol. Dis.
<volume>34</volume>, <fpage>78</fpage>–<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2008.12.017</pub-id><pub-id pub-id-type="pmid">19168136</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fernandes-Rosa</surname><given-names>F. L.</given-names></name><name><surname>Williams</surname><given-names>T. A.</given-names></name><name><surname>Riester</surname><given-names>A.</given-names></name><name><surname>Steichen</surname><given-names>O.</given-names></name><name><surname>Beuschlein</surname><given-names>F.</given-names></name><name><surname>Boulkroun</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma</article-title>. <source/>Hypertension
<volume>64</volume>, <fpage>354</fpage>–<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.114.03419</pub-id><pub-id pub-id-type="pmid">24866132</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Foo</surname><given-names>K.</given-names></name><name><surname>Blumenthal</surname><given-names>L.</given-names></name><name><surname>Man</surname><given-names>H. Y.</given-names></name></person-group> (<year>2012</year>). <article-title>Regulation of neuronal bioenergy homeostasis by glutamate</article-title>. <source/>Neurochem. Int.
<volume>61</volume>, <fpage>389</fpage>–<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2012.06.003</pub-id><pub-id pub-id-type="pmid">22709672</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forbush</surname><given-names>B.</given-names><suffix>III.</suffix></name><name><surname>Kaplan</surname><given-names>J. H.</given-names></name><name><surname>Hoffman</surname><given-names>J. F.</given-names></name></person-group> (<year>1978</year>). <article-title>Characterization of a new photoaffinity derivative of ouabain: labeling of the large polypeptide and of a proteolipid component of the Na, K-ATPase</article-title>. <source/>Biochemistry
<volume>17</volume>, <fpage>3667</fpage>–<lpage>3676</lpage>. <pub-id pub-id-type="doi">10.1021/bi00610a037</pub-id><pub-id pub-id-type="pmid">210802</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukuda</surname><given-names>Y.</given-names></name><name><surname>Bertorello</surname><given-names>A.</given-names></name><name><surname>Aperia</surname><given-names>A.</given-names></name></person-group> (<year>1991</year>). <article-title>Ontogeny of the regulation of Na+, K(+)-ATPase activity in the renal proximal tubule cell</article-title>. <source/>Pediatr. Res.
<volume>30</volume>, <fpage>131</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1203/00006450-199108000-00001</pub-id><pub-id pub-id-type="pmid">1654542</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Furness</surname><given-names>D. N.</given-names></name><name><surname>Dehnes</surname><given-names>Y.</given-names></name><name><surname>Akhtar</surname><given-names>A. Q.</given-names></name><name><surname>Rossi</surname><given-names>D. J.</given-names></name><name><surname>Hamann</surname><given-names>M.</given-names></name><name><surname>Grutle</surname><given-names>N. J.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>A quantitative assessment of glutamate uptake into hippocampal synaptic terminals and astrocytes: new insights into a neuronal role for excitatory amino acid transporter 2 (EAAT2)</article-title>. <source/>Neuroscience
<volume>157</volume>, <fpage>80</fpage>–<lpage>94</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.08.043</pub-id><pub-id pub-id-type="pmid">18805467</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallucci</surname><given-names>M.</given-names></name><name><surname>Zanardo</surname><given-names>A.</given-names></name><name><surname>De Valentin</surname><given-names>L.</given-names></name><name><surname>Vianello</surname><given-names>A.</given-names></name></person-group> (<year>2004</year>). <article-title>Homocysteine in Alzheimer disease and vascular dementia</article-title>. <source/>Archiv. Gerontol. Geriatr. (<issue>Suppl. 9</issue>), <volume>38</volume>, <fpage>195</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1016/j.archger.2004.04.027</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garinis</surname><given-names>G. A.</given-names></name><name><surname>van der Horst</surname><given-names>G. T.</given-names></name><name><surname>Vijg</surname><given-names>J.</given-names></name><name><surname>Hoeijmakers</surname><given-names>J. H.</given-names></name></person-group> (<year>2008</year>). <article-title>DNA damage and ageing: new-age ideas for an age-old problem</article-title>. <source/>Nat. Cell Biol.
<volume>10</volume>, <fpage>1241</fpage>–<lpage>1247</lpage>. <pub-id pub-id-type="doi">10.1038/ncb1108-1241</pub-id><pub-id pub-id-type="pmid">18978832</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geering</surname><given-names>K.</given-names></name></person-group> (<year>2006</year>). <article-title>FXYD proteins: new regulators of Na-K-ATPase</article-title>. <source/>Am. J. Physiol. Renal Physiol.
<volume>290</volume>, <fpage>F241</fpage>–<lpage>F250</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.00126.2005</pub-id><pub-id pub-id-type="pmid">16403837</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Geering</surname><given-names>K.</given-names></name></person-group> (<year>2008</year>). <article-title>Functional roles of Na, K-ATPase subunits</article-title>. <source/>Curr. Opin. Nephrol. Hypertens.
<volume>17</volume>, <fpage>526</fpage>–<lpage>532</lpage>. <pub-id pub-id-type="doi">10.1097/MNH.0b013e3283036cbf</pub-id><pub-id pub-id-type="pmid">18695395</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gegelashvili</surname><given-names>M.</given-names></name><name><surname>Rodriguez-Kern</surname><given-names>A.</given-names></name><name><surname>Sung</surname><given-names>L.</given-names></name><name><surname>Shimamoto</surname><given-names>K.</given-names></name><name><surname>Gegelashvili</surname><given-names>G.</given-names></name></person-group> (<year>2007</year>). <article-title>Glutamate transporter GLAST/EAAT1 directs cell surface expression of FXYD2/gamma subunit of Na, K-ATPase in human fetal astrocytes</article-title>. <source/>Neurochem. Int.
<volume>50</volume>, <fpage>916</fpage>–<lpage>920</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2006.12.015</pub-id><pub-id pub-id-type="pmid">17316900</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Genda</surname><given-names>E. N.</given-names></name><name><surname>Jackson</surname><given-names>J. G.</given-names></name><name><surname>Sheldon</surname><given-names>A. L.</given-names></name><name><surname>Locke</surname><given-names>S. F.</given-names></name><name><surname>Greco</surname><given-names>T. M.</given-names></name><name><surname>O'Donnell</surname><given-names>J. C.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Co-compartmentalization of the astroglial glutamate transporter, GLT-1, with glycolytic enzymes and mitochondria</article-title>. <source/>J. Neurosci.
<volume>31</volume>, <fpage>18275</fpage>–<lpage>18288</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3305-11.2011</pub-id><pub-id pub-id-type="pmid">22171032</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goadsby</surname><given-names>P. J.</given-names></name></person-group> (<year>2002</year>). <article-title>New directions in migraine research</article-title>. <source/>J. Clin. Neurosci.
<volume>9</volume>, <fpage>368</fpage>–<lpage>373</lpage>. <pub-id pub-id-type="doi">10.1054/jocn.2001.0967</pub-id><pub-id pub-id-type="pmid">12217664</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goadsby</surname><given-names>P. J.</given-names></name><name><surname>Lipton</surname><given-names>R. B.</given-names></name><name><surname>Ferrari</surname><given-names>M. D.</given-names></name></person-group> (<year>2002</year>). <article-title>Migraine–current understanding and treatment</article-title>. <source/>N. Engl. J. Med.
<volume>346</volume>, <fpage>257</fpage>–<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMra010917</pub-id><pub-id pub-id-type="pmid">11807151</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golden</surname><given-names>W. C.</given-names></name><name><surname>Martin</surname><given-names>L. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Low-dose ouabain protects against excitotoxic apoptosis and up-regulates nuclear Bcl-2 <italic>in vivo</italic></article-title>. <source/>Neuroscience
<volume>137</volume>, <fpage>133</fpage>–<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2005.10.004</pub-id><pub-id pub-id-type="pmid">16297565</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golovina</surname><given-names>V. A.</given-names></name><name><surname>Song</surname><given-names>H.</given-names></name><name><surname>James</surname><given-names>P. F.</given-names></name><name><surname>Lingrel</surname><given-names>J. B.</given-names></name><name><surname>Blaustein</surname><given-names>M. P.</given-names></name></person-group> (<year>2003</year>). <article-title>Na+ pump alpha 2-subunit expression modulates Ca2+ signaling</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>284</volume>, <fpage>C475</fpage>–<lpage>C486</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00383.2002</pub-id><pub-id pub-id-type="pmid">12388076</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>González-González</surname><given-names>I. M.</given-names></name><name><surname>García-Tardon</surname><given-names>N.</given-names></name><name><surname>Cubelos</surname><given-names>B.</given-names></name><name><surname>Giménez</surname><given-names>C.</given-names></name><name><surname>Zafra</surname><given-names>F.</given-names></name></person-group> (<year>2008</year>). <article-title>The glutamate transporter GLT1b interacts with the scaffold protein PSD-95</article-title>. <source/>J. Neurochem.
<volume>105</volume>, <fpage>1834</fpage>–<lpage>1848</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2008.05281.x</pub-id><pub-id pub-id-type="pmid">18248606</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groveman</surname><given-names>B. R.</given-names></name><name><surname>Feng</surname><given-names>S.</given-names></name><name><surname>Fang</surname><given-names>X. Q.</given-names></name><name><surname>Pflueger</surname><given-names>M.</given-names></name><name><surname>Lin</surname><given-names>S. X.</given-names></name><name><surname>Bienkiewicz</surname><given-names>E. A.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>The regulation of N-methyl-D-aspartate receptors by Src kinase</article-title>. <source/>FEBS J.
<volume>279</volume>, <fpage>20</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4658.2011.08413.x</pub-id><pub-id pub-id-type="pmid">22060915</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guimaraes</surname><given-names>I. M.</given-names></name><name><surname>Carvalho</surname><given-names>T. G.</given-names></name><name><surname>Ferguson</surname><given-names>S. S.</given-names></name><name><surname>Pereira</surname><given-names>G. S.</given-names></name><name><surname>Ribeiro</surname><given-names>F. M.</given-names></name></person-group> (<year>2015</year>). <article-title>The metabotropic glutamate receptor 5 role on motor behavior involves specific neural substrates</article-title>. <source/>Mol. Brain
<volume>8</volume>, <fpage>24</fpage>. <pub-id pub-id-type="doi">10.1186/s13041-015-0113-2</pub-id><pub-id pub-id-type="pmid">25885370</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haas</surname><given-names>L. T.</given-names></name><name><surname>Salazar</surname><given-names>S. V.</given-names></name><name><surname>Kostylev</surname><given-names>M. A.</given-names></name><name><surname>Um</surname><given-names>J. W.</given-names></name><name><surname>Kaufman</surname><given-names>A. C.</given-names></name><name><surname>Strittmatter</surname><given-names>S. M.</given-names></name></person-group> (<year>2016</year>). <article-title>Metabotropic glutamate receptor 5 couples cellular prion protein to intracellular signalling in Alzheimer's disease</article-title>. <source/>Brain
<volume>139(Pt 2)</volume>, <fpage>526</fpage>–<lpage>546</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awv356</pub-id><pub-id pub-id-type="pmid">26667279</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haas</surname><given-names>M.</given-names></name><name><surname>Askari</surname><given-names>A.</given-names></name><name><surname>Xie</surname><given-names>Z.</given-names></name></person-group> (<year>2000</year>). <article-title>Involvement of Src and epidermal growth factor receptor in the signal-transducing function of Na+/K+-ATPase</article-title>. <source/>J. Biol. Chem.
<volume>275</volume>, <fpage>27832</fpage>–<lpage>27837</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m002951200</pub-id><pub-id pub-id-type="pmid">10874030</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hadjikhani</surname><given-names>N.</given-names></name><name><surname>Sanchez Del Rio</surname><given-names>M.</given-names></name><name><surname>Wu</surname><given-names>O.</given-names></name><name><surname>Schwartz</surname><given-names>D.</given-names></name><name><surname>Bakker</surname><given-names>D.</given-names></name><name><surname>Fischl</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Mechanisms of migraine aura revealed by functional MRI in human visual cortex</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>98</volume>, <fpage>4687</fpage>–<lpage>4692</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.071582498</pub-id><pub-id pub-id-type="pmid">11287655</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hattori</surname><given-names>N.</given-names></name><name><surname>Kitagawa</surname><given-names>K.</given-names></name><name><surname>Higashida</surname><given-names>T.</given-names></name><name><surname>Yagyu</surname><given-names>K.</given-names></name><name><surname>Shimohama</surname><given-names>S.</given-names></name><name><surname>Wataya</surname><given-names>T.</given-names></name><etal></etal></person-group> (<year>1998</year>). <article-title>CI-ATPase and Na+/K(+)-ATPase activities in Alzheimer's disease brains</article-title>. <source/>Neurosci. Lett.
<volume>254</volume>, <fpage>141</fpage>–<lpage>144</lpage>. <pub-id pub-id-type="doi">10.1016/S0304-3940(98)00654-5</pub-id><pub-id pub-id-type="pmid">10214977</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinzen</surname><given-names>E. L.</given-names></name><name><surname>Swoboda</surname><given-names>K. J.</given-names></name><name><surname>Hitomi</surname><given-names>Y.</given-names></name><name><surname>Gurrieri</surname><given-names>F.</given-names></name><name><surname>Nicole</surname><given-names>S.</given-names></name><name><surname>de Vries</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>De novo mutations in ATP1A3 cause alternating hemiplegia of childhood</article-title>. <source/>Nat. Genet.
<volume>44</volume>, <fpage>1030</fpage>–<lpage>1034</lpage>. <pub-id pub-id-type="doi">10.1038/ng.2358</pub-id><pub-id pub-id-type="pmid">22842232</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herman</surname><given-names>M. A.</given-names></name><name><surname>Jahr</surname><given-names>C. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Extracellular glutamate concentration in hippocampal slice</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>9736</fpage>–<lpage>9741</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3009-07.2007</pub-id><pub-id pub-id-type="pmid">17804634</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoei-Hansen</surname><given-names>C. E.</given-names></name><name><surname>Dali</surname><given-names>C. Í.</given-names></name><name><surname>Lyngbye</surname><given-names>T. J.</given-names></name><name><surname>Duno</surname><given-names>M.</given-names></name><name><surname>Uldall</surname><given-names>P.</given-names></name></person-group> (<year>2014</year>). <article-title>Alternating hemiplegia of childhood in Denmark: clinical manifestations and ATP1A3 mutation status</article-title>. <source/>Eur. J. Paediatric Neurol.
<volume>18</volume>, <fpage>50</fpage>–<lpage>54</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejpn.2013.08.007</pub-id><pub-id pub-id-type="pmid">24100174</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Xie</surname><given-names>Z.</given-names></name></person-group> (<year>1997</year>). <article-title>Ouabain-induced hypertrophy in cultured cardiac myocytes is accompanied by changes in expression of several late response genes</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>29</volume>, <fpage>429</fpage>–<lpage>437</lpage>. <pub-id pub-id-type="doi">10.1006/jmcc.1996.0320</pub-id><pub-id pub-id-type="pmid">9140803</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>L. Q.</given-names></name><name><surname>Rowan</surname><given-names>M. J.</given-names></name><name><surname>Anwyl</surname><given-names>R.</given-names></name></person-group> (<year>1997</year>). <article-title>mGluR II agonist inhibition of LTP induction, and mGluR II antagonist inhibition of LTD induction, in the dentate gyrus <italic>in vitro</italic></article-title>. <source/>Neuroreport
<volume>8</volume>, <fpage>687</fpage>–<lpage>693</lpage>. <pub-id pub-id-type="doi">10.1097/00001756-199702100-00022</pub-id><pub-id pub-id-type="pmid">9106748</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hunanyan</surname><given-names>A. S.</given-names></name><name><surname>Fainberg</surname><given-names>N. A.</given-names></name><name><surname>Linabarger</surname><given-names>M.</given-names></name><name><surname>Arehart</surname><given-names>E.</given-names></name><name><surname>Leonard</surname><given-names>A. S.</given-names></name><name><surname>Adil</surname><given-names>S. M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Knock-in mouse model of alternating hemiplegia of childhood: behavioral and electrophysiologic characterization</article-title>. <source/>Epilepsia
<volume>56</volume>, <fpage>82</fpage>–<lpage>93</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12878</pub-id><pub-id pub-id-type="pmid">25523819</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>K.</given-names></name><name><surname>Onaka</surname><given-names>T.</given-names></name><name><surname>Yamakado</surname><given-names>M.</given-names></name><name><surname>Nakai</surname><given-names>J.</given-names></name><name><surname>Ishikawa</surname><given-names>T. O.</given-names></name><name><surname>Taketo</surname><given-names>M. M.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Degeneration of the amygdala/piriform cortex and enhanced fear/anxiety behaviors in sodium pump α2 subunit (<italic>Atp1a2</italic>)-deficient mice</article-title>. <source/>J. Neurosci.
<volume>23</volume>, <fpage>4667</fpage>–<lpage>4676</lpage>. <pub-id pub-id-type="pmid">12805306</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>K.</given-names></name><name><surname>Onimaru</surname><given-names>H.</given-names></name><name><surname>Yamada</surname><given-names>J.</given-names></name><name><surname>Inoue</surname><given-names>K.</given-names></name><name><surname>Ueno</surname><given-names>S.</given-names></name><name><surname>Onaka</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Malfunction of respiratory-related neuronal activity in Na+, K+-ATPase alpha2 subunit-deficient mice is attributable to abnormal Cl- homeostasis in brainstem neurons</article-title>. <source/>J. Neurosci.
<volume>24</volume>, <fpage>10693</fpage>–<lpage>10701</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2909-04.2004</pub-id><pub-id pub-id-type="pmid">15564586</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>K.</given-names></name><name><surname>Satake</surname><given-names>S.</given-names></name><name><surname>Onaka</surname><given-names>T.</given-names></name><name><surname>Sugimoto</surname><given-names>H.</given-names></name><name><surname>Takeda</surname><given-names>N.</given-names></name><name><surname>Imoto</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Enhanced inhibitory neurotransmission in the cerebellar cortex of Atp1a3-deficient heterozygous mice</article-title>. <source/>J. Physiol. (Lond).
<volume>591</volume>, <fpage>3433</fpage>–<lpage>3449</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2012.247817</pub-id><pub-id pub-id-type="pmid">23652595</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Illarionova</surname><given-names>N. B.</given-names></name><name><surname>Brismar</surname><given-names>H.</given-names></name><name><surname>Aperia</surname><given-names>A.</given-names></name><name><surname>Gunnarson</surname><given-names>E.</given-names></name></person-group> (<year>2014</year>). <article-title>Role of Na,K-ATPase alpha1 and alpha2 isoforms in the support of astrocyte glutamate uptake</article-title>. <source/>PLoS ONE
<volume>9</volume>:<fpage>e98469</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0098469</pub-id><pub-id pub-id-type="pmid">24901986</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>N.</given-names></name><name><surname>Matsui</surname><given-names>H.</given-names></name></person-group> (<year>1990</year>). <article-title>Activation of a brain type Na pump after glutamate excitation of cerebral neurons</article-title>. <source/>Brain Res.
<volume>534</volume>, <fpage>309</fpage>–<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(90)90146-3</pub-id><pub-id pub-id-type="pmid">1981484</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Inoue</surname><given-names>N.</given-names></name><name><surname>Soga</surname><given-names>T.</given-names></name><name><surname>Kato</surname><given-names>T.</given-names></name></person-group> (<year>1999</year>). <article-title>Glutamate receptors mediate regulation of Na pump isoform activities in neurons</article-title>. <source/>Neuroreport
<volume>10</volume>, <fpage>3289</fpage>–<lpage>3293</lpage>. <pub-id pub-id-type="doi">10.1097/00001756-199911080-00008</pub-id><pub-id pub-id-type="pmid">10599836</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>A.</given-names></name><name><surname>Saito</surname><given-names>Y.</given-names></name><name><surname>Mitsui</surname><given-names>J.</given-names></name><name><surname>Ishiura</surname><given-names>H.</given-names></name><name><surname>Yoshimura</surname><given-names>J.</given-names></name><name><surname>Arai</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Identification of ATP1A3 mutations by exome sequencing as the cause of alternating hemiplegia of childhood in Japanese patients</article-title>. <source/>PLoS ONE
<volume>8</volume>:<fpage>e56120</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0056120</pub-id><pub-id pub-id-type="pmid">23409136</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaffer</surname><given-names>F.</given-names></name><name><surname>Avbersek</surname><given-names>A.</given-names></name><name><surname>Vavassori</surname><given-names>R.</given-names></name><name><surname>Fons</surname><given-names>C.</given-names></name><name><surname>Campistol</surname><given-names>J.</given-names></name><name><surname>Stagnaro</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2015</year>). <article-title>Faulty cardiac repolarization reserve in alternating hemiplegia of childhood broadens the phenotype</article-title>. <source/>Brain
<volume>138(Pt 10)</volume>, <fpage>2859</fpage>–<lpage>2874</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awv243</pub-id><pub-id pub-id-type="pmid">26297560</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jantzie</surname><given-names>L. L.</given-names></name><name><surname>Talos</surname><given-names>D. M.</given-names></name><name><surname>Jackson</surname><given-names>M. C.</given-names></name><name><surname>Park</surname><given-names>H. K.</given-names></name><name><surname>Graham</surname><given-names>D. A.</given-names></name><name><surname>Lechpammer</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Developmental expression of N-methyl-D-aspartate (NMDA) receptor subunits in human white and gray matter: potential mechanism of increased vulnerability in the immature brain</article-title>. <source/>Cereb. Cortex
<volume>25</volume>, <fpage>482</fpage>–<lpage>495</lpage>. <pub-id pub-id-type="doi">10.1093/cercor/bht246</pub-id><pub-id pub-id-type="pmid">24046081</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jen</surname><given-names>J. C.</given-names></name><name><surname>Wan</surname><given-names>J.</given-names></name><name><surname>Palos</surname><given-names>T. P.</given-names></name><name><surname>Howard</surname><given-names>B. D.</given-names></name><name><surname>Baloh</surname><given-names>R. W.</given-names></name></person-group> (<year>2005</year>). <article-title>Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures</article-title>. <source/>Neurology
<volume>65</volume>, <fpage>529</fpage>–<lpage>534</lpage>. <pub-id pub-id-type="doi">10.1212/01.WNL.0000172638.58172.5a</pub-id><pub-id pub-id-type="pmid">16116111</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johri</surname><given-names>A.</given-names></name><name><surname>Beal</surname><given-names>M. F.</given-names></name></person-group> (<year>2012</year>). <article-title>Mitochondrial dysfunction in neurodegenerative diseases</article-title>. <source/>J. Pharmacol. Exp. Ther.
<volume>342</volume>, <fpage>619</fpage>–<lpage>630</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.112.192138</pub-id><pub-id pub-id-type="pmid">22700435</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jorgensen</surname><given-names>P. L.</given-names></name><name><surname>Hakansson</surname><given-names>K. O.</given-names></name><name><surname>Karlish</surname><given-names>S. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Structure and mechanism of Na,K-ATPase: functional sites and their interactions</article-title>. <source/>Annu. Rev. Physiol.
<volume>65</volume>, <fpage>817</fpage>–<lpage>849</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.physiol.65.092101.142558</pub-id><pub-id pub-id-type="pmid">12524462</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Juhaszova</surname><given-names>M.</given-names></name><name><surname>Blaustein</surname><given-names>M. P.</given-names></name></person-group> (<year>1997</year>). <article-title>Na+ pump low and high ouabain affinity alpha subunit isoforms are differently distributed in cells</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>94</volume>, <fpage>1800</fpage>–<lpage>1805</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.5.1800</pub-id><pub-id pub-id-type="pmid">9050859</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Julien</surname><given-names>J. P.</given-names></name></person-group> (<year>2001</year>). <article-title>Amyotrophic lateral sclerosis. unfolding the toxicity of the misfolded</article-title>. <source/>Cell
<volume>104</volume>, <fpage>581</fpage>–<lpage>591</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(01)00244-6</pub-id><pub-id pub-id-type="pmid">11239414</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabakci</surname><given-names>K.</given-names></name><name><surname>Isbruch</surname><given-names>K.</given-names></name><name><surname>Schilling</surname><given-names>K.</given-names></name><name><surname>Hedrich</surname><given-names>K.</given-names></name><name><surname>de Carvalho Aguiar</surname><given-names>P.</given-names></name><name><surname>Ozelius</surname><given-names>L. J.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Genetic heterogeneity in rapid onset dystonia-parkinsonism: description of a new family</article-title>. <source/>J. Neurol. Neurosurg. Psychiatr.
<volume>76</volume>, <fpage>860</fpage>–<lpage>862</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.2004.046730</pub-id><pub-id pub-id-type="pmid">15897512</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalaydjian</surname><given-names>A.</given-names></name><name><surname>Zandi</surname><given-names>P. P.</given-names></name><name><surname>Swartz</surname><given-names>K. L.</given-names></name><name><surname>Eaton</surname><given-names>W. W.</given-names></name><name><surname>Lyketsos</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>How migraines impact cognitive function: findings from the Baltimore, E. C. A</article-title>. <source/>Neurology
<volume>68</volume>, <fpage>1417</fpage>–<lpage>1424</lpage>. <pub-id pub-id-type="doi">10.1212/01.wnl.0000268250.10171.b3</pub-id><pub-id pub-id-type="pmid">17452587</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalia</surname><given-names>L. V.</given-names></name><name><surname>Pitcher</surname><given-names>G. M.</given-names></name><name><surname>Pelkey</surname><given-names>K. A.</given-names></name><name><surname>Salter</surname><given-names>M. W.</given-names></name></person-group> (<year>2006</year>). <article-title>PSD-95 is a negative regulator of the tyrosine kinase Src in the NMDA receptor complex</article-title>. <source/>EMBO J.
<volume>25</volume>, <fpage>4971</fpage>–<lpage>4982</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601342</pub-id><pub-id pub-id-type="pmid">16990796</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanner</surname><given-names>B. I.</given-names></name></person-group> (<year>2006</year>). <article-title>Structure and function of sodium-coupled GABA and glutamate transporters</article-title>. <source/>J. Membr. Biol.
<volume>213</volume>, <fpage>89</fpage>–<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1007/s00232-006-0877-5</pub-id><pub-id pub-id-type="pmid">17417704</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawakami</surname><given-names>K.</given-names></name><name><surname>Onaka</surname><given-names>T.</given-names></name><name><surname>Iwase</surname><given-names>M.</given-names></name><name><surname>Homma</surname><given-names>I.</given-names></name><name><surname>Ikeda</surname><given-names>K.</given-names></name></person-group> (<year>2005</year>). <article-title>Hyperphagia and obesity in Na,K-ATPase alpha2 subunit-defective mice</article-title>. <source/>Obes. Res.
<volume>13</volume>, <fpage>1661</fpage>–<lpage>1671</lpage>. <pub-id pub-id-type="doi">10.1038/oby.2005.204</pub-id><pub-id pub-id-type="pmid">16286513</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawamoto</surname><given-names>E. M.</given-names></name><name><surname>Lima</surname><given-names>L. S.</given-names></name><name><surname>Munhoz</surname><given-names>C. D.</given-names></name><name><surname>Yshii</surname><given-names>L. M.</given-names></name><name><surname>Kinoshita</surname><given-names>P. F.</given-names></name><name><surname>Amara</surname><given-names>F. G.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Influence of N-methyl-D-aspartate receptors on ouabain activation of nuclear factor-kappaB in the rat hippocampus</article-title>. <source/>J. Neurosci. Res.
<volume>90</volume>, <fpage>213</fpage>–<lpage>228</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.22745</pub-id><pub-id pub-id-type="pmid">22006678</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawamoto</surname><given-names>E. M.</given-names></name><name><surname>Munhoz</surname><given-names>C. D.</given-names></name><name><surname>Lepsch</surname><given-names>L. B.</given-names></name><name><surname>de Sá Lima</surname><given-names>L.</given-names></name><name><surname>Glezer</surname><given-names>I.</given-names></name><name><surname>Markus</surname><given-names>R. P.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Age-related changes in cerebellar phosphatase-1 reduce Na,K-ATPase activity</article-title>. <source/>Neurobiol. Aging
<volume>29</volume>, <fpage>1712</fpage>–<lpage>1720</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2007.04.008</pub-id><pub-id pub-id-type="pmid">17537548</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khachaturian</surname><given-names>Z. S.</given-names></name></person-group> (<year>1985</year>). <article-title>Diagnosis of Alzheimer's disease</article-title>. <source/>Arch. Neurol.
<volume>42</volume>, <fpage>1097</fpage>–<lpage>1105</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.1985.04060100083029</pub-id><pub-id pub-id-type="pmid">2864910</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>M. S.</given-names></name><name><surname>Akera</surname><given-names>T.</given-names></name></person-group> (<year>1987</year>). <article-title>O2 free radicals: cause of ischemia-reperfusion injury to cardiac Na+-K+-ATPase</article-title>. <source/>Am. J. Physiol.
<volume>252(2 Pt 2)</volume>, <fpage>H252</fpage>–<lpage>H257</lpage>.<pub-id pub-id-type="pmid">3028176</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirchmann</surname><given-names>M.</given-names></name><name><surname>Thomsen</surname><given-names>L. L.</given-names></name><name><surname>Olesen</surname><given-names>J.</given-names></name></person-group> (<year>2006</year>). <article-title>The CACNA1A and ATP1A2 genes are not involved in dominantly inherited migraine with aura</article-title>. <source/>Am. J. Med. Genetics Part B Neuropsychiatric Genetics
<volume>141B</volume>, <fpage>250</fpage>–<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.b.30277</pub-id><pub-id pub-id-type="pmid">16508934</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirischuk</surname><given-names>S.</given-names></name><name><surname>Parpura</surname><given-names>V.</given-names></name><name><surname>Verkhratsky</surname><given-names>A.</given-names></name></person-group> (<year>2012</year>). <article-title>Sodium dynamics: another key to astroglial excitability?</article-title>
<source/>Trends Neurosci.
<volume>35</volume>, <fpage>497</fpage>–<lpage>506</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2012.04.003</pub-id><pub-id pub-id-type="pmid">22633141</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirshenbaum</surname><given-names>G. S.</given-names></name><name><surname>Burgess</surname><given-names>C. R.</given-names></name><name><surname>Déry</surname><given-names>N.</given-names></name><name><surname>Fahnestock</surname><given-names>M.</given-names></name><name><surname>Peever</surname><given-names>J. H.</given-names></name><name><surname>Roder</surname><given-names>J. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Attenuation of mania-like behavior in Na(+),K(+)-ATPase alpha3 mutant mice by prospective therapies for bipolar disorder: melatonin and exercise</article-title>. <source/>Neuroscience
<volume>260</volume>, <fpage>195</fpage>–<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.12.011</pub-id><pub-id pub-id-type="pmid">24342563</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirshenbaum</surname><given-names>G. S.</given-names></name><name><surname>Dawson</surname><given-names>N.</given-names></name><name><surname>Mullins</surname><given-names>J. G.</given-names></name><name><surname>Johnston</surname><given-names>T. H.</given-names></name><name><surname>Drinkhill</surname><given-names>M. J.</given-names></name><name><surname>Edwards</surname><given-names>I. J.</given-names></name><etal></etal></person-group> (<year>2013</year>). <article-title>Alternating hemiplegia of childhood-related neural and behavioural phenotypes in Na+,K+-ATPase alpha3 missense mutant mice</article-title>. <source/>PLoS ONE
<volume>8</volume>:<fpage>e60141</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0060141</pub-id><pub-id pub-id-type="pmid">23527305</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kleene</surname><given-names>R.</given-names></name><name><surname>Loers</surname><given-names>G.</given-names></name><name><surname>Langer</surname><given-names>J.</given-names></name><name><surname>Frobert</surname><given-names>Y.</given-names></name><name><surname>Buck</surname><given-names>F.</given-names></name><name><surname>Schachner</surname><given-names>M.</given-names></name></person-group> (<year>2007</year>). <article-title>Prion protein regulates glutamate-dependent lactate transport of astrocytes</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>12331</fpage>–<lpage>12340</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1358-07.2007</pub-id><pub-id pub-id-type="pmid">17989297</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kocak-Toker</surname><given-names>N.</given-names></name><name><surname>Giris</surname><given-names>M.</given-names></name><name><surname>Tülübas</surname><given-names>F.</given-names></name><name><surname>Uysal</surname><given-names>M.</given-names></name><name><surname>Aykac-Toker</surname><given-names>G.</given-names></name></person-group> (<year>2005</year>). <article-title>Peroxynitrite induced decrease in Na+, K+-ATPase activity is restored by taurine</article-title>. <source/>World J. Gastroenterol.
<volume>11</volume>, <fpage>3554</fpage>–<lpage>3557</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v11.i23.3554</pub-id><pub-id pub-id-type="pmid">15962373</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kometiani</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Gnudi</surname><given-names>L.</given-names></name><name><surname>Kahn</surname><given-names>B. B.</given-names></name><name><surname>Askari</surname><given-names>A.</given-names></name><name><surname>Xie</surname><given-names>Z.</given-names></name></person-group> (<year>1998</year>). <article-title>Multiple signal transduction pathways link Na+/K+-ATPase to growth-related genes in cardiac myocytes. The roles of Ras and mitogen-activated protein kinases</article-title>. <source/>J. Biol. Chem.
<volume>273</volume>, <fpage>15249</fpage>–<lpage>15256</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.273.24.15249</pub-id><pub-id pub-id-type="pmid">9614140</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krebs</surname><given-names>H. A.</given-names></name></person-group> (<year>1935</year>). <article-title>Metabolism of amino-acids: The synthesis of glutamine from glutamic acid and ammonia, and the enzymic hydrolysis of glutamine in animal tissues</article-title>. <source/>Biochem. J.
<volume>29</volume>, <fpage>1951</fpage>–<lpage>1969</lpage>. <pub-id pub-id-type="doi">10.1042/bj0291951</pub-id><pub-id pub-id-type="pmid">16745865</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krupp</surname><given-names>J. J.</given-names></name><name><surname>Vissel</surname><given-names>B.</given-names></name><name><surname>Thomas</surname><given-names>C. G.</given-names></name><name><surname>Heinemann</surname><given-names>S. F.</given-names></name><name><surname>Westbrook</surname><given-names>G. L.</given-names></name></person-group> (<year>2002</year>). <article-title>Calcineurin acts via the C-terminus of NR2A to modulate desensitization of NMDA receptors</article-title>. <source/>Neuropharmacology
<volume>42</volume>, <fpage>593</fpage>–<lpage>602</lpage>. <pub-id pub-id-type="doi">10.1016/S0028-3908(02)00031-X</pub-id><pub-id pub-id-type="pmid">11985816</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname><given-names>W.</given-names></name><name><surname>Roebroek</surname><given-names>R.</given-names></name><name><surname>Blom</surname><given-names>H.</given-names></name><name><surname>van Oppenraaij</surname><given-names>D.</given-names></name><name><surname>Przuntek</surname><given-names>H.</given-names></name><name><surname>Kretschmer</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>1998</year>). <article-title>Elevated plasma levels of homocysteine in Parkinson's disease</article-title>. <source/>Eur. Neurol.
<volume>40</volume>, <fpage>225</fpage>–<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1159/000007984</pub-id><pub-id pub-id-type="pmid">9813406</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyte</surname><given-names>J.</given-names></name></person-group> (<year>1971</year>). <article-title>Purification of the sodium- and potassium-dependent adenosine triphosphatase from canine renal medulla</article-title>. <source/>J. Biol. Chem.
<volume>246</volume>, <fpage>4157</fpage>–<lpage>4165</lpage>. <pub-id pub-id-type="pmid">4253595</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kyte</surname><given-names>J.</given-names></name></person-group> (<year>1975</year>). <article-title>Structural studies of sodium and potassium ion-activated adenosine triphosphatase. The relationship between molecular structure and the mechanism of active transport</article-title>. <source/>J. Biol. Chem.
<volume>250</volume>, <fpage>7443</fpage>–<lpage>7449</lpage>. <pub-id pub-id-type="pmid">126237</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauderback</surname><given-names>C. M.</given-names></name><name><surname>Hackett</surname><given-names>J. M.</given-names></name><name><surname>Huang</surname><given-names>F. F.</given-names></name><name><surname>Keller</surname><given-names>J. N.</given-names></name><name><surname>Szweda</surname><given-names>L. I.</given-names></name><name><surname>Markesbery</surname><given-names>W. R.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Abeta1-42</article-title>. <source/>J. Neurochem.
<volume>78</volume>, <fpage>413</fpage>–<lpage>416</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.2001.00451.x</pub-id><pub-id pub-id-type="pmid">11461977</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lauritzen</surname><given-names>M.</given-names></name></person-group> (<year>1994</year>). <article-title>Pathophysiology of the migraine aura. The spreading depression theory</article-title>. <source/>Brain
<volume>117</volume>, <fpage>199</fpage>–<lpage>210</lpage>. <pub-id pub-id-type="doi">10.1093/brain/117.1.199</pub-id><pub-id pub-id-type="pmid">7908596</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lees</surname><given-names>G. J.</given-names></name><name><surname>Lehmann</surname><given-names>A.</given-names></name><name><surname>Sandberg</surname><given-names>M.</given-names></name><name><surname>Hamberger</surname><given-names>A.</given-names></name></person-group> (<year>1990</year>). <article-title>The neurotoxicity of ouabain, a sodium-potassium ATPase inhibitor, in the rat hippocampus</article-title>. <source/>Neurosci. Lett.
<volume>120</volume>, <fpage>159</fpage>–<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1016/0304-3940(90)90027-7</pub-id><pub-id pub-id-type="pmid">1705675</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Pira</surname><given-names>F.</given-names></name><name><surname>Lanaia</surname><given-names>F.</given-names></name><name><surname>Zappalà</surname><given-names>G.</given-names></name><name><surname>Morana</surname><given-names>R.</given-names></name><name><surname>Panetta</surname><given-names>M. R.</given-names></name><name><surname>Reggio</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Relationship between clinical variables and cognitive performances in migraineurs with and without aura</article-title>. <source/>Funct. Neurol.
<volume>19</volume>, <fpage>101</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="pmid">15274516</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levy</surname><given-names>L. M.</given-names></name><name><surname>Warr</surname><given-names>O.</given-names></name><name><surname>Attwell</surname><given-names>D.</given-names></name></person-group> (<year>1998</year>). <article-title>Stoichiometry of the glial glutamate transporter GLT-1 expressed inducibly in a Chinese hamster ovary cell line selected for low endogenous Na+-dependent glutamate uptake</article-title>. <source/>J. Neurosci.
<volume>18</volume>, <fpage>9620</fpage>–<lpage>9628</lpage>. <pub-id pub-id-type="pmid">9822723</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lewerenz</surname><given-names>J.</given-names></name><name><surname>Maher</surname><given-names>P.</given-names></name></person-group> (<year>2015</year>). <article-title>Chronic glutamate toxicity in neurodegenerative diseases-what is the evidence?</article-title>
<source/>Front. Neurosci.
<volume>9</volume>:<issue>469</issue>. <pub-id pub-id-type="doi">10.3389/fnins.2015.00469</pub-id><pub-id pub-id-type="pmid">26733784</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liang</surname><given-names>M.</given-names></name><name><surname>Cai</surname><given-names>T.</given-names></name><name><surname>Tian</surname><given-names>J.</given-names></name><name><surname>Qu</surname><given-names>W.</given-names></name><name><surname>Xie</surname><given-names>Z. J.</given-names></name></person-group> (<year>2006</year>). <article-title>Functional characterization of Src-interacting Na/K-ATPase using RNA interference assay</article-title>. <source/>J. Biol. Chem.
<volume>281</volume>, <fpage>19709</fpage>–<lpage>19719</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M512240200</pub-id><pub-id pub-id-type="pmid">16698801</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lieberman</surname><given-names>D. N.</given-names></name><name><surname>Mody</surname><given-names>I.</given-names></name></person-group> (<year>1994</year>). <article-title>Regulation of NMDA channel function by endogenous Ca(2+)-dependent phosphatase</article-title>. <source/>Nature
<volume>369</volume>, <fpage>235</fpage>–<lpage>239</lpage>. <pub-id pub-id-type="doi">10.1038/369235a0</pub-id><pub-id pub-id-type="pmid">7514273</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liguri</surname><given-names>G.</given-names></name><name><surname>Taddei</surname><given-names>N.</given-names></name><name><surname>Nassi</surname><given-names>P.</given-names></name><name><surname>Latorraca</surname><given-names>S.</given-names></name><name><surname>Nediani</surname><given-names>C.</given-names></name><name><surname>Sorbi</surname><given-names>S.</given-names></name></person-group> (<year>1990</year>). <article-title>Changes in Na+,K(+)-ATPase, Ca2(+)-ATPase and some soluble enzymes related to energy metabolism in brains of patients with Alzheimer's disease</article-title>. <source/>Neurosci. Lett.
<volume>112</volume>, <fpage>338</fpage>–<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1016/0304-3940(90)90227-Z</pub-id><pub-id pub-id-type="pmid">2163043</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>M. T.</given-names></name><name><surname>Beal</surname><given-names>M. F.</given-names></name></person-group> (<year>2006</year>). <article-title>Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases</article-title>. <source/>Nature
<volume>443</volume>, <fpage>787</fpage>–<lpage>795</lpage>. <pub-id pub-id-type="doi">10.1038/nature05292</pub-id><pub-id pub-id-type="pmid">17051205</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lipsky</surname><given-names>R. H.</given-names></name><name><surname>Xu</surname><given-names>K.</given-names></name><name><surname>Zhu</surname><given-names>D.</given-names></name><name><surname>Kelly</surname><given-names>C.</given-names></name><name><surname>Terhakopian</surname><given-names>A.</given-names></name><name><surname>Novelli</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Nuclear factor kappaB is a critical determinant in N-methyl-D-aspartate receptor-mediated neuroprotection</article-title>. <source/>J. Neurochem.
<volume>78</volume>, <fpage>254</fpage>–<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.2001.00386.x</pub-id><pub-id pub-id-type="pmid">11461961</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Mohammadi</surname><given-names>K.</given-names></name><name><surname>Aynafshar</surname><given-names>B.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Liu</surname><given-names>J.</given-names></name><etal></etal></person-group> (<year>2003</year>). <article-title>Role of caveolae in signal-transducing function of cardiac Na+/K+-ATPase</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>284</volume>, <fpage>C1550</fpage>–<lpage>C1560</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00555.2002</pub-id><pub-id pub-id-type="pmid">12606314</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>T.</given-names></name><name><surname>Konkalmatt</surname><given-names>P. R.</given-names></name><name><surname>Yang</surname><given-names>Y.</given-names></name><name><surname>Jose</surname><given-names>P. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Gastrin decreases Na<sup>+</sup>, K<sup>+</sup>-ATPase activity via a PI<sup>3</sup> kinase- and PKC-dependent pathway in human renal proximal tubule cells</article-title>. <source/>Am. J. Physiol. Endocrinol. Metab.
<volume>310</volume>, <fpage>E565</fpage>–<lpage>E571</lpage>. <pub-id pub-id-type="doi">10.1152/ajpendo.00360.2015</pub-id><pub-id pub-id-type="pmid">26786777</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longuemare</surname><given-names>M. C.</given-names></name><name><surname>Rose</surname><given-names>C. R.</given-names></name><name><surname>Farrell</surname><given-names>K.</given-names></name><name><surname>Ransom</surname><given-names>B. R.</given-names></name><name><surname>Waxman</surname><given-names>S. G.</given-names></name><name><surname>Swanson</surname><given-names>R. A.</given-names></name></person-group> (<year>1999</year>). <article-title>K(+)-induced reversal of astrocyte glutamate uptake is limited by compensatory changes in intracellular Na+</article-title>. <source/>Neuroscience
<volume>93</volume>, <fpage>285</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1016/S0306-4522(99)00152-9</pub-id><pub-id pub-id-type="pmid">10430492</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lucas</surname><given-names>T. F.</given-names></name><name><surname>Amaral</surname><given-names>L. S.</given-names></name><name><surname>Porto</surname><given-names>C. S.</given-names></name><name><surname>Quintas</surname><given-names>L. E.</given-names></name></person-group> (<year>2012</year>). <article-title>Na+/K+-ATPase alpha1 isoform mediates ouabain-induced expression of cyclin D1 and proliferation of rat sertoli cells</article-title>. <source/>Reproduction
<volume>144</volume>, <fpage>737</fpage>–<lpage>745</lpage>. <pub-id pub-id-type="doi">10.1530/REP-12-0232</pub-id><pub-id pub-id-type="pmid">23028124</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machado</surname><given-names>F. R.</given-names></name><name><surname>Ferreira</surname><given-names>A. G.</given-names></name><name><surname>da Cunha</surname><given-names>A. A.</given-names></name><name><surname>Tagliari</surname><given-names>B.</given-names></name><name><surname>Mussulini</surname><given-names>B. H.</given-names></name><name><surname>Wofchuk</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Homocysteine alters glutamate uptake and Na+,K+-ATPase activity and oxidative status in rats hippocampus: protection by vitamin C</article-title>. <source/>Metab. Brain Dis.
<volume>26</volume>, <fpage>61</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1007/s11011-011-9232-3</pub-id><pub-id pub-id-type="pmid">21287399</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maes</surname><given-names>M.</given-names></name><name><surname>Anderson</surname><given-names>G.</given-names></name></person-group> (<year>2016</year>). <article-title>Overlapping the Tryptophan Catabolite (TRYCAT) and melatoninergic pathways in Alzheimer's Disease</article-title>. <source/>Curr. Pharm. Des.
<volume>22</volume>, <fpage>1074</fpage>–<lpage>1085</lpage>. <pub-id pub-id-type="doi">10.2174/1381612822666151214125804</pub-id><pub-id pub-id-type="pmid">25547097</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malenka</surname><given-names>R. C.</given-names></name><name><surname>Bear</surname><given-names>M. F.</given-names></name></person-group> (<year>2004</year>). <article-title>LTP and LTD: an embarrassment of riches</article-title>. <source/>Neuron
<volume>44</volume>, <fpage>5</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2004.09.012</pub-id><pub-id pub-id-type="pmid">15450156</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manahan-Vaughan</surname><given-names>D.</given-names></name></person-group> (<year>1997</year>). <article-title>Group 1 and 2 metabotropic glutamate receptors play differential roles in hippocampal long-term depression and long-term potentiation in freely moving rats</article-title>. <source/>J. Neurosci.
<volume>17</volume>, <fpage>3303</fpage>–<lpage>3311</lpage>. <pub-id pub-id-type="pmid">9096163</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcaida</surname><given-names>G.</given-names></name><name><surname>Kosenko</surname><given-names>E.</given-names></name><name><surname>Miñana</surname><given-names>M. D.</given-names></name><name><surname>Grisolía</surname><given-names>S.</given-names></name><name><surname>Felipo</surname><given-names>V.</given-names></name></person-group> (<year>1996</year>). <article-title>Glutamate induces a calcineurin-mediated dephosphorylation of Na+,K(+)-ATPase that results in its activation in cerebellar neurons in culture</article-title>. <source/>J. Neurochem.
<volume>66</volume>, <fpage>99</fpage>–<lpage>104</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.1996.66010099.x</pub-id><pub-id pub-id-type="pmid">8522995</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mark</surname><given-names>R. J.</given-names></name><name><surname>Hensley</surname><given-names>K.</given-names></name><name><surname>Butterfield</surname><given-names>D. A.</given-names></name><name><surname>Mattson</surname><given-names>M. P.</given-names></name></person-group> (<year>1995</year>). <article-title>Amyloid beta-peptide impairs ion-motive ATPase activities: evidence for a role in loss of neuronal Ca2+ homeostasis and cell death</article-title>. <source/>J. Neurosci.
<volume>15</volume>, <fpage>6239</fpage>–<lpage>6249</lpage>. <pub-id pub-id-type="pmid">7666206</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marks</surname><given-names>M. J.</given-names></name><name><surname>Seeds</surname><given-names>N. W.</given-names></name></person-group> (<year>1978</year>). <article-title>A heterogeneous ouabain-ATPase interaction in mouse brain</article-title>. <source/>Life Sci.
<volume>23</volume>, <fpage>2735</fpage>–<lpage>2744</lpage>. <pub-id pub-id-type="doi">10.1016/0024-3205(78)90654-9</pub-id><pub-id pub-id-type="pmid">216868</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matos</surname><given-names>M.</given-names></name><name><surname>Augusto</surname><given-names>E.</given-names></name><name><surname>Agostinho</surname><given-names>P.</given-names></name><name><surname>Cunha</surname><given-names>R. A.</given-names></name><name><surname>Chen</surname><given-names>J. F.</given-names></name></person-group> (<year>2013</year>). <article-title>Antagonistic interaction between adenosine A2A receptors and Na+/K+-ATPase-alpha2 controlling glutamate uptake in astrocytes</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>18492</fpage>–<lpage>18502</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1828-13.2013</pub-id><pub-id pub-id-type="pmid">24259572</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuno</surname><given-names>H.</given-names></name><name><surname>Ohi</surname><given-names>K.</given-names></name><name><surname>Hashimoto</surname><given-names>R.</given-names></name><name><surname>Yamamori</surname><given-names>H.</given-names></name><name><surname>Yasuda</surname><given-names>Y.</given-names></name><name><surname>Fujimoto</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>A naturally occurring null variant of the NMDA type glutamate receptor NR3B subunit is a risk factor of schizophrenia</article-title>. <source/>PLoS ONE
<volume>10</volume>:<fpage>e0116319</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0116319</pub-id><pub-id pub-id-type="pmid">25768306</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattson</surname><given-names>M. P.</given-names></name></person-group> (<year>2004</year>). <article-title>Pathways towards and away from Alzheimer's disease</article-title>. <source/>Nature
<volume>430</volume>, <fpage>631</fpage>–<lpage>639</lpage>. <pub-id pub-id-type="doi">10.1038/nature02621</pub-id><pub-id pub-id-type="pmid">15295589</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McGrail</surname><given-names>K. M.</given-names></name><name><surname>Phillips</surname><given-names>J. M.</given-names></name><name><surname>Sweadner</surname><given-names>K. J.</given-names></name></person-group> (<year>1991</year>). <article-title>Immunofluorescent localization of three Na,K-ATPase isozymes in the rat central nervous system: both neurons and glia can express more than one Na,K-ATPase</article-title>. <source/>J. Neurosci.
<volume>11</volume>, <fpage>381</fpage>–<lpage>391</lpage>. <pub-id pub-id-type="pmid">1846906</pub-id></mixed-citation>
</ref>
<ref id="B186">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKee</surname><given-names>M.</given-names></name><name><surname>Scavone</surname><given-names>C.</given-names></name><name><surname>Nathanson</surname><given-names>J. A.</given-names></name></person-group> (<year>1994</year>). <article-title>Nitric oxide, cGMP, and hormone regulation of active sodium transport</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>91</volume>, <fpage>12056</fpage>–<lpage>12060</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.91.25.12056</pub-id><pub-id pub-id-type="pmid">7527549</pub-id></mixed-citation>
</ref>
<ref id="B187">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McLennan</surname><given-names>H.</given-names></name></person-group> (<year>1981</year>). <article-title>On the nature of the receptors for various excitatory amino acids in the mammalian central nervous system</article-title>. <source/>Adv. Biochem. Psychopharmacol.
<volume>27</volume>, <fpage>253</fpage>–<lpage>262</lpage>. <pub-id pub-id-type="pmid">6255760</pub-id></mixed-citation>
</ref>
<ref id="B188">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mense</surname><given-names>M.</given-names></name><name><surname>Stark</surname><given-names>G.</given-names></name><name><surname>Apell</surname><given-names>H. J.</given-names></name></person-group> (<year>1997</year>). <article-title>Effects of free radicals on partial reactions of the Na, K-ATPase</article-title>. <source/>J. Membr. Biol.
<volume>156</volume>, <fpage>63</fpage>–<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1007/s002329900188</pub-id><pub-id pub-id-type="pmid">9070465</pub-id></mixed-citation>
</ref>
<ref id="B189">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mobasheri</surname><given-names>A.</given-names></name><name><surname>Avila</surname><given-names>J.</given-names></name><name><surname>Cózar-Castellano</surname><given-names>I.</given-names></name><name><surname>Brownleader</surname><given-names>M. D.</given-names></name><name><surname>Trevan</surname><given-names>M.</given-names></name><name><surname>Francis</surname><given-names>M. J.</given-names></name><etal></etal></person-group>. (<year>2000</year>). <article-title>Na+, K+-ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions</article-title>. <source/>Biosci. Rep.
<volume>20</volume>, <fpage>51</fpage>–<lpage>91</lpage>. <pub-id pub-id-type="doi">10.1023/A:1005580332144</pub-id><pub-id pub-id-type="pmid">10965965</pub-id></mixed-citation>
</ref>
<ref id="B190">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morin</surname><given-names>N.</given-names></name><name><surname>Morissette</surname><given-names>M.</given-names></name><name><surname>Grégoire</surname><given-names>L.</given-names></name><name><surname>Di Paolo</surname><given-names>T.</given-names></name></person-group> (<year>2015</year>). <article-title>Effect of a chronic treatment with an mGlu5 receptor antagonist on brain serotonin markers in parkinsonian monkeys</article-title>. <source/>Prog. Neuropsychopharmacol. Biol. Psychiatry
<volume>56</volume>, <fpage>27</fpage>–<lpage>38</lpage>. <pub-id pub-id-type="doi">10.1016/j.pnpbp.2014.07.006</pub-id><pub-id pub-id-type="pmid">25046277</pub-id></mixed-citation>
</ref>
<ref id="B191">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moseley</surname><given-names>A. E.</given-names></name><name><surname>Lieske</surname><given-names>S. P.</given-names></name><name><surname>Wetzel</surname><given-names>R. K.</given-names></name><name><surname>James</surname><given-names>P. F.</given-names></name><name><surname>He</surname><given-names>S.</given-names></name><name><surname>Shelly</surname><given-names>D. A.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>The Na,K-ATPase alpha 2 isoform is expressed in neurons, and its absence disrupts neuronal activity in newborn mice</article-title>. <source/>J. Biol. Chem.
<volume>278</volume>, <fpage>5317</fpage>–<lpage>5324</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M211315200</pub-id><pub-id pub-id-type="pmid">12458206</pub-id></mixed-citation>
</ref>
<ref id="B192">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Munhoz</surname><given-names>C. D.</given-names></name><name><surname>Kawamoto</surname><given-names>E. M.</given-names></name><name><surname>de Sá Lima</surname><given-names>L.</given-names></name><name><surname>Lepsch</surname><given-names>L. B.</given-names></name><name><surname>Glezer</surname><given-names>I.</given-names></name><name><surname>Marcourakis</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Glutamate modulates sodium-potassium-ATPase through cyclic GMP and cyclic GMP-dependent protein kinase in rat striatum</article-title>. <source/>Cell Biochem. Funct.
<volume>23</volume>, <fpage>115</fpage>–<lpage>123</lpage>. <pub-id pub-id-type="doi">10.1002/cbf.1217</pub-id><pub-id pub-id-type="pmid">15624118</pub-id></mixed-citation>
</ref>
<ref id="B193">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muriel</surname><given-names>P.</given-names></name><name><surname>Sandoval</surname><given-names>G.</given-names></name></person-group> (<year>2000</year>). <article-title>Nitric oxide and peroxynitrite anion modulate liver plasma membrane fluidity and Na(+)/K(+)-ATPase activity</article-title>. <source/>Nitric Oxide
<volume>4</volume>, <fpage>333</fpage>–<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1006/niox.2000.0285</pub-id><pub-id pub-id-type="pmid">10944417</pub-id></mixed-citation>
</ref>
<ref id="B194">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakagawa</surname><given-names>T.</given-names></name><name><surname>Otsubo</surname><given-names>Y.</given-names></name><name><surname>Yatani</surname><given-names>Y.</given-names></name><name><surname>Shirakawa</surname><given-names>H.</given-names></name><name><surname>Kaneko</surname><given-names>S.</given-names></name></person-group> (<year>2008</year>). <article-title>Mechanisms of substrate transport-induced clustering of a glial glutamate transporter GLT-1 in astroglial-neuronal cultures</article-title>. <source/>Eur. J. Neurosci.
<volume>28</volume>, <fpage>1719</fpage>–<lpage>1730</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06494.x</pub-id><pub-id pub-id-type="pmid">18973588</pub-id></mixed-citation>
</ref>
<ref id="B195">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nathanson</surname><given-names>J. A.</given-names></name><name><surname>Scavone</surname><given-names>C.</given-names></name><name><surname>Scanlon</surname><given-names>C.</given-names></name><name><surname>McKee</surname><given-names>M.</given-names></name></person-group> (<year>1995</year>). <article-title>The cellular Na+ pump as a site of action for carbon monoxide and glutamate: a mechanism for long-term modulation of cellular activity</article-title>. <source/>Neuron
<volume>14</volume>, <fpage>781</fpage>–<lpage>794</lpage>. <pub-id pub-id-type="doi">10.1016/0896-6273(95)90222-8</pub-id><pub-id pub-id-type="pmid">7718240</pub-id></mixed-citation>
</ref>
<ref id="B196">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nesher</surname><given-names>M.</given-names></name><name><surname>Shpolansky</surname><given-names>U.</given-names></name><name><surname>Rosen</surname><given-names>H.</given-names></name><name><surname>Lichtstein</surname><given-names>D.</given-names></name></person-group> (<year>2007</year>). <article-title>The digitalis-like steroid hormones: new mechanisms of action and biological significance</article-title>. <source/>Life Sci.
<volume>80</volume>, <fpage>2093</fpage>–<lpage>2107</lpage>. <pub-id pub-id-type="doi">10.1016/j.lfs.2007.03.013</pub-id><pub-id pub-id-type="pmid">17499813</pub-id></mixed-citation>
</ref>
<ref id="B197">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname><given-names>K. T.</given-names></name><name><surname>Buljan</surname><given-names>V.</given-names></name><name><surname>Else</surname><given-names>P. L.</given-names></name><name><surname>Pow</surname><given-names>D. V.</given-names></name><name><surname>Balcar</surname><given-names>V. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Cardiac glycosides ouabain and digoxin interfere with the regulation of glutamate transporter GLAST in astrocytes cultured from neonatal rat brain</article-title>. <source/>Neurochem. Res.
<volume>35</volume>, <fpage>2062</fpage>–<lpage>2069</lpage>. <pub-id pub-id-type="doi">10.1007/s11064-010-0274-4</pub-id><pub-id pub-id-type="pmid">20890657</pub-id></mixed-citation>
</ref>
<ref id="B198">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoletti</surname><given-names>F.</given-names></name><name><surname>Wroblewski</surname><given-names>J. T.</given-names></name><name><surname>Novelli</surname><given-names>A.</given-names></name><name><surname>Alho</surname><given-names>H.</given-names></name><name><surname>Guidotti</surname><given-names>A.</given-names></name><name><surname>Costa</surname><given-names>E.</given-names></name></person-group> (<year>1986</year>). <article-title>The activation of inositol phospholipid metabolism as a signal-transducing system for excitatory amino acids in primary cultures of cerebellar granule cells</article-title>. <source/>J. Neurosci.
<volume>6</volume>, <fpage>1905</fpage>–<lpage>1911</lpage>. <pub-id pub-id-type="pmid">3016212</pub-id></mixed-citation>
</ref>
<ref id="B199">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicoll</surname><given-names>R. A.</given-names></name><name><surname>Oliet</surname><given-names>S. H.</given-names></name><name><surname>Malenka</surname><given-names>R. C.</given-names></name></person-group> (<year>1998</year>). <article-title>NMDA receptor-dependent and metabotropic glutamate receptor-dependent forms of long-term depression coexist in CA1 hippocampal pyramidal cells</article-title>. <source/>Neurobiol. Learn. Mem.
<volume>70</volume>, <fpage>62</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1006/nlme.1998.3838</pub-id><pub-id pub-id-type="pmid">9753587</pub-id></mixed-citation>
</ref>
<ref id="B200">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishi</surname><given-names>A.</given-names></name><name><surname>Fisone</surname><given-names>G.</given-names></name><name><surname>Snyder</surname><given-names>G. L.</given-names></name><name><surname>Dulubova</surname><given-names>I.</given-names></name><name><surname>Aperia</surname><given-names>A.</given-names></name><name><surname>Nairn</surname><given-names>A. C.</given-names></name><etal></etal></person-group>. (<year>1999</year>). <article-title>Regulation of Na+, K+-ATPase isoforms in rat neostriatum by dopamine and protein kinase C</article-title>. <source/>J. Neurochem.
<volume>73</volume>, <fpage>1492</fpage>–<lpage>1501</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.1999.0731492.x</pub-id><pub-id pub-id-type="pmid">10501194</pub-id></mixed-citation>
</ref>
<ref id="B201">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nithianantharajah</surname><given-names>J.</given-names></name><name><surname>Hannan</surname><given-names>A. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease</article-title>. <source/>Neuroscience
<volume>251</volume>, <fpage>66</fpage>–<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2012.05.043</pub-id><pub-id pub-id-type="pmid">22633949</pub-id></mixed-citation>
</ref>
<ref id="B202">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noel</surname><given-names>F.</given-names></name><name><surname>Godfraind</surname><given-names>T.</given-names></name></person-group> (<year>1984</year>). <article-title>Heterogeneity of ouabain specific binding sites and (Na+ + K+)-ATPase inhibition in microsomes from rat heart</article-title>. <source/>Biochem. Pharmacol.
<volume>33</volume>, <fpage>47</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/0006-2952(84)90369-1</pub-id><pub-id pub-id-type="pmid">6322793</pub-id></mixed-citation>
</ref>
<ref id="B203">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novy</surname><given-names>J.</given-names></name><name><surname>McWilliams</surname><given-names>E.</given-names></name><name><surname>Sisodiya</surname><given-names>S. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Asystole in alternating hemiplegia with de novo ATP1A3 mutation</article-title>. <source/>Eur. J. Med. Genet.
<volume>57</volume>, <fpage>37</fpage>–<lpage>39</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2013.11.003</pub-id><pub-id pub-id-type="pmid">24291144</pub-id></mixed-citation>
</ref>
<ref id="B204">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oblak</surname><given-names>A. L.</given-names></name><name><surname>Hagen</surname><given-names>M. C.</given-names></name><name><surname>Sweadner</surname><given-names>K. J.</given-names></name><name><surname>Haq</surname><given-names>I.</given-names></name><name><surname>Whitlow</surname><given-names>C. T.</given-names></name><name><surname>Maldjian</surname><given-names>J. A.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Rapid-onset dystonia-parkinsonism associated with the I758S mutation of the ATP1A3 gene: a neuropathologic and neuroanatomical study of four siblings</article-title>. <source/>Acta Neuropathol.
<volume>128</volume>, <fpage>81</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1007/s00401-014-1279-x</pub-id><pub-id pub-id-type="pmid">24803225</pub-id></mixed-citation>
</ref>
<ref id="B205">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohtani</surname><given-names>Y.</given-names></name><name><surname>Miyata</surname><given-names>M.</given-names></name><name><surname>Hashimoto</surname><given-names>K.</given-names></name><name><surname>Tabata</surname><given-names>T.</given-names></name><name><surname>Kishimoto</surname><given-names>Y.</given-names></name><name><surname>Fukaya</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>The synaptic targeting of mGluR1 by its carboxyl-terminal domain is crucial for cerebellar function</article-title>. <source/>J. Neurosci.
<volume>34</volume>, <fpage>2702</fpage>–<lpage>2712</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3542-13.2014</pub-id><pub-id pub-id-type="pmid">24523559</pub-id></mixed-citation>
</ref>
<ref id="B206">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ophoff</surname><given-names>R. A.</given-names></name><name><surname>Terwindt</surname><given-names>G. M.</given-names></name><name><surname>Vergouwe</surname><given-names>M. N.</given-names></name><name><surname>van Eijk</surname><given-names>R.</given-names></name><name><surname>Oefner</surname><given-names>P. J.</given-names></name><name><surname>Hoffman</surname><given-names>S. M.</given-names></name><etal></etal></person-group>. (<year>1996</year>). <article-title>Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4</article-title>. <source/>Cell
<volume>87</volume>, <fpage>543</fpage>–<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1016/S0092-8674(00)81373-2</pub-id><pub-id pub-id-type="pmid">8898206</pub-id></mixed-citation>
</ref>
<ref id="B207">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ossowska</surname><given-names>K.</given-names></name><name><surname>Wolfarth</surname><given-names>S.</given-names></name><name><surname>Schulze</surname><given-names>G.</given-names></name><name><surname>Wardas</surname><given-names>J.</given-names></name><name><surname>Pietraszek</surname><given-names>M.</given-names></name><name><surname>Lorenc-Koci</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Decline in motor functions in aging is related to the loss of NMDA receptors</article-title>. <source/>Brain Res.
<volume>907</volume>, <fpage>71</fpage>–<lpage>83</lpage>. <pub-id pub-id-type="doi">10.1016/S0006-8993(01)02601-4</pub-id><pub-id pub-id-type="pmid">11430887</pub-id></mixed-citation>
</ref>
<ref id="B208">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozelius</surname><given-names>L. J.</given-names></name></person-group> (<year>2012</year>). <article-title>Clinical spectrum of disease associated with ATP1A3 mutations</article-title>. <source/>Lancet Neurol.
<volume>11</volume>, <fpage>741</fpage>–<lpage>743</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(12)70185-0</pub-id><pub-id pub-id-type="pmid">22857851</pub-id></mixed-citation>
</ref>
<ref id="B209">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Paciorkowski</surname><given-names>A. R.</given-names></name><name><surname>McDaniel</surname><given-names>S. S.</given-names></name><name><surname>Jansen</surname><given-names>L. A.</given-names></name><name><surname>Tully</surname><given-names>H.</given-names></name><name><surname>Tuttle</surname><given-names>E.</given-names></name><name><surname>Ghoneim</surname><given-names>D. H.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Novel mutations in ATP1A3 associated with catastrophic early life epilepsy, episodic prolonged apnea, and postnatal microcephaly</article-title>. <source/>Epilepsia
<volume>56</volume>, <fpage>422</fpage>–<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12914</pub-id><pub-id pub-id-type="pmid">25656163</pub-id></mixed-citation>
</ref>
<ref id="B210">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panagiotakaki</surname><given-names>E.</given-names></name><name><surname>De Grandis</surname><given-names>E.</given-names></name><name><surname>Stagnaro</surname><given-names>M.</given-names></name><name><surname>Heinzen</surname><given-names>E. L.</given-names></name><name><surname>Fons</surname><given-names>C.</given-names></name><name><surname>Sisodiya</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Clinical profile of patients with ATP1A3 mutations in alternating hemiplegia of childhood-a study of 155 patients</article-title>. <source/>Orphanet J. Rare Dis.
<volume>10</volume>, <fpage>123</fpage>. <pub-id pub-id-type="doi">10.1186/s13023-015-0335-5</pub-id><pub-id pub-id-type="pmid">26410222</pub-id></mixed-citation>
</ref>
<ref id="B211">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pekhletski</surname><given-names>R.</given-names></name><name><surname>Gerlai</surname><given-names>R.</given-names></name><name><surname>Overstreet</surname><given-names>L. S.</given-names></name><name><surname>Huang</surname><given-names>X. P.</given-names></name><name><surname>Agopyan</surname><given-names>N.</given-names></name><name><surname>Slater</surname><given-names>N. T.</given-names></name><etal></etal></person-group>. (<year>1996</year>). <article-title>Impaired cerebellar synaptic plasticity and motor performance in mice lacking the mGluR4 subtype of metabotropic glutamate receptor</article-title>. <source/>J. Neurosci.
<volume>16</volume>, <fpage>6364</fpage>–<lpage>6373</lpage>. <pub-id pub-id-type="pmid">8815915</pub-id></mixed-citation>
</ref>
<ref id="B212">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pellerin</surname><given-names>L.</given-names></name><name><surname>Magistretti</surname><given-names>P. J.</given-names></name></person-group> (<year>1997</year>). <article-title>Glutamate uptake stimulates Na+,K+-ATPase activity in astrocytes via activation of a distinct subunit highly sensitive to ouabain</article-title>. <source/>J. Neurochem.
<volume>69</volume>, <fpage>2132</fpage>–<lpage>2137</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.1997.69052132.x</pub-id><pub-id pub-id-type="pmid">9349559</pub-id></mixed-citation>
</ref>
<ref id="B213">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>L.</given-names></name><name><surname>Martin-Vasallo</surname><given-names>P.</given-names></name><name><surname>Sweadner</surname><given-names>K. J.</given-names></name></person-group> (<year>1997</year>). <article-title>Isoforms of Na,K-ATPase alpha and beta subunits in the rat cerebellum and in granule cell cultures</article-title>. <source/>J. Neurosci.
<volume>17</volume>, <fpage>3488</fpage>–<lpage>3502</lpage>. <pub-id pub-id-type="pmid">9133374</pub-id></mixed-citation>
</ref>
<ref id="B214">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>M.</given-names></name><name><surname>Huang</surname><given-names>L.</given-names></name><name><surname>Xie</surname><given-names>Z.</given-names></name><name><surname>Huang</surname><given-names>W. H.</given-names></name><name><surname>Askari</surname><given-names>A.</given-names></name></person-group> (<year>1996</year>). <article-title>Partial inhibition of Na+/K+-ATPase by ouabain induces the Ca2+-dependent expressions of early-response genes in cardiac myocytes</article-title>. <source/>J. Biol. Chem.
<volume>271</volume>, <fpage>10372</fpage>–<lpage>10378</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.271.17.10372</pub-id><pub-id pub-id-type="pmid">8626609</pub-id></mixed-citation>
</ref>
<ref id="B215">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>W. F.</given-names></name><name><surname>Ding</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Fan</surname><given-names>F.</given-names></name><name><surname>Zhang</surname><given-names>Q. Q.</given-names></name><name><surname>Wang</surname><given-names>X.</given-names></name></person-group> (<year>2016</year>). <article-title>N-methyl-d-aspartate receptor NR2B subunit involved in depression-like behaviours in lithium chloride-pilocarpine chronic rat epilepsy model</article-title>. <source/>Epilepsy Res.
<volume>119</volume>, <fpage>77</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2015.09.013</pub-id><pub-id pub-id-type="pmid">26688426</pub-id></mixed-citation>
</ref>
<ref id="B216">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peres</surname><given-names>M. F.</given-names></name><name><surname>Zukerman</surname><given-names>E.</given-names></name><name><surname>Senne Soares</surname><given-names>C. A.</given-names></name><name><surname>Alonso</surname><given-names>E. O.</given-names></name><name><surname>Santos</surname><given-names>B. F.</given-names></name><name><surname>Faulhaber</surname><given-names>M. H.</given-names></name></person-group> (<year>2004</year>). <article-title>Cerebrospinal fluid glutamate levels in chronic migraine</article-title>. <source/>Cephalalgia
<volume>24</volume>, <fpage>735</fpage>–<lpage>739</lpage>. <pub-id pub-id-type="doi">10.1111/j.1468-2982.2004.00750.x</pub-id><pub-id pub-id-type="pmid">15315529</pub-id></mixed-citation>
</ref>
<ref id="B217">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perry</surname><given-names>C. J.</given-names></name><name><surname>Reed</surname><given-names>F.</given-names></name><name><surname>Zbukvic</surname><given-names>I. C.</given-names></name><name><surname>Kim</surname><given-names>J. H.</given-names></name><name><surname>Lawrence</surname><given-names>A. J.</given-names></name></person-group> (<year>2016</year>). <article-title>The metabotropic glutamate 5 receptor is necessary for extinction of cocaine-associated cues</article-title>. <source/>Br. J. Pharmacol. <volume>173</volume>, <fpage>1085</fpage>–<lpage>1094</lpage>. <pub-id pub-id-type="doi">10.1111/bph.13437</pub-id><pub-id pub-id-type="pmid">26784278</pub-id></mixed-citation>
</ref>
<ref id="B218">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>C.</given-names></name><name><surname>Cotman</surname><given-names>C. W.</given-names></name></person-group> (<year>1989</year>). <article-title>Strain-dependent decrease in glutamate binding to the N-methyl-D-aspartic acid receptor during aging</article-title>. <source/>Neurosci. Lett.
<volume>104</volume>, <fpage>309</fpage>–<lpage>313</lpage>. <pub-id pub-id-type="doi">10.1016/0304-3940(89)90594-6</pub-id><pub-id pub-id-type="pmid">2573018</pub-id></mixed-citation>
</ref>
<ref id="B219">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petr</surname><given-names>G. T.</given-names></name><name><surname>Sun</surname><given-names>Y.</given-names></name><name><surname>Frederick</surname><given-names>N. M.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Dhamne</surname><given-names>S. C.</given-names></name><name><surname>Hameed</surname><given-names>M. Q.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Conditional deletion of the glutamate transporter GLT-1 reveals that astrocytic GLT-1 protects against fatal epilepsy while neuronal GLT-1 contributes significantly to glutamate uptake into synaptosomes</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>5187</fpage>–<lpage>5201</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4255-14.2015</pub-id><pub-id pub-id-type="pmid">25834045</pub-id></mixed-citation>
</ref>
<ref id="B220">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierelli</surname><given-names>F.</given-names></name><name><surname>Grieco</surname><given-names>G. S.</given-names></name><name><surname>Pauri</surname><given-names>F.</given-names></name><name><surname>Pirro</surname><given-names>C.</given-names></name><name><surname>Fiermonte</surname><given-names>G.</given-names></name><name><surname>Ambrosini</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>A novel ATP1A2 mutation in a family with FHM type II</article-title>. <source/>Cephalalgia
<volume>26</volume>, <fpage>324</fpage>–<lpage>328</lpage>. <pub-id pub-id-type="doi">10.1111/j.1468-2982.2006.01002.x</pub-id><pub-id pub-id-type="pmid">16472340</pub-id></mixed-citation>
</ref>
<ref id="B221">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietrobon</surname><given-names>D.</given-names></name></person-group> (<year>2005</year>). <article-title>Migraine: new molecular mechanisms</article-title>. <source/>Neuroscientist
<volume>11</volume>, <fpage>373</fpage>–<lpage>386</lpage>. <pub-id pub-id-type="doi">10.1177/1073858405275554</pub-id><pub-id pub-id-type="pmid">16061523</pub-id></mixed-citation>
</ref>
<ref id="B222">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietrobon</surname><given-names>D.</given-names></name><name><surname>Striessnig</surname><given-names>J.</given-names></name></person-group> (<year>2003</year>). <article-title>Neurobiology of migraine</article-title>. <source/>Nat. Rev. Neurosci.
<volume>4</volume>, <fpage>386</fpage>–<lpage>398</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1102</pub-id><pub-id pub-id-type="pmid">12728266</pub-id></mixed-citation>
</ref>
<ref id="B223">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Plaitakis</surname><given-names>A.</given-names></name><name><surname>Constantakakis</surname><given-names>E.</given-names></name><name><surname>Smith</surname><given-names>J.</given-names></name></person-group> (<year>1988</year>). <article-title>The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis</article-title>. <source/>Ann. Neurol.
<volume>24</volume>, <fpage>446</fpage>–<lpage>449</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410240314</pub-id><pub-id pub-id-type="pmid">2906529</pub-id></mixed-citation>
</ref>
<ref id="B224">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porras</surname><given-names>O. H.</given-names></name><name><surname>Ruminot</surname><given-names>I.</given-names></name><name><surname>Loaiza</surname><given-names>A.</given-names></name><name><surname>Barros</surname><given-names>L. F.</given-names></name></person-group> (<year>2008</year>). <article-title>Na(+)-Ca(2+) cosignaling in the stimulation of the glucose transporter GLUT1 in cultured astrocytes</article-title>. <source/>Glia
<volume>56</volume>, <fpage>59</fpage>–<lpage>68</lpage>. <pub-id pub-id-type="doi">10.1002/glia.20589</pub-id><pub-id pub-id-type="pmid">17924581</pub-id></mixed-citation>
</ref>
<ref id="B225">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Post</surname><given-names>R. L.</given-names></name><name><surname>Hegyvary</surname><given-names>C.</given-names></name><name><surname>Kume</surname><given-names>S.</given-names></name></person-group> (<year>1972</year>). <article-title>Activation by adenosine triphosphate in the phosphorylation kinetics of sodium and potassium ion transport adenosine triphosphatase</article-title>. <source/>J. Biol. Chem.
<volume>247</volume>, <fpage>6530</fpage>–<lpage>6540</lpage>. <pub-id pub-id-type="pmid">4263199</pub-id></mixed-citation>
</ref>
<ref id="B226">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Post</surname><given-names>R. L.</given-names></name><name><surname>Jolly</surname><given-names>P. C.</given-names></name></person-group> (<year>1957</year>). <article-title>The linkage of sodium, potassium, and ammonium active transport across the human erythrocyte membrane</article-title>. <source/>Biochim. Biophys. Acta
<volume>25</volume>, <fpage>118</fpage>–<lpage>128</lpage>. <pub-id pub-id-type="doi">10.1016/0006-3002(57)90426-2</pub-id><pub-id pub-id-type="pmid">13445725</pub-id></mixed-citation>
</ref>
<ref id="B227">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Post</surname><given-names>R. L.</given-names></name><name><surname>Kume</surname><given-names>S.</given-names></name></person-group> (<year>1973</year>). <article-title>Evidence for an aspartyl phosphate residue at the active site of sodium and potassium ion transport adenosine triphosphatase</article-title>. <source/>J. Biol. Chem.
<volume>248</volume>, <fpage>6993</fpage>–<lpage>7000</lpage>. <pub-id pub-id-type="pmid">4270326</pub-id></mixed-citation>
</ref>
<ref id="B228">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Post</surname><given-names>R. L.</given-names></name><name><surname>Merritt</surname><given-names>C. R.</given-names></name><name><surname>Kinsolving</surname><given-names>C. R.</given-names></name><name><surname>Albright</surname><given-names>C. D.</given-names></name></person-group> (<year>1960</year>). <article-title>Membrane adenosine triphosphatase as a participant in the active transport of sodium and potassium in the human erythrocyte</article-title>. <source/>J. Biol. Chem.
<volume>235</volume>, <fpage>1796</fpage>–<lpage>1802</lpage>. <pub-id pub-id-type="pmid">14434402</pub-id></mixed-citation>
</ref>
<ref id="B229">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Post</surname><given-names>R. L.</given-names></name><name><surname>Sen</surname><given-names>A. K.</given-names></name><name><surname>Rosenthal</surname><given-names>A. S.</given-names></name></person-group> (<year>1965</year>). <article-title>A phosphorylated intermediate in adenosine triphosphate-dependent sodium and potassium transport across kidney membranes</article-title>. <source/>J. Biol. Chem.
<volume>240</volume>, <fpage>1437</fpage>–<lpage>1445</lpage>. <pub-id pub-id-type="pmid">14284759</pub-id></mixed-citation>
</ref>
<ref id="B230">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Potic</surname><given-names>A.</given-names></name><name><surname>Nmezi</surname><given-names>B.</given-names></name><name><surname>Padiath</surname><given-names>Q. S.</given-names></name></person-group> (<year>2015</year>). <article-title>CAPOS syndrome and hemiplegic migraine in a novel pedigree with the specific ATP1A3 mutation</article-title>. <source/>J. Neurol. Sci.
<volume>358</volume>, <fpage>453</fpage>–<lpage>456</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2015.10.002</pub-id><pub-id pub-id-type="pmid">26453127</pub-id></mixed-citation>
</ref>
<ref id="B231">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poulsen</surname><given-names>F. R.</given-names></name><name><surname>Blaabjerg</surname><given-names>M.</given-names></name><name><surname>Montero</surname><given-names>M.</given-names></name><name><surname>Zimmer</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>Glutamate receptor antagonists and growth factors modulate dentate granule cell neurogenesis in organotypic, rat hippocampal slice cultures</article-title>. <source/>Brain Res.
<volume>1051</volume>, <fpage>35</fpage>–<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2005.05.050</pub-id><pub-id pub-id-type="pmid">15993864</pub-id></mixed-citation>
</ref>
<ref id="B232">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quintas</surname><given-names>L. E.</given-names></name><name><surname>Pierre</surname><given-names>S. V.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Bai</surname><given-names>Y.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Xie</surname><given-names>Z. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Alterations of Na+/K+-ATPase function in caveolin-1 knockout cardiac fibroblasts</article-title>. <source/>J. Mol. Cell. Cardiol.
<volume>49</volume>, <fpage>525</fpage>–<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2010.04.015</pub-id><pub-id pub-id-type="pmid">20451529</pub-id></mixed-citation>
</ref>
<ref id="B233">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rambo</surname><given-names>L. M.</given-names></name><name><surname>Ribeiro</surname><given-names>L. R.</given-names></name><name><surname>Schramm</surname><given-names>V. G.</given-names></name><name><surname>Berch</surname><given-names>A. M.</given-names></name><name><surname>Stamm</surname><given-names>D. N.</given-names></name><name><surname>Della-Pace</surname><given-names>I. D.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Creatine increases hippocampal Na(+),K(+)-ATPase activity via NMDA-calcineurin pathway</article-title>. <source/>Brain Res. Bull.
<volume>88</volume>, <fpage>553</fpage>–<lpage>559</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainresbull.2012.06.007</pub-id><pub-id pub-id-type="pmid">22742935</pub-id></mixed-citation>
</ref>
<ref id="B234">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ransom</surname><given-names>C. B.</given-names></name><name><surname>Ransom</surname><given-names>B. R.</given-names></name><name><surname>Sontheimer</surname><given-names>H.</given-names></name></person-group> (<year>2000</year>). <article-title>Activity-dependent extracellular K+ accumulation in rat optic nerve: the role of glial and axonal Na+ pumps</article-title>. <source/>J. Physiol.
<volume>522</volume>, <fpage>427</fpage>–<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.2000.00427.x</pub-id><pub-id pub-id-type="pmid">10713967</pub-id></mixed-citation>
</ref>
<ref id="B235">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reifenberger</surname><given-names>M. S.</given-names></name><name><surname>Arnett</surname><given-names>K. L.</given-names></name><name><surname>Gatto</surname><given-names>C.</given-names></name><name><surname>Milanick</surname><given-names>M. A.</given-names></name></person-group> (<year>2008</year>). <article-title>The reactive nitrogen species peroxynitrite is a potent inhibitor of renal Na-K-ATPase activity</article-title>. <source/>Am. J. Physiol. Ren. Physiol.
<volume>295</volume>, <fpage>F1191</fpage>–<lpage>F1198</lpage>. <pub-id pub-id-type="doi">10.1152/ajprenal.90296.2008</pub-id><pub-id pub-id-type="pmid">18701626</pub-id></mixed-citation>
</ref>
<ref id="B236">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinés</surname><given-names>A.</given-names></name><name><surname>Peña</surname><given-names>C.</given-names></name><name><surname>Rodríguez de Lores Arnaiz</surname><given-names>G.</given-names></name></person-group> (<year>2001</year>). <article-title>[3H]dizocilpine binding to N-methyl-D-aspartate (NMDA) receptor is modulated by an endogenous Na+, K+-ATPase inhibitor. Comparison with ouabain</article-title>. <source/>Neurochem. Int.
<volume>39</volume>, <fpage>301</fpage>–<lpage>310</lpage>. <pub-id pub-id-type="doi">10.1016/S0197-0186(01)00034-1</pub-id><pub-id pub-id-type="pmid">11551670</pub-id></mixed-citation>
</ref>
<ref id="B237">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reines</surname><given-names>A.</given-names></name><name><surname>Pena</surname><given-names>C.</given-names></name><name><surname>Rodriguez de Lores Arnaiz</surname><given-names>G.</given-names></name></person-group> (<year>2004</year>). <article-title>Allosteric modulation of [3H]dizocilpine binding to N-methyl-D-aspartate receptor by an endogenous Na+, K+-ATPase inhibitor: dependence on receptor activation</article-title>. <source/>Brain Res.
<volume>996</volume>, <fpage>117</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2003.10.018</pub-id><pub-id pub-id-type="pmid">14670638</pub-id></mixed-citation>
</ref>
<ref id="B238">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reinhard</surname><given-names>L.</given-names></name><name><surname>Tidow</surname><given-names>H.</given-names></name><name><surname>Clausen</surname><given-names>M. J.</given-names></name><name><surname>Nissen</surname><given-names>P.</given-names></name></person-group> (<year>2013</year>). <article-title>Na(+),K (+)-ATPase as a docking station: protein-protein complexes of the Na(+),K (+)-ATPase</article-title>. <source/>Cell. Mol. Life Sci.
<volume>70</volume>, <fpage>205</fpage>–<lpage>222</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-012-1039-9</pub-id><pub-id pub-id-type="pmid">22695678</pub-id></mixed-citation>
</ref>
<ref id="B239">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Riganti</surname><given-names>C.</given-names></name><name><surname>Campia</surname><given-names>I.</given-names></name><name><surname>Kopecka</surname><given-names>J.</given-names></name><name><surname>Gazzano</surname><given-names>E.</given-names></name><name><surname>Doublier</surname><given-names>S.</given-names></name><name><surname>Aldieri</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Pleiotropic effects of cardioactive glycosides</article-title>. <source/>Curr. Med. Chem.
<volume>18</volume>, <fpage>872</fpage>–<lpage>885</lpage>. <pub-id pub-id-type="doi">10.2174/092986711794927685</pub-id><pub-id pub-id-type="pmid">21182478</pub-id></mixed-citation>
</ref>
<ref id="B240">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>E.</given-names></name><name><surname>Frankel</surname><given-names>S.</given-names></name></person-group> (<year>1950</year>). <article-title>gamma-Aminobutyric acid in brain: its formation from glutamic acid</article-title>. <source/>J. Biol. Chem.
<volume>187</volume>, <fpage>55</fpage>–<lpage>63</lpage>. <pub-id pub-id-type="pmid">14794689</pub-id></mixed-citation>
</ref>
<ref id="B241">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogawski</surname><given-names>M. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Common pathophysiologic mechanisms in migraine and epilepsy</article-title>. <source/>Arch. Neurol.
<volume>65</volume>, <fpage>709</fpage>–<lpage>714</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.65.6.709</pub-id><pub-id pub-id-type="pmid">18541791</pub-id></mixed-citation>
</ref>
<ref id="B242">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>C. R.</given-names></name><name><surname>Chatton</surname><given-names>J. Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Astrocyte sodium signaling and neuro-metabolic coupling in the brain</article-title>. <source/>Neuroscience
<volume>323</volume>, <fpage>121</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2015.03.002</pub-id><pub-id pub-id-type="pmid">25791228</pub-id></mixed-citation>
</ref>
<ref id="B243">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>E. M.</given-names></name><name><surname>Koo</surname><given-names>J. C.</given-names></name><name><surname>Antflick</surname><given-names>J. E.</given-names></name><name><surname>Ahmed</surname><given-names>S. M.</given-names></name><name><surname>Angers</surname><given-names>S.</given-names></name><name><surname>Hampson</surname><given-names>D. R.</given-names></name></person-group> (<year>2009</year>). <article-title>Glutamate transporter coupling to Na,K-ATPase</article-title>. <source/>J. Neurosci.
<volume>29</volume>, <fpage>8143</fpage>–<lpage>8155</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1081-09.2009</pub-id><pub-id pub-id-type="pmid">19553454</pub-id></mixed-citation>
</ref>
<ref id="B244">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosewich</surname><given-names>H.</given-names></name><name><surname>Baethmann</surname><given-names>M.</given-names></name><name><surname>Ohlenbusch</surname><given-names>A.</given-names></name><name><surname>Gärtner</surname><given-names>J.</given-names></name><name><surname>Brockmann</surname><given-names>K.</given-names></name></person-group> (<year>2014</year>). <article-title>A novel ATP1A3 mutation with unique clinical presentation</article-title>. <source/>J. Neurol. Sci.
<volume>341</volume>, <fpage>133</fpage>–<lpage>135</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2014.03.034</pub-id><pub-id pub-id-type="pmid">24713507</pub-id></mixed-citation>
</ref>
<ref id="B245">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothstein</surname><given-names>J. D.</given-names></name><name><surname>Dykes-Hoberg</surname><given-names>M.</given-names></name><name><surname>Pardo</surname><given-names>C. A.</given-names></name><name><surname>Bristol</surname><given-names>L. A.</given-names></name><name><surname>Jin</surname><given-names>L.</given-names></name><name><surname>Kuncl</surname><given-names>R. W.</given-names></name><etal></etal></person-group>. (<year>1996</year>). <article-title>Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate</article-title>. <source/>Neuron
<volume>16</volume>, <fpage>675</fpage>–<lpage>686</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(00)80086-0</pub-id><pub-id pub-id-type="pmid">8785064</pub-id></mixed-citation>
</ref>
<ref id="B246">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rothstein</surname><given-names>J. D.</given-names></name><name><surname>Van Kammen</surname><given-names>M.</given-names></name><name><surname>Levey</surname><given-names>A. I.</given-names></name><name><surname>Martin</surname><given-names>L. J.</given-names></name><name><surname>Kuncl</surname><given-names>R. W.</given-names></name></person-group> (<year>1995</year>). <article-title>Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis</article-title>. <source/>Ann. Neurol.
<volume>38</volume>, <fpage>73</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1002/ana.410380114</pub-id><pub-id pub-id-type="pmid">7611729</pub-id></mixed-citation>
</ref>
<ref id="B247">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roubergue</surname><given-names>A.</given-names></name><name><surname>Philibert</surname><given-names>B.</given-names></name><name><surname>Gautier</surname><given-names>A.</given-names></name><name><surname>Kuster</surname><given-names>A.</given-names></name><name><surname>Markowicz</surname><given-names>K.</given-names></name><name><surname>Billette de Villemeur</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Excellent response to a ketogenic diet in a patient with alternating hemiplegia of childhood</article-title>. <source/>JIMD Rep.
<volume>15</volume>, <fpage>7</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1007/8904_2013_292</pub-id><pub-id pub-id-type="pmid">24532324</pub-id></mixed-citation>
</ref>
<ref id="B248">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rozas</surname><given-names>J. L.</given-names></name><name><surname>Gómez-Sánchez</surname><given-names>L.</given-names></name><name><surname>Tomás-Zapico</surname><given-names>C.</given-names></name><name><surname>Lucas</surname><given-names>J. J.</given-names></name><name><surname>Fernández-Chacón</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>Presynaptic dysfunction in Huntington's disease</article-title>. <source/>Biochem. Soc. Trans.
<volume>38</volume>, <fpage>488</fpage>–<lpage>492</lpage>. <pub-id pub-id-type="doi">10.1042/BST0380488</pub-id><pub-id pub-id-type="pmid">20298208</pub-id></mixed-citation>
</ref>
<ref id="B249">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>M. B.</given-names></name><name><surname>Iversen</surname><given-names>H. K.</given-names></name><name><surname>Olesen</surname><given-names>J.</given-names></name></person-group> (<year>1994</year>). <article-title>Improved description of the migraine aura by a diagnostic aura diary</article-title>. <source/>Cephalalgia
<volume>14</volume>, <fpage>107</fpage>–<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1046/j.1468-2982.1994.1402107.x</pub-id><pub-id pub-id-type="pmid">8062348</pub-id></mixed-citation>
</ref>
<ref id="B250">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rycroft</surname><given-names>B. K.</given-names></name><name><surname>Gibb</surname><given-names>A. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Inhibitory interactions of calcineurin (phosphatase 2B) and calmodulin on rat hippocampal NMDA receptors</article-title>. <source/>Neuropharmacology
<volume>47</volume>, <fpage>505</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2004.06.001</pub-id><pub-id pub-id-type="pmid">15380369</pub-id></mixed-citation>
</ref>
<ref id="B251">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>G.</given-names></name><name><surname>Nguyen</surname><given-names>A. N.</given-names></name><name><surname>Timmerberg</surname><given-names>B.</given-names></name><name><surname>Tash</surname><given-names>J. S.</given-names></name><name><surname>Blanco</surname><given-names>G.</given-names></name></person-group> (<year>2006</year>). <article-title>The Na,K-ATPase alpha4 isoform from humans has distinct enzymatic properties and is important for sperm motility</article-title>. <source/>Mol. Hum. Reprod.
<volume>12</volume>, <fpage>565</fpage>–<lpage>576</lpage>. <pub-id pub-id-type="doi">10.1093/molehr/gal062</pub-id><pub-id pub-id-type="pmid">16861705</pub-id></mixed-citation>
</ref>
<ref id="B252">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sarantis</surname><given-names>K.</given-names></name><name><surname>Tsiamaki</surname><given-names>E.</given-names></name><name><surname>Kouvaros</surname><given-names>S.</given-names></name><name><surname>Papatheodoropoulos</surname><given-names>C.</given-names></name><name><surname>Angelatou</surname><given-names>F.</given-names></name></person-group> (<year>2015</year>). <article-title>Adenosine A(2)A receptors permit mGluR5-evoked tyrosine phosphorylation of NR2B (Tyr1472) in rat hippocampus: a possible key mechanism in NMDA receptor modulation</article-title>. <source/>J. Neurochem.
<volume>135</volume>, <fpage>714</fpage>–<lpage>726</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13291</pub-id><pub-id pub-id-type="pmid">26303340</pub-id></mixed-citation>
</ref>
<ref id="B253">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sato</surname><given-names>T.</given-names></name><name><surname>Kamata</surname><given-names>Y.</given-names></name><name><surname>Irifune</surname><given-names>M.</given-names></name><name><surname>Nishikawa</surname><given-names>T.</given-names></name></person-group> (<year>1997</year>). <article-title>Inhibitory effect of several nitric oxide-generating compounds on purified Na+,K(+)-ATPase activity from porcine cerebral cortex</article-title>. <source/>J. Neurochem.
<volume>68</volume>, <fpage>1312</fpage>–<lpage>1318</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.1997.68031312.x</pub-id><pub-id pub-id-type="pmid">9048779</pub-id></mixed-citation>
</ref>
<ref id="B254">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scavone</surname><given-names>C.</given-names></name><name><surname>Glezer</surname><given-names>I.</given-names></name><name><surname>Demarchi Munhoz</surname><given-names>C.</given-names></name><name><surname>de Sena Bernardes</surname><given-names>C.</given-names></name><name><surname>Pekelmann Markus</surname><given-names>R.</given-names></name></person-group> (<year>2000</year>). <article-title>Influence of age on nitric oxide modulatory action on Na(+), K(+)-ATPase activity through cyclic GMP pathway in proximal rat trachea</article-title>. <source/>Eur. J. Pharmacol.
<volume>388</volume>, <fpage>1</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1016/S0014-2999(99)00850-X</pub-id><pub-id pub-id-type="pmid">10657540</pub-id></mixed-citation>
</ref>
<ref id="B255">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scavone</surname><given-names>C.</given-names></name><name><surname>Munhoz</surname><given-names>C. D.</given-names></name><name><surname>Kawamoto</surname><given-names>E. M.</given-names></name><name><surname>Glezer</surname><given-names>I.</given-names></name><name><surname>de Sá Lima</surname><given-names>L.</given-names></name><name><surname>Marcourakis</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Age-related changes in cyclic GMP and PKG-stimulated cerebellar Na,K-ATPase activity</article-title>. <source/>Neurobiol. Aging
<volume>26</volume>, <fpage>907</fpage>–<lpage>916</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2004.08.013</pub-id><pub-id pub-id-type="pmid">15718050</pub-id></mixed-citation>
</ref>
<ref id="B256">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schatzmann</surname><given-names>H. J.</given-names></name></person-group> (<year>1953</year>). <article-title>[Cardiac glycosides as inhibitors of active potassium and sodium transport by erythrocyte membrane]</article-title>. <source/>Helv. Physiol. Pharmacol. Acta
<volume>11</volume>, <fpage>346</fpage>–<lpage>354</lpage>. <pub-id pub-id-type="pmid">13142506</pub-id></mixed-citation>
</ref>
<ref id="B257">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schatzmann</surname><given-names>H. J.</given-names></name><name><surname>Witt</surname><given-names>P. N.</given-names></name></person-group> (<year>1954</year>). <article-title>Action of k-strophanthin on potassium leakage from frog sartorius muscle</article-title>. <source/>J. Pharmacol. Exp. Ther.
<volume>112</volume>, <fpage>501</fpage>–<lpage>508</lpage>. <pub-id pub-id-type="pmid">13222244</pub-id></mixed-citation>
</ref>
<ref id="B258">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>J. W.</given-names></name><name><surname>Mercer</surname><given-names>R. W.</given-names></name><name><surname>Gilmore-Hebert</surname><given-names>M.</given-names></name><name><surname>Utset</surname><given-names>M. F.</given-names></name><name><surname>Lai</surname><given-names>C.</given-names></name><name><surname>Greene</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>1988</year>). <article-title>Tissue specificity, localization in brain, and cell-free translation of mRNA encoding the A3 isoform of Na+,K+-ATPase</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>85</volume>, <fpage>284</fpage>–<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.85.1.284</pub-id><pub-id pub-id-type="pmid">2829175</pub-id></mixed-citation>
</ref>
<ref id="B259">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schumacher</surname><given-names>B.</given-names></name><name><surname>Garinis</surname><given-names>G. A.</given-names></name><name><surname>Hoeijmakers</surname><given-names>J. H.</given-names></name></person-group> (<year>2008</year>). <article-title>Age to survive: DNA damage and aging</article-title>. <source/>Trends Genet.
<volume>24</volume>, <fpage>77</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/j.tig.2007.11.004</pub-id><pub-id pub-id-type="pmid">18192065</pub-id></mixed-citation>
</ref>
<ref id="B260">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shamraj</surname><given-names>O. I.</given-names></name><name><surname>Lingrel</surname><given-names>J. B.</given-names></name></person-group> (<year>1994</year>). <article-title>A putative fourth Na+,K(+)-ATPase alpha-subunit gene is expressed in testis</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>91</volume>, <fpage>12952</fpage>–<lpage>12956</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.91.26.12952</pub-id><pub-id pub-id-type="pmid">7809153</pub-id></mixed-citation>
</ref>
<ref id="B261">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shan</surname><given-names>D.</given-names></name><name><surname>Mount</surname><given-names>D.</given-names></name><name><surname>Moore</surname><given-names>S.</given-names></name><name><surname>Haroutunian</surname><given-names>V.</given-names></name><name><surname>Meador-Woodruff</surname><given-names>J. H.</given-names></name><name><surname>McCullumsmith</surname><given-names>R. E.</given-names></name></person-group> (<year>2014</year>). <article-title>Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia</article-title>. <source/>Schizophr. Res.
<volume>154</volume>, <fpage>1</fpage>–<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1016/j.schres.2014.01.028</pub-id><pub-id pub-id-type="pmid">24560881</pub-id></mixed-citation>
</ref>
<ref id="B262">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheean</surname><given-names>R. K.</given-names></name><name><surname>Lau</surname><given-names>C. L.</given-names></name><name><surname>Shin</surname><given-names>Y. S.</given-names></name><name><surname>O'shea</surname><given-names>R. D.</given-names></name><name><surname>Beart</surname><given-names>P. M.</given-names></name></person-group> (<year>2013</year>). <article-title>Links between L-glutamate transporters, Na+/K+-ATPase and cytoskeleton in astrocytes: evidence following inhibition with rottlerin</article-title>. <source/>Neuroscience
<volume>254</volume>, <fpage>335</fpage>–<lpage>346</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2013.09.043</pub-id><pub-id pub-id-type="pmid">24095695</pub-id></mixed-citation>
</ref>
<ref id="B263">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shehadeh</surname><given-names>J.</given-names></name><name><surname>Fernandes</surname><given-names>H. B.</given-names></name><name><surname>Zeron Mullins</surname><given-names>M. M.</given-names></name><name><surname>Graham</surname><given-names>R. K.</given-names></name><name><surname>Leavitt</surname><given-names>B. R.</given-names></name><name><surname>Hayden</surname><given-names>M. R.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Striatal neuronal apoptosis is preferentially enhanced by NMDA receptor activation in YAC transgenic mouse model of Huntington disease</article-title>. <source/>Neurobiol. Dis.
<volume>21</volume>, <fpage>392</fpage>–<lpage>403</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2005.08.001</pub-id><pub-id pub-id-type="pmid">16165367</pub-id></mixed-citation>
</ref>
<ref id="B264">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheldon</surname><given-names>A. L.</given-names></name><name><surname>Robinson</surname><given-names>M. B.</given-names></name></person-group> (<year>2007</year>). <article-title>The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention</article-title>. <source/>Neurochem. Int.
<volume>51</volume>, <fpage>333</fpage>–<lpage>355</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2007.03.012</pub-id><pub-id pub-id-type="pmid">17517448</pub-id></mixed-citation>
</ref>
<ref id="B265">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shull</surname><given-names>G. E.</given-names></name><name><surname>Greeb</surname><given-names>J.</given-names></name><name><surname>Lingrel</surname><given-names>J. B.</given-names></name></person-group> (<year>1986</year>). <article-title>Molecular cloning of three distinct forms of the Na+,K+-ATPase alpha-subunit from rat brain</article-title>. <source/>Biochemistry
<volume>25</volume>, <fpage>8125</fpage>–<lpage>8132</lpage>. <pub-id pub-id-type="doi">10.1021/bi00373a001</pub-id><pub-id pub-id-type="pmid">3028470</pub-id></mixed-citation>
</ref>
<ref id="B266">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shull</surname><given-names>G. E.</given-names></name><name><surname>Schwartz</surname><given-names>A.</given-names></name><name><surname>Lingrel</surname><given-names>J. B.</given-names></name></person-group> (<year>1985</year>). <article-title>Amino-acid sequence of the catalytic subunit of the (Na+ + K+)ATPase deduced from a complementary DNA</article-title>. <source/>Nature
<volume>316</volume>, <fpage>691</fpage>–<lpage>695</lpage>. <pub-id pub-id-type="doi">10.1038/316691a0</pub-id><pub-id pub-id-type="pmid">2993903</pub-id></mixed-citation>
</ref>
<ref id="B267">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sibarov</surname><given-names>D. A.</given-names></name><name><surname>Bolshakov</surname><given-names>A. E.</given-names></name><name><surname>Abushik</surname><given-names>P. A.</given-names></name><name><surname>Krivoi</surname><given-names>I. I.</given-names></name><name><surname>Antonov</surname><given-names>S. M.</given-names></name></person-group> (<year>2012</year>). <article-title>Na+,K+-ATPase functionally interacts with the plasma membrane Na+,Ca2+ exchanger to prevent Ca2+ overload and neuronal apoptosis in excitotoxic stress</article-title>. <source/>J. Pharmacol. Exp. Ther.
<volume>343</volume>, <fpage>596</fpage>–<lpage>607</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.112.198341</pub-id><pub-id pub-id-type="pmid">22927545</pub-id></mixed-citation>
</ref>
<ref id="B268">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skou</surname><given-names>J. C.</given-names></name></person-group> (<year>1957</year>). <article-title>The influence of some cations on an adenosine triphosphatase from peripheral nerves</article-title>. <source/>Biochim. Biophys. Acta
<volume>23</volume>, <fpage>394</fpage>–<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1016/0006-3002(57)90343-8</pub-id><pub-id pub-id-type="pmid">13412736</pub-id></mixed-citation>
</ref>
<ref id="B269">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skou</surname><given-names>J. C.</given-names></name></person-group> (<year>1998</year>). <article-title>Nobel Lecture. The identification of the sodium pump</article-title>. <source/>Biosci. Rep.
<volume>18</volume>, <fpage>155</fpage>–<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1023/A:1020196612909</pub-id><pub-id pub-id-type="pmid">9877230</pub-id></mixed-citation>
</ref>
<ref id="B270">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>R.</given-names></name><name><surname>Brundin</surname><given-names>P.</given-names></name><name><surname>Li</surname><given-names>J. Y.</given-names></name></person-group> (<year>2005</year>). <article-title>Synaptic dysfunction in Huntington's disease: a new perspective</article-title>. <source/>Cell. Mol. Life Sci.
<volume>62</volume>, <fpage>1901</fpage>–<lpage>1912</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-005-5084-5</pub-id><pub-id pub-id-type="pmid">15968465</pub-id></mixed-citation>
</ref>
<ref id="B271">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spangaro</surname><given-names>M.</given-names></name><name><surname>Bosia</surname><given-names>M.</given-names></name><name><surname>Zanoletti</surname><given-names>A.</given-names></name><name><surname>Bechi</surname><given-names>M.</given-names></name><name><surname>Cocchi</surname><given-names>F.</given-names></name><name><surname>Pirovano</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Cognitive dysfunction and glutamate reuptake: effect of EAAT2 polymorphism in schizophrenia</article-title>. <source/>Neurosci. Lett.
<volume>522</volume>, <fpage>151</fpage>–<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2012.06.030</pub-id><pub-id pub-id-type="pmid">22728822</pub-id></mixed-citation>
</ref>
<ref id="B272">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stevens</surname><given-names>C. F.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name></person-group> (<year>1993</year>). <article-title>Reversal of long-term potentiation by inhibitors of haem oxygenase</article-title>. <source/>Nature
<volume>364</volume>, <fpage>147</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1038/364147a0</pub-id><pub-id pub-id-type="pmid">8321285</pub-id></mixed-citation>
</ref>
<ref id="B273">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>A.</given-names></name><name><surname>Stern</surname><given-names>S. A.</given-names></name><name><surname>Bozdagi</surname><given-names>O.</given-names></name><name><surname>Huntley</surname><given-names>G. W.</given-names></name><name><surname>Walker</surname><given-names>R. H.</given-names></name><name><surname>Magistretti</surname><given-names>P. J.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Astrocyte-neuron lactate transport is required for long-term memory formation</article-title>. <source/>Cell
<volume>144</volume>, <fpage>810</fpage>–<lpage>823</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2011.02.018</pub-id><pub-id pub-id-type="pmid">21376239</pub-id></mixed-citation>
</ref>
<ref id="B274">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweadner</surname><given-names>K. J.</given-names></name></person-group> (<year>1979</year>). <article-title>Two molecular forms of (Na+ + K+)-stimulated ATPase in brain. Separation, and difference in affinity for strophanthidin</article-title>. <source/>J. Biol. Chem.
<volume>254</volume>, <fpage>6060</fpage>–<lpage>6067</lpage>. <pub-id pub-id-type="pmid">221488</pub-id></mixed-citation>
</ref>
<ref id="B275">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweadner</surname><given-names>K. J.</given-names></name></person-group> (<year>1989</year>). <article-title>Isozymes of the Na+/K+-ATPase</article-title>. <source/>Biochim. Biophys. Acta
<volume>988</volume>, <fpage>185</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1016/0304-4157(89)90019-1</pub-id><pub-id pub-id-type="pmid">2541792</pub-id></mixed-citation>
</ref>
<ref id="B276">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweadner</surname><given-names>K. J.</given-names></name><name><surname>Gilkeson</surname><given-names>R. C.</given-names></name></person-group> (<year>1985</year>). <article-title>Two isozymes of the Na,K-ATPase have distinct antigenic determinants</article-title>. <source/>J. Biol. Chem.
<volume>260</volume>, <fpage>9016</fpage>–<lpage>9022</lpage>. <pub-id pub-id-type="pmid">2410405</pub-id></mixed-citation>
</ref>
<ref id="B277">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sweney</surname><given-names>M. T.</given-names></name><name><surname>Newcomb</surname><given-names>T. M.</given-names></name><name><surname>Swoboda</surname><given-names>K. J.</given-names></name></person-group> (<year>2015</year>). <article-title>The expanding spectrum of neurological phenotypes in children with ATP1A3 mutations, Alternating Hemiplegia of Childhood, Rapid-onset Dystonia-Parkinsonism, CAPOS and beyond</article-title>. <source/>Pediatr. Neurol.
<volume>52</volume>, <fpage>56</fpage>–<lpage>64</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2014.09.015</pub-id><pub-id pub-id-type="pmid">25447930</pub-id></mixed-citation>
</ref>
<ref id="B278">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K.</given-names></name><name><surname>Kong</surname><given-names>Q.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name><name><surname>Stouffer</surname><given-names>N.</given-names></name><name><surname>Schulte</surname><given-names>D. A.</given-names></name><name><surname>Lai</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer's disease</article-title>. <source/>J. Exp. Med.
<volume>212</volume>, <fpage>319</fpage>–<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1084/jem.20140413</pub-id><pub-id pub-id-type="pmid">25711212</pub-id></mixed-citation>
</ref>
<ref id="B279">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takaki</surname><given-names>J.</given-names></name><name><surname>Fujimori</surname><given-names>K.</given-names></name><name><surname>Miura</surname><given-names>M.</given-names></name><name><surname>Suzuki</surname><given-names>T.</given-names></name><name><surname>Sekino</surname><given-names>Y.</given-names></name><name><surname>Sato</surname><given-names>K.</given-names></name></person-group> (<year>2012</year>). <article-title>L-glutamate released from activated microglia downregulates astrocytic L-glutamate transporter expression in neuroinflammation: the ‘collusion’ hypothesis for increased extracellular L-glutamate concentration in neuroinflammation</article-title>. <source/>J. Neuroinflammation
<volume>9</volume>, <fpage>275</fpage>. <pub-id pub-id-type="doi">10.1186/1742-2094-9-275</pub-id><pub-id pub-id-type="pmid">23259598</pub-id></mixed-citation>
</ref>
<ref id="B280">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talpalar</surname><given-names>A. E.</given-names></name><name><surname>Kiehn</surname><given-names>O.</given-names></name></person-group> (<year>2010</year>). <article-title>Glutamatergic mechanisms for speed control and network operation in the rodent locomotor CpG</article-title>. <source/>Front. Neural Circuits
<volume>4</volume>:<issue>19</issue>. <pub-id pub-id-type="doi">10.3389/fncir.2010.00019</pub-id><pub-id pub-id-type="pmid">20844601</pub-id></mixed-citation>
</ref>
<ref id="B281">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tamaru</surname><given-names>M.</given-names></name><name><surname>Yoneda</surname><given-names>Y.</given-names></name><name><surname>Ogita</surname><given-names>K.</given-names></name><name><surname>Shimizu</surname><given-names>J.</given-names></name><name><surname>Nagata</surname><given-names>Y.</given-names></name></person-group> (<year>1991</year>). <article-title>Age-related decreases of the N-methyl-D-aspartate receptor complex in the rat cerebral cortex and hippocampus</article-title>. <source/>Brain Res.
<volume>542</volume>, <fpage>83</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/0006-8993(91)91001-H</pub-id><pub-id pub-id-type="pmid">1829017</pub-id></mixed-citation>
</ref>
<ref id="B282">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanaka</surname><given-names>K.</given-names></name></person-group> (<year>2000</year>). <article-title>Functions of glutamate transporters in the brain</article-title>. <source/>Neurosci. Res.
<volume>37</volume>, <fpage>15</fpage>–<lpage>19</lpage>. <pub-id pub-id-type="doi">10.1016/S0168-0102(00)00104-8</pub-id><pub-id pub-id-type="pmid">10802340</pub-id></mixed-citation>
</ref>
<ref id="B283">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taub</surname><given-names>M.</given-names></name><name><surname>Springate</surname><given-names>J. E.</given-names></name><name><surname>Cutuli</surname><given-names>F.</given-names></name></person-group> (<year>2010</year>). <article-title>Targeting of renal proximal tubule Na,K-ATPase by salt-inducible kinase</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>393</volume>, <fpage>339</fpage>–<lpage>344</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2010.02.037</pub-id><pub-id pub-id-type="pmid">20152810</pub-id></mixed-citation>
</ref>
<ref id="B284">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thevenod</surname><given-names>F.</given-names></name><name><surname>Friedmann</surname><given-names>J. M.</given-names></name></person-group> (<year>1999</year>). <article-title>Cadmium-mediated oxidative stress in kidney proximal tubule cells induces degradation of Na+/K(+)-ATPase through proteasomal and endo-/lysosomal proteolytic pathways</article-title>. <source/>FASEB J.
<volume>13</volume>, <fpage>1751</fpage>–<lpage>1761</lpage>.<pub-id pub-id-type="pmid">10506578</pub-id></mixed-citation>
</ref>
<ref id="B285">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomsen</surname><given-names>L. L.</given-names></name><name><surname>Eriksen</surname><given-names>M. K.</given-names></name><name><surname>Roemer</surname><given-names>S. F.</given-names></name><name><surname>Andersen</surname><given-names>I.</given-names></name><name><surname>Olesen</surname><given-names>J.</given-names></name><name><surname>Russell</surname><given-names>M. B.</given-names></name></person-group> (<year>2002</year>). <article-title>A population-based study of familial hemiplegic migraine suggests revised diagnostic criteria</article-title>. <source/>Brain 125. <fpage>1379</fpage>–<lpage>1391</lpage>. <pub-id pub-id-type="doi">10.1093/brain/awf132</pub-id><pub-id pub-id-type="pmid">12023326</pub-id></mixed-citation>
</ref>
<ref id="B286">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomsen</surname><given-names>L. L.</given-names></name><name><surname>Olesen</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Sporadic hemiplegic migraine</article-title>. <source/>Cephalalgia
<volume>24</volume>, <fpage>1016</fpage>–<lpage>1023</lpage>. <pub-id pub-id-type="doi">10.1111/j.1468-2982.2004.00788.x</pub-id><pub-id pub-id-type="pmid">15566415</pub-id></mixed-citation>
</ref>
<ref id="B287">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>J.</given-names></name><name><surname>Cai</surname><given-names>T.</given-names></name><name><surname>Yuan</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Haas</surname><given-names>M.</given-names></name><etal></etal></person-group> (<year>2006</year>). <article-title>Binding of Src to Na+/K+-ATPase forms a functional signaling complex</article-title>. <source/>Mol. Biol. Cell
<volume>17</volume>, <fpage>317</fpage>–<lpage>326</lpage>. <pub-id pub-id-type="doi">10.1091/mbc.E05-08-0735</pub-id><pub-id pub-id-type="pmid">16267270</pub-id></mixed-citation>
</ref>
<ref id="B288">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tobin</surname><given-names>T.</given-names></name><name><surname>Brody</surname><given-names>T. M.</given-names></name></person-group> (<year>1972</year>). <article-title>Rates of dissociation of enzyme-ouabain complexes and K 0.5 values in (Na + + K +) adenosine triphosphatase from different species</article-title>. <source/>Biochem. Pharmacol.
<volume>21</volume>, <fpage>1553</fpage>–<lpage>1560</lpage>. <pub-id pub-id-type="doi">10.1016/0006-2952(72)90305-X</pub-id><pub-id pub-id-type="pmid">4265025</pub-id></mixed-citation>
</ref>
<ref id="B289">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toustrup-Jensen</surname><given-names>M. S.</given-names></name><name><surname>Einholm</surname><given-names>A. P.</given-names></name><name><surname>Schack</surname><given-names>V. R.</given-names></name><name><surname>Nielsen</surname><given-names>H. N.</given-names></name><name><surname>Holm</surname><given-names>R.</given-names></name><name><surname>Sobrido</surname><given-names>M. J.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Relationship between intracellular Na<sup>+</sup> concentration and reduced Na<sup>+</sup> affinity in Na<sup>+</sup>,K<sup>+</sup>-ATPase mutants causing neurological disease</article-title>. <source/>J. Biol. Chem.
<volume>289</volume>, <fpage>3186</fpage>–<lpage>3197</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M113.543272</pub-id><pub-id pub-id-type="pmid">24356962</pub-id></mixed-citation>
</ref>
<ref id="B290">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trotti</surname><given-names>D.</given-names></name><name><surname>Rolfs</surname><given-names>A.</given-names></name><name><surname>Danbolt</surname><given-names>N. C.</given-names></name><name><surname>Brown</surname><given-names>R. H.</given-names><suffix>Jr.</suffix></name><name><surname>Hediger</surname><given-names>M. A.</given-names></name></person-group> (<year>1999</year>). <article-title>SOD1 mutants linked to amyotrophic lateral sclerosis selectively inactivate a glial glutamate transporter</article-title>. <source/>Nat. Neurosci.
<volume>2</volume>, <fpage>848</fpage>. <pub-id pub-id-type="doi">10.1038/12227</pub-id><pub-id pub-id-type="pmid">10461226</pub-id></mixed-citation>
</ref>
<ref id="B291">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tzingounis</surname><given-names>A. V.</given-names></name><name><surname>Wadiche</surname><given-names>J. I.</given-names></name></person-group> (<year>2007</year>). <article-title>Glutamate transporters: confining runaway excitation by shaping synaptic transmission</article-title>. <source/>Nat. Rev. Neurosci.
<volume>8</volume>, <fpage>935</fpage>–<lpage>947</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2274</pub-id><pub-id pub-id-type="pmid">17987031</pub-id></mixed-citation>
</ref>
<ref id="B292">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulate-Campos</surname><given-names>A.</given-names></name><name><surname>Fons</surname><given-names>C.</given-names></name><name><surname>Artuch</surname><given-names>R.</given-names></name><name><surname>Castejón</surname><given-names>E.</given-names></name><name><surname>Martorell</surname><given-names>L.</given-names></name><name><surname>Ozelius</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Alternating hemiplegia of childhood with a de novo mutation in ATP1A3 and changes in SLC2A1 responsive to a ketogenic diet</article-title>. <source/>Pediatr. Neurol.
<volume>50</volume>, <fpage>377</fpage>–<lpage>379</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2013.11.017</pub-id><pub-id pub-id-type="pmid">24491413</pub-id></mixed-citation>
</ref>
<ref id="B293">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Unoki</surname><given-names>T.</given-names></name><name><surname>Matsuda</surname><given-names>S.</given-names></name><name><surname>Kakegawa</surname><given-names>W.</given-names></name><name><surname>Van</surname><given-names>N. T.</given-names></name><name><surname>Kohda</surname><given-names>K.</given-names></name><name><surname>Suzuki</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>NMDA receptor-mediated PIP5K activation to produce PI(4,5)P(2) is essential for AMPA receptor endocytosis during LTD</article-title>. <source/>Neuron
<volume>73</volume>, <fpage>135</fpage>–<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.09.034</pub-id><pub-id pub-id-type="pmid">22243752</pub-id></mixed-citation>
</ref>
<ref id="B294">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vagin</surname><given-names>O.</given-names></name><name><surname>Dada</surname><given-names>L. A.</given-names></name><name><surname>Tokhtaeva</surname><given-names>E.</given-names></name><name><surname>Sachs</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>The Na-K-ATPase alpha(1)beta(1) heterodimer as a cell adhesion molecule in epithelia</article-title>. <source/>Am. J. Physiol. Cell Physiol.
<volume>302</volume>, <fpage>C1271</fpage>–<lpage>C1281</lpage>. <pub-id pub-id-type="doi">10.1152/ajpcell.00456.2011</pub-id><pub-id pub-id-type="pmid">22277755</pub-id></mixed-citation>
</ref>
<ref id="B295">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valencia</surname><given-names>A.</given-names></name><name><surname>Reeves</surname><given-names>P. B.</given-names></name><name><surname>Sapp</surname><given-names>E.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Alexander</surname><given-names>J.</given-names></name><name><surname>Kegel</surname><given-names>K. B.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Mutant huntingtin and glycogen synthase kinase 3-beta accumulate in neuronal lipid rafts of a presymptomatic knock-in mouse model of Huntington's disease</article-title>. <source/>J. Neurosci. Res.
<volume>88</volume>, <fpage>179</fpage>–<lpage>190</lpage>. <pub-id pub-id-type="doi">10.1002/jnr.22184</pub-id><pub-id pub-id-type="pmid">19642201</pub-id></mixed-citation>
</ref>
<ref id="B296">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Valencia</surname><given-names>A.</given-names></name><name><surname>Sapp</surname><given-names>E.</given-names></name><name><surname>Kimm</surname><given-names>J. S.</given-names></name><name><surname>McClory</surname><given-names>H.</given-names></name><name><surname>Ansong</surname><given-names>K. A.</given-names></name><name><surname>Yohrling</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Striatal synaptosomes from Hdh<sup>140<italic>Q</italic>∕140<italic>Q</italic></sup> knock-in mice have altered protein levels, novel sites of methionine oxidation, and excess glutamate release after stimulation</article-title>. <source/>J. Huntingtons Dis.
<volume>2</volume>, <fpage>459</fpage>–<lpage>475</lpage>. <pub-id pub-id-type="doi">10.3233/JHD-130080</pub-id><pub-id pub-id-type="pmid">24696705</pub-id></mixed-citation>
</ref>
<ref id="B297">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallebuona</surname><given-names>F.</given-names></name><name><surname>Raiteri</surname><given-names>M.</given-names></name></person-group> (<year>1995</year>). <article-title>Age-related changes in the NMDA receptor/nitric oxide/cGMP pathway in the hippocampus and cerebellum of freely moving rats subjected to transcerebral microdialysis</article-title>. <source/>Eur. J. Neurosci.
<volume>7</volume>, <fpage>694</fpage>–<lpage>701</lpage>. <pub-id pub-id-type="doi">10.1111/j.1460-9568.1995.tb00673.x</pub-id><pub-id pub-id-type="pmid">7542528</pub-id></mixed-citation>
</ref>
<ref id="B298">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasconcelos</surname><given-names>A. R.</given-names></name><name><surname>Kinoshita</surname><given-names>P. F.</given-names></name><name><surname>Yshii</surname><given-names>L. M.</given-names></name><name><surname>Marques Orellana</surname><given-names>A. M.</given-names></name><name><surname>Böhmer</surname><given-names>A. E.</given-names></name><name><surname>de Sá Lima</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Effects of intermittent fasting on age-related changes on Na,K-ATPase activity and oxidative status induced by lipopolysaccharide in rat hippocampus</article-title>. <source/>Neurobiol. Aging
<volume>36</volume>, <fpage>1914</fpage>–<lpage>1923</lpage>. <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2015.02.020</pub-id><pub-id pub-id-type="pmid">25818175</pub-id></mixed-citation>
</ref>
<ref id="B299">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Végh</surname><given-names>M. J.</given-names></name><name><surname>de Waard</surname><given-names>M. C.</given-names></name><name><surname>van der Pluijm</surname><given-names>I.</given-names></name><name><surname>Ridwan</surname><given-names>Y.</given-names></name><name><surname>Sassen</surname><given-names>M. J.</given-names></name><name><surname>van Nierop</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Synaptic proteome changes in a DNA repair deficient ercc1 mouse model of accelerated aging</article-title>. <source/>J. Proteome Res.
<volume>11</volume>, <fpage>1855</fpage>–<lpage>1867</lpage>. <pub-id pub-id-type="doi">10.1021/pr201203m</pub-id><pub-id pub-id-type="pmid">22289077</pub-id></mixed-citation>
</ref>
<ref id="B300">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verret</surname><given-names>S.</given-names></name><name><surname>Steele</surname><given-names>J. C.</given-names></name></person-group> (<year>1971</year>). <article-title>Alternating hemiplegia in childhood: a report of eight patients with complicated migraine beginning in infancy</article-title>. <source/>Pediatrics
<volume>47</volume>, <fpage>675</fpage>–<lpage>680</lpage>. <pub-id pub-id-type="pmid">5089756</pub-id></mixed-citation>
</ref>
<ref id="B301">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Veyrat-Durebex</surname><given-names>C.</given-names></name><name><surname>Corcia</surname><given-names>P.</given-names></name><name><surname>Piver</surname><given-names>E.</given-names></name><name><surname>Devos</surname><given-names>D.</given-names></name><name><surname>Dangoumau</surname><given-names>A.</given-names></name><name><surname>Gouel</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Disruption of TCA cycle and glutamate metabolism identified by metabolomics in an <italic>in vitro</italic> model of amyotrophic lateral sclerosis</article-title>. <source/>Mol. Neurobiol. <pub-id pub-id-type="doi">10.1007/s12035-015-9567-6</pub-id>. [Epub ahead of print].<pub-id pub-id-type="pmid">26666663</pub-id></mixed-citation>
</ref>
<ref id="B302">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vickery</surname><given-names>R. M.</given-names></name><name><surname>Morris</surname><given-names>S. H.</given-names></name><name><surname>Bindman</surname><given-names>L. J.</given-names></name></person-group> (<year>1997</year>). <article-title>Metabotropic glutamate receptors are involved in long-term potentiation in isolated slices of rat medial frontal cortex</article-title>. <source/>J. Neurophysiol.
<volume>78</volume>, <fpage>3039</fpage>–<lpage>3046</lpage>. <pub-id pub-id-type="pmid">9405523</pub-id></mixed-citation>
</ref>
<ref id="B303">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Viollet</surname><given-names>L.</given-names></name><name><surname>Glusman</surname><given-names>G.</given-names></name><name><surname>Murphy</surname><given-names>K. J.</given-names></name><name><surname>Newcomb</surname><given-names>T. M.</given-names></name><name><surname>Reyna</surname><given-names>S. P.</given-names></name><name><surname>Sweney</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Alternating hemiplegia of childhood: retrospective genetic study and genotype-phenotype correlations in 187 subjects from the US AHCF registry</article-title>. <source/>PLoS ONE
<volume>10</volume>:<fpage>e0127045</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0127045</pub-id><pub-id pub-id-type="pmid">25996915</pub-id></mixed-citation>
</ref>
<ref id="B304">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vitvitsky</surname><given-names>V. M.</given-names></name><name><surname>Garg</surname><given-names>S. K.</given-names></name><name><surname>Keep</surname><given-names>R. F.</given-names></name><name><surname>Albin</surname><given-names>R. L.</given-names></name><name><surname>Banerjee</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Na+ and K+ ion imbalances in Alzheimer's disease</article-title>. <source/>Biochim. Biophys. Acta
<volume>1822</volume>, <fpage>1671</fpage>–<lpage>1681</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2012.07.004</pub-id><pub-id pub-id-type="pmid">22820549</pub-id></mixed-citation>
</ref>
<ref id="B305">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Haas</surname><given-names>M.</given-names></name><name><surname>Liang</surname><given-names>M.</given-names></name><name><surname>Cai</surname><given-names>T.</given-names></name><name><surname>Tian</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><etal></etal></person-group> (<year>2004</year>). <article-title>Ouabain assembles signaling cascades through the caveolar Na+/K+-ATPase</article-title>. <source/>J. Biol. Chem.
<volume>279</volume>, <fpage>17250</fpage>–<lpage>17259</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M313239200</pub-id><pub-id pub-id-type="pmid">14963033</pub-id></mixed-citation>
</ref>
<ref id="B306">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Neely</surname><given-names>R.</given-names></name><name><surname>Landisman</surname><given-names>C. E.</given-names></name></person-group> (<year>2015</year>). <article-title>Activation of GROUP, I., and Group II metabotropic glutamate receptors causes, L. T. D., and LTP of electrical synapses in the rat thalamic reticular nucleus</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>7616</fpage>–<lpage>7625</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3688-14.2015</pub-id><pub-id pub-id-type="pmid">25972185</pub-id></mixed-citation>
</ref>
<ref id="B307">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wardas</surname><given-names>J.</given-names></name><name><surname>Pietraszek</surname><given-names>M.</given-names></name><name><surname>Schulze</surname><given-names>G.</given-names></name><name><surname>Ossowska</surname><given-names>K.</given-names></name><name><surname>Wolfarth</surname><given-names>S.</given-names></name></person-group> (<year>1997</year>). <article-title>Age-related changes in glutamate receptors: an autoradiographic analysis</article-title>. <source/>Pol. J. Pharmacol.
<volume>49</volume>, <fpage>401</fpage>–<lpage>410</lpage>. <pub-id pub-id-type="pmid">9566043</pub-id></mixed-citation>
</ref>
<ref id="B308">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watts</surname><given-names>A. G.</given-names></name><name><surname>Sanchez-Watts</surname><given-names>G.</given-names></name><name><surname>Emanuel</surname><given-names>J. R.</given-names></name><name><surname>Levenson</surname><given-names>R.</given-names></name></person-group> (<year>1991</year>). <article-title>Cell-specific expression of mRNAs encoding Na+,K(+)-ATPase alpha- and beta-subunit isoforms within the rat central nervous system</article-title>. <source/>Proc. Natl. Acad. Sci. U.S.A.
<volume>88</volume>, <fpage>7425</fpage>–<lpage>7429</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.88.16.7425</pub-id><pub-id pub-id-type="pmid">1651505</pub-id></mixed-citation>
</ref>
<ref id="B309">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weigand</surname><given-names>K. M.</given-names></name><name><surname>Messchaert</surname><given-names>M.</given-names></name><name><surname>Swarts</surname><given-names>H. G.</given-names></name><name><surname>Russel</surname><given-names>F. G.</given-names></name><name><surname>Koenderink</surname><given-names>J. B.</given-names></name></person-group> (<year>2014</year>). <article-title>Alternating Hemiplegia of Childhood mutations have a differential effect on Na(+),K(+)-ATPase activity and ouabain binding</article-title>. <source/>Biochim. Biophys. Acta
<volume>1842</volume>, <fpage>1010</fpage>–<lpage>1016</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbadis.2014.03.002</pub-id><pub-id pub-id-type="pmid">24631656</pub-id></mixed-citation>
</ref>
<ref id="B310">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weller</surname><given-names>C. M.</given-names></name><name><surname>Leen</surname><given-names>W. G.</given-names></name><name><surname>Neville</surname><given-names>B. G.</given-names></name><name><surname>Duncan</surname><given-names>J. S.</given-names></name><name><surname>de Vries</surname><given-names>B.</given-names></name><name><surname>Geilenkirchen</surname><given-names>M. A.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>A novel SLC2A1 mutation linking hemiplegic migraine with alternating hemiplegia of childhood</article-title>. <source/>Cephalalgia
<volume>35</volume>, <fpage>10</fpage>–<lpage>15</lpage>. <pub-id pub-id-type="doi">10.1177/0333102414532379</pub-id><pub-id pub-id-type="pmid">24824604</pub-id></mixed-citation>
</ref>
<ref id="B311">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenk</surname><given-names>G. L.</given-names></name><name><surname>Walker</surname><given-names>L. C.</given-names></name><name><surname>Price</surname><given-names>D. L.</given-names></name><name><surname>Cork</surname><given-names>L. C.</given-names></name></person-group> (<year>1991</year>). <article-title>Loss of NMDA, but not GABA-A, binding in the brains of aged rats and monkeys</article-title>. <source/>Neurobiol. Aging
<volume>12</volume>, <fpage>93</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1016/0197-4580(91)90047-N</pub-id><pub-id pub-id-type="pmid">1646968</pub-id></mixed-citation>
</ref>
<ref id="B312">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wieronska</surname><given-names>J. M.</given-names></name><name><surname>Zorn</surname><given-names>S. H.</given-names></name><name><surname>Doller</surname><given-names>D.</given-names></name><name><surname>Pilc</surname><given-names>A.</given-names></name></person-group> (<year>2016</year>). <article-title>Metabotropic glutamate receptors as targets for new antipsychotic drugs: historical perspective and critical comparative assessment</article-title>. <source/>Pharmacol. Ther.
<volume>157</volume>, <fpage>10</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2015.10.007</pub-id><pub-id pub-id-type="pmid">26549541</pub-id></mixed-citation>
</ref>
<ref id="B313">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilcox</surname><given-names>R.</given-names></name><name><surname>Brænne</surname><given-names>I.</given-names></name><name><surname>Brüggemann</surname><given-names>N.</given-names></name><name><surname>Winkler</surname><given-names>S.</given-names></name><name><surname>Wiegers</surname><given-names>K.</given-names></name><name><surname>Bertram</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Genome sequencing identifies a novel mutation in ATP1A3 in a family with dystonia in females only</article-title>. <source/>J. Neurol.
<volume>262</volume>, <fpage>187</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1007/s00415-014-7547-9</pub-id><pub-id pub-id-type="pmid">25359261</pub-id></mixed-citation>
</ref>
<ref id="B314">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wink</surname><given-names>D. A.</given-names></name><name><surname>Cook</surname><given-names>J. A.</given-names></name><name><surname>Pacelli</surname><given-names>R.</given-names></name><name><surname>DeGraff</surname><given-names>W.</given-names></name><name><surname>Gamson</surname><given-names>J.</given-names></name><name><surname>Liebmann</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>1996</year>). <article-title>The effect of various nitric oxide-donor agents on hydrogen peroxide-mediated toxicity: a direct correlation between nitric oxide formation and protection</article-title>. <source/>Arch. Biochem. Biophys.
<volume>331</volume>, <fpage>241</fpage>–<lpage>248</lpage>. <pub-id pub-id-type="doi">10.1006/abbi.1996.0304</pub-id><pub-id pub-id-type="pmid">8660704</pub-id></mixed-citation>
</ref>
<ref id="B315">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>S. B.</given-names></name><name><surname>Cheng</surname><given-names>S. J.</given-names></name><name><surname>Hung</surname><given-names>W. C.</given-names></name><name><surname>Lee</surname><given-names>W. T.</given-names></name><name><surname>Min</surname><given-names>M. Y.</given-names></name></person-group> (<year>2015</year>). <article-title>Rosiglitazone suppresses <italic>in vitro</italic> seizures in hippocampal slice by inhibiting presynaptic glutamate release in a model of temporal lobe epilepsy</article-title>. <source/>PLoS ONE
<volume>10</volume>:<fpage>e0144806</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0144806</pub-id><pub-id pub-id-type="pmid">26659605</pub-id></mixed-citation>
</ref>
<ref id="B316">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>V. C.</given-names></name><name><surname>Kwong</surname><given-names>A. K.</given-names></name></person-group> (<year>2015</year>). <article-title>ATP1A3 mutation in a Chinese girl with alternating hemiplegia of childhood–Potential target of treatment?</article-title>
<source/>Brain Dev.
<volume>37</volume>, <fpage>907</fpage>–<lpage>910</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2015.01.003</pub-id><pub-id pub-id-type="pmid">25662428</pub-id></mixed-citation>
</ref>
<ref id="B317">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>A. L.</given-names></name><name><surname>James</surname><given-names>P. F.</given-names></name><name><surname>Lingrel</surname><given-names>J. B.</given-names></name></person-group> (<year>1999</year>). <article-title>Characterization of the fourth alpha isoform of the Na,K-ATPase</article-title>. <source/>J. Membr. Biol.
<volume>169</volume>, <fpage>39</fpage>–<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1007/PL00005899</pub-id><pub-id pub-id-type="pmid">10227850</pub-id></mixed-citation>
</ref>
<ref id="B318">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Z.</given-names></name><name><surname>Xie</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>The Na/K-ATPase-mediated signal transduction as a target for new drug development</article-title>. <source/>Front. Biosci.
<volume>10</volume>, <fpage>3100</fpage>–<lpage>3109</lpage>. <pub-id pub-id-type="doi">10.2741/1766</pub-id><pub-id pub-id-type="pmid">15970564</pub-id></mixed-citation>
</ref>
<ref id="B319">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamasaki</surname><given-names>M.</given-names></name><name><surname>Okada</surname><given-names>R.</given-names></name><name><surname>Takasaki</surname><given-names>C.</given-names></name><name><surname>Toki</surname><given-names>S.</given-names></name><name><surname>Fukaya</surname><given-names>M.</given-names></name><name><surname>Natsume</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Opposing role of NMDA receptor GluN2B and GluN2D in somatosensory development and maturation</article-title>. <source/>J. Neurosci.
<volume>34</volume>, <fpage>11534</fpage>–<lpage>11548</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1811-14.2014</pub-id><pub-id pub-id-type="pmid">25164652</pub-id></mixed-citation>
</ref>
<ref id="B320">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>X.</given-names></name><name><surname>Gao</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Xu</surname><given-names>X.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Wu</surname><given-names>X.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>ATP1A3 mutations and genotype-phenotype correlation of alternating hemiplegia of childhood in Chinese patients</article-title>. <source/>PLoS ONE
<volume>9</volume>:<fpage>e97274</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0097274</pub-id><pub-id pub-id-type="pmid">24842602</pub-id></mixed-citation>
</ref>
<ref id="B321">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yankner</surname><given-names>B. A.</given-names></name><name><surname>Lu</surname><given-names>T.</given-names></name><name><surname>Loerch</surname><given-names>P.</given-names></name></person-group> (<year>2008</year>). <article-title>The aging brain</article-title>. <source/>Annu. Rev. Pathol.
<volume>3</volume>, <fpage>41</fpage>–<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.pathmechdis.2.010506.092044</pub-id><pub-id pub-id-type="pmid">18039130</pub-id></mixed-citation>
</ref>
<ref id="B322">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ye</surname><given-names>Q.</given-names></name><name><surname>Lai</surname><given-names>F.</given-names></name><name><surname>Banerjee</surname><given-names>M.</given-names></name><name><surname>Duan</surname><given-names>Q.</given-names></name><name><surname>Li</surname><given-names>Z.</given-names></name><name><surname>Si</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Expression of mutant alpha1 Na/K-ATPase defective in conformational transition attenuates Src-mediated signal transduction</article-title>. <source/>J. Biol. Chem.
<volume>288</volume>, <fpage>5803</fpage>–<lpage>5814</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M112.442608</pub-id><pub-id pub-id-type="pmid">23288841</pub-id></mixed-citation>
</ref>
<ref id="B323">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yokoi</surname><given-names>M.</given-names></name><name><surname>Kobayashi</surname><given-names>K.</given-names></name><name><surname>Manabe</surname><given-names>T.</given-names></name><name><surname>Takahashi</surname><given-names>T.</given-names></name><name><surname>Sakaguchi</surname><given-names>I.</given-names></name><name><surname>Katsuura</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>1996</year>). <article-title>Impairment of hippocampal mossy fiber LTD in mice lacking mGluR2</article-title>. <source/>Science
<volume>273</volume>, <fpage>645</fpage>–<lpage>647</lpage>. <pub-id pub-id-type="doi">10.1126/science.273.5275.645</pub-id><pub-id pub-id-type="pmid">8662555</pub-id></mixed-citation>
</ref>
<ref id="B324">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zahn</surname><given-names>J. M.</given-names></name><name><surname>Poosala</surname><given-names>S.</given-names></name><name><surname>Owen</surname><given-names>A. B.</given-names></name><name><surname>Ingram</surname><given-names>D. K.</given-names></name><name><surname>Lustig</surname><given-names>A.</given-names></name><name><surname>Carter</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>AGEMAP: a gene expression database for aging in mice</article-title>. <source/>PLoS Genet.
<volume>3</volume>:<fpage>e201</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.0030201</pub-id><pub-id pub-id-type="pmid">18081424</pub-id></mixed-citation>
</ref>
<ref id="B325">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zanotti-Fregonara</surname><given-names>P.</given-names></name><name><surname>Vidailhet</surname><given-names>M.</given-names></name><name><surname>Kas</surname><given-names>A.</given-names></name><name><surname>Ozelius</surname><given-names>L. J.</given-names></name><name><surname>Clot</surname><given-names>F.</given-names></name><name><surname>Hindie</surname><given-names>E.</given-names></name><etal></etal></person-group> (<year>2008</year>). <article-title>[123I]-FP-CIT and [99mTc]-HMPAO single photon emission computed tomography in a new sporadic case of rapid-onset dystonia-parkinsonism</article-title>. <source/>J. Neurol. Sci.
<volume>273</volume>, <fpage>148</fpage>–<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1016/j.jns.2008.06.033</pub-id><pub-id pub-id-type="pmid">18675996</pub-id></mixed-citation>
</ref>
<ref id="B326">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zennaro</surname><given-names>M. C.</given-names></name><name><surname>Boulkroun</surname><given-names>S.</given-names></name><name><surname>Fernandes-Rosa</surname><given-names>F.</given-names></name></person-group> (<year>2015</year>). <article-title>An update on novel mechanisms of primary aldosteronism</article-title>. <source/>J. Endocrinol.
<volume>224</volume>, <fpage>R63</fpage>–<lpage>R77</lpage>. <pub-id pub-id-type="doi">10.1530/joe-14-0597</pub-id><pub-id pub-id-type="pmid">25424518</pub-id></mixed-citation>
</ref>
<ref id="B327">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeron</surname><given-names>M. M.</given-names></name><name><surname>Hansson</surname><given-names>O.</given-names></name><name><surname>Chen</surname><given-names>N.</given-names></name><name><surname>Wellington</surname><given-names>C. L.</given-names></name><name><surname>Leavitt</surname><given-names>B. R.</given-names></name><name><surname>Brundin</surname><given-names>P.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease</article-title>. <source/>Neuron
<volume>33</volume>, <fpage>849</fpage>–<lpage>860</lpage>. <pub-id pub-id-type="doi">10.1016/S0896-6273(02)00615-3</pub-id><pub-id pub-id-type="pmid">11906693</pub-id></mixed-citation>
</ref>
<ref id="B328">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>D.</given-names></name><name><surname>Hou</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Lin</surname><given-names>A.</given-names></name><name><surname>Jarzylo</surname><given-names>L.</given-names></name><name><surname>Navis</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Na,K-ATPase activity regulates AMPA receptor turnover through proteasome-mediated proteolysis</article-title>. <source/>J. Neurosci.
<volume>29</volume>, <fpage>4498</fpage>–<lpage>4511</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.6094-08.2009</pub-id><pub-id pub-id-type="pmid">19357275</pub-id></mixed-citation>
</ref>
<ref id="B329">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L. N.</given-names></name><name><surname>Sun</surname><given-names>Y. J.</given-names></name><name><surname>Wang</surname><given-names>L. X.</given-names></name><name><surname>Gao</surname><given-names>Z. B.</given-names></name></person-group> (<year>2016</year>). <article-title>Glutamate Transporters/Na(+), K(+)-ATPase Involving in the Neuroprotective Effect as a Potential Regulatory Target of Glutamate Uptake</article-title>. <source/>Mol. Neurobiol.
<volume>53</volume>, <fpage>1124</fpage>–<lpage>1131</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-014-9071-4</pub-id><pub-id pub-id-type="pmid">25586061</pub-id></mixed-citation>
</ref>
<ref id="B330">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Levy</surname><given-names>D.</given-names></name><name><surname>Noseda</surname><given-names>R.</given-names></name><name><surname>Kainz</surname><given-names>V.</given-names></name><name><surname>Jakubowski</surname><given-names>M.</given-names></name><name><surname>Burstein</surname><given-names>R.</given-names></name></person-group> (<year>2010</year>). <article-title>Activation of meningeal nociceptors by cortical spreading depression: implications for migraine with aura</article-title>. <source/>J. Neurosci.
<volume>30</volume>, <fpage>8807</fpage>–<lpage>8814</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0511-10.2010</pub-id><pub-id pub-id-type="pmid">20592202</pub-id></mixed-citation>
</ref>
<ref id="B331">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhuo</surname><given-names>M.</given-names></name><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Schultz</surname><given-names>C.</given-names></name><name><surname>Kandel</surname><given-names>E. R.</given-names></name><name><surname>Hawkins</surname><given-names>R. D.</given-names></name></person-group> (<year>1994</year>). <article-title>Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation</article-title>. <source/>Nature
<volume>368</volume>, <fpage>635</fpage>–<lpage>639</lpage>. <pub-id pub-id-type="doi">10.1038/368635a0</pub-id><pub-id pub-id-type="pmid">7908417</pub-id></mixed-citation>
</ref>
<ref id="B332">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zolotarjova</surname><given-names>N.</given-names></name><name><surname>Ho</surname><given-names>C.</given-names></name><name><surname>Mellgren</surname><given-names>R. L.</given-names></name><name><surname>Askari</surname><given-names>A.</given-names></name><name><surname>Huang</surname><given-names>W. H.</given-names></name></person-group> (<year>1994</year>). <article-title>Different sensitivities of native and oxidized forms of Na+/K(+)-ATPase to intracellular proteinases</article-title>. <source/>Biochim. Biophys. Acta
<volume>1192</volume>, <fpage>125</fpage>–<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1016/0005-2736(94)90152-X</pub-id><pub-id pub-id-type="pmid">8204642</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>